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ABSTRACT 
 
Scott A. Davis: Meducation: A Randomized Controlled Trial of an Online Educational Video 
Intervention to Improve Glaucoma Eye Drop Technique and Adherence 
(Under the direction of Betsy Sleath) 
 
 
 Glaucoma is the second-leading cause of blindness in the United States. Progression of 
glaucoma can be prevented by reducing intraocular pressure using eye drop medications, but 
patients tend to have difficulty instilling eye drops correctly. Short educational videos may be 
helpful to instruct patients on correct eye drop instillation, but only one small study testing an 
educational video for glaucoma eye drop technique has been performed to date. Therefore, the 
objective of this dissertation was to determine the effectiveness of an online video intervention in 
improving self-efficacy, technique, and adherence to eye drops in glaucoma patients. 
 Ninety-two patients with glaucoma, who self-administered their own eye drops and had 
less than perfect technique, were enrolled in this pilot randomized controlled trial. They were 
randomized to watch the Meducation® eye drop technique video in the intervention group, or a 
nutrition video in the control group. Five eye drop technique steps were assessed using objective 
video recordings at baseline, immediately after the video, and 1 month later. The secondary 
outcomes were eye drop technique self-efficacy and medication adherence. Linear regression 
models were used to determine whether the intervention group had better self-efficacy, 
technique, and adherence than the control group after adjusting for important covariates. 
 iv 
 Adjusted for baseline self-efficacy, intervention patients had better eye drop technique 
self-efficacy than controls immediately after the video (p=0.024) and at 1 month (p=0.015). 
Adjusted for baseline technique and other covariates, eye drop technique averaged 0.75 steps 
better in intervention patients than controls immediately after the video (p=0.002) and 0.63 steps 
better at 1 month (p=0.011). The intervention did not significantly improve adherence. 
Participants’ mean rating of usefulness of the video was 3.40 on a 4-point scale. Patients’ most 
preferred method for having access to the intervention was in the doctor’s office exam room, but 
also desired online options for watching the video. 
We concluded that a short educational video can significantly improve glaucoma 
patients’ self-efficacy and eye drop technique. The video should be disseminated in multiple 
ways: in the exam room when drops are prescribed as well as online.  
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Chapter 1: Introduction 
 
1.1 Overview	
Glaucoma affects over 2 million Americans, and about one-sixth of cases eventually 
result in blindness.1,2 Eye drops are the first-line treatment for patients with glaucoma, aiming to 
decrease intraocular pressure (IOP).3 Proper eye drop technique involves multiple steps to instill 
the medication into the eye for maximum effectiveness without contamination. However, in 
today’s rushed and overburdened clinical settings, many patients are prescribed eye drops with 
little or no instruction on proper self-administration technique.4,5 When patients do not instill eye 
drops correctly, their clinical outcomes can be negatively affected.5 Glaucoma that is not 
effectively treated with eye drops can lead to blindness or the need for eye surgery. Therefore, 
improving technique and adherence to eye drop therapy is a major unmet need that can likely be 
addressed by novel educational interventions. 
Short instructional videos that can be watched on a website, tablet, or smartphone, offer 
the potential to instruct patients either during or after clinic visits, with little or no time burden to 
the provider. Animated videos can be provided in multiple languages. The Meducation® system 
(Polyglot Systems, Morrisville, NC) has shown success with improving inhaler technique in 
asthma6 and adherence to daily medication for cardiovascular conditions.7 Although many eye 
drop technique videos exist on YouTube and other websites, no peer-reviewed literature has 
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evaluated any of these videos to determine whether they actually improve eye drop technique in 
glaucoma patients. Existing YouTube videos do not cover all the important steps in correct eye 
drop technique, and often use language that is too difficult for low literate patients, who tend to 
have the greatest need for education to improve their technique and adherence.8 The new 
Meducation eye drop technique video is designed to explain all the major technique steps in 
more accessible language. This dissertation evaluated the impact of the Meducation eye drop 
technique video on technique and adherence in a randomized controlled trial of glaucoma 
patients, making this the first study to evaluate the effectiveness of an eye drop technique online 
video intervention. 
 
1.2 Specific	Aims	
A major reason that glaucoma patients do not achieve proper control of intraocular 
pressure, which can potentially lead to blindness, is patients’ improper eye drop instillation 
technique. In a recent study, 60% of patients contaminated their eye drop bottle by touching the 
eye or face with the bottle tip, 10% missed the eye, and 49% wasted drops by not squeezing the 
bottle to produce exactly one drop.9 Just 18.5% of patients reported that their physicians had 
explained correct technique to them.5 Indeed, physicians usually lack adequate time to instruct 
patients on the proper use of eye drops,9 so there is an urgent need for effective methods to 
communicate proper technique to patients with minimal time burden to providers. 
Educational videos are a promising method for patient education on self-management of 
chronic diseases, but only one small study, and no randomized controlled trials, have specifically 
used video instruction to improve patients’ eye drop technique.10 In that study (n=34), Feng et al. 
used a video plus educational handout and observed an improvement in average technique score 
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from 2.53 out of 15 points at baseline, to 6.15 points immediately after the intervention 
(p=0.008).10 The only other intervention studies addressing eye drop technique focused on either 
a mechanical dosing aid, live provider education, or printed instructions to educate patients.11,12 
Given the gap in knowledge of interventions to improve eye drop technique in glaucoma, and the 
research gap in evaluating the effectiveness of eye drop technique videos, an effective video 
intervention offers considerable potential to teach patients proper technique and improve their 
outcomes, while saving the healthcare system the costs of improperly instilled eye drops. Social 
Cognitive Theory states that improving patients’ self-efficacy to perform a health behavior 
correctly is the key to enabling continued regular performance of the behavior.13 This study 
tested the Meducation® eye drop technique video developed by Polyglot Systems, a company 
that makes educational materials for low literate patients, to see how well it can improve eye 
drop technique. The video instructs patients on all the critical steps of proper eye drop technique 
and has not yet been tested in a real-world population. The video can be made accessible on 
mobile devices and at home so that patients can watch it anytime, at their convenience. Our 
overall objective was to determine how well a video works to improve patients’ eye drop 
technique self-efficacy, technique, and adherence to treatment. Our central hypothesis was that 
glaucoma patients who watch the Meducation video would have improved self-efficacy, 
technique, and adherence compared to patients who receive standard care. 
Therefore, we conducted a randomized controlled trial in which 92 glaucoma patients 
either watched the Meducation video or received standard care. Those in the experimental group 
watched the Meducation video, and those in the control group watched a 3-minute nutrition 
video on cooking with whole grains. To be enrolled, patients had to self-administer their eye 
drops and perform at least one eye drop instillation step incorrectly. Patients were recruited at an 
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academic ophthalmology clinic in suburban North Carolina and a private practice in urban 
Maryland. Eye drop technique was objectively assessed by video recording at three time points: 
before watching the video, immediately after watching the video, and at 1-month follow-up. This 
trial was expected to achieve the following specific aims: 
Aim 1: To determine whether glaucoma patients’ eye drop self-efficacy and technique are 
improved immediately after watching a video instructing them on proper technique. 
The primary comparison was the number of steps performed correctly immediately after 
watching the Meducation or nutrition video by members of the intervention group 
compared to members of the control group. 
Aim 2: To determine whether intervention patients have better self-efficacy, eye drop 
technique, and medication adherence than control patients at 1 month after study 
enrollment. 
The primary comparison was the number of steps performed correctly at 1 month by 
members of the intervention group compared to members of the control group. 
Aim 3: To describe patient perspectives on how to improve the video and how to disseminate 
it to other glaucoma patients. 
Patients completed interview questions at the end of the study on improving the video 
and disseminating it to other patients. 
 
Completion of these aims is expected to fill a significant gap in our understanding of how 
providers can use videos to educate patients about correct eye drop technique at a very low cost 
with minimal time burden. The video intervention also has the potential to be disseminated 
nationwide with minimal resources. Patients who have improved technique will likely avoid loss 
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of vision, and will be less likely to incur unnecessary costs by wasting medication. If the video is 
effective, providers may benefit from being able to improve patient satisfaction and reach 
patients with evidence-based instruction that is easily understood, even by low literate patients. 
 
1.3	Significance	
Glaucoma is a chronic eye disease that is one of the leading causes of blindness in the 
United States, especially in African Americans.1,2,14 Eye drops are the usual treatment to prevent 
progression of glaucoma,3 but are difficult to use properly.15 Studies show that more than half of 
patients contaminate the tip of the eye drop bottle by touching their eye or face.5,9 Patients also 
frequently miss the eye or waste drops by not squeezing the bottle correctly. These problems 
with technique can prevent patients from reaping the full benefit of the medications, can give rise 
to unanticipated eye infections, and may cause patients to become frustrated and discontinue the 
regimen altogether.16 Health disparities also exist in eye drop technique and adherence; African 
American race and lower educational level tend to be associated with worse technique and 
adherence.4,9,17 
Studies show that healthcare providers usually lack time during clinical visits to educate 
patients adequately on correct eye drop technique.9,18 Thus, interventions that can be delivered 
outside the clinical setting are needed to promote correct eye drop technique.19 Yet few such 
interventions have been developed and evaluated. The only study using a video was a pre-post 
study of 34 participants by Feng et al., which showed an improvement from an average score of 
2.53 out of 15 possible points before the video, to 6.15 points after (p=0.008).10 Another study by 
McVeigh and Vakros investigated an educational intervention, which consisted of a printed eye 
drop chart with detailed instructions. This intervention increased performance of hand washing 
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from 64% to 92%, shaking the bottle from 40% to 84%, and punctal occlusion from 44% to 
72%.11 However, technique was assessed by self-report; thus, patients may have overestimated 
their improvement. The design also lacked a control group, and patients failed to show 
improvement in instilling exactly one drop and avoiding contamination of the bottle tip. In 
addition, although not directly addressing technique, Okeke et al. showed that a multifaceted 
intervention consisting of an educational video, reminders, and a review of barriers with a study 
coordinator significantly improved adherence to glaucoma eye drops.19 However, there were no 
data on the effect of the video alone, and the intervention appeared less effective in African 
American patients. 
Educational interventions using short videos have shown success in other diseases, 
catering to many patients’ preferences for visual learning, and allowing repetition as many times 
as necessary to learn complex skills.6,7 The Meducation® system developed by Polyglot Systems 
consists of customizable printed materials and videos in 21 languages that can be accessed online 
or on smartphones. The new Meducation video on eye drop technique explains each of the 5 
critical steps in plain language, very much like a clinician would demonstrate the procedure to 
patients. The present pilot randomized controlled trial assessed patients’ technique self-efficacy, 
eye drop instillation technique, and medication adherence immediately and 1 month after 
watching the Meducation video. In addition to the specific features of the Meducation video and 
the fact that it can be accessed online, this study was expected to be an advance over prior 
studies because it used a randomized controlled design, included a 1-month return visit to 
measure intervention effect over a period of time, was well powered (n=92, providing 80% 
power to detect a difference in technique between intervention and control groups), and also 
assessed the relationship between technique and medication adherence. Intervention group 
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patients viewed the 4-minute Meducation video in the clinic and had online access to view it 
again at home by computer or smartphone, while control group patients viewed a 3-minute 
nutrition video called “How to Cook with Budget Friendly Whole Grains”. We anticipated that 
the study results would be significant because patients who successfully learn better eye drop 
technique can have a greatly improved chance of performing the crucial skill of eye drop 
instillation correctly, without added burden to overworked clinicians. 
This study was also innovative because it assesses eye drop technique objectively by 
video recording and used a masked observer to score each patient’s technique. Some studies, 
such as the previous intervention study by McVeigh and Vakros, used a self-report 
questionnaire, which is too reliant on patients’ ability to assess and report their own performance 
accurately.11 Feng et al. video-recorded each patient’s technique, but the recordings were scored 
by an unmasked researcher.10 Another intervention study by Lazcano-Gomez et al. used video 
recording and showed significant improvements in technique, but required a great deal of 
physician time to educate the patients.12 Observational studies have also found video recording 
of eye drop technique to be highly reliable and effective.9 The present study combined the best 
available method of technique assessment – video recording of the patient’s technique – with a 
practical intervention that takes essentially no clinician time to deliver. 
If successful, the Meducation video can be disseminated to millions of patients on clinic 
websites, in waiting rooms, or via YouTube. By enabling more patients to successfully manage 
their glaucoma by using eye drops correctly, costs to both the healthcare system and society may 
be reduced. Patients who avoid vision loss may preserve their ability to stay in the workforce or  
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perform more tasks of daily living independently, avoiding expensive long-term care costs. 
Future studies will assess the impact of the Meducation video on clinical outcomes and long-
term effects of avoiding vision loss.  
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Chapter 2: Literature Review 
	
2.1	Glaucoma:	Importance	and	Disease	Burden	
2.1.1	Disease	characteristics	
 Primary open-angle glaucoma (POAG) is a common, chronic, progressive eye 
disease.20,21 Glaucoma is characterized by elevated intraocular pressure (IOP), which gradually 
leads to several adverse consequences to different parts of the eye.20 In POAG, increased 
resistance to aqueous humor drainage through the trabecular meshwork keeps IOP elevated, 
whereas in primary angle-closure glaucoma (PACG), the drainage pathways tend to be 
obstructed by the iris.20 The result of the increasing IOP is stress and strain on the posterior part 
of the eye, especially the lamina cribrosa. As glaucoma progresses, the retinal ganglion cells and 
their axons gradually suffer degeneration, which leads to a gradual narrowing of the range of 
vision until complete blindness may result.22 
 Despite a strong correlation between IOP and glaucoma symptoms, there is not a certain 
level of IOP that is necessarily associated with glaucoma.21,22 Some patients with relatively 
normal IOP can have damage from glaucoma, while some patients with elevated IOP may not 
ever develop glaucoma. Therefore, glaucoma must be diagnosed by inspecting the optic nerve 
head and retinal nerve fiber layer using an ophthalmoscope, examining optic nerve head 
photographs, or any of several more advanced methods.20 Glaucoma is asymptomatic in its early 
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stages, so patients often do not realize that they have it until they start to lose vision. Therefore, it 
is important to screen for glaucoma every 1-2 years in patients ages 65 or older, and also 
consider regular screening in younger patients who are African American or have a family 
history of glaucoma.20-22 
 PACG usually must be treated with surgery, unlike POAG, which can be treated with 
topical medications to lower IOP (see section 2.2 below).20 The pathophysiology of PACG is 
substantially different, and since PACG is usually not susceptible to management with 
medications, the present study focused on POAG. PACG is more common in Asian populations, 
particularly in China and India, and relatively less common in populations of African or 
European descent.21 It is estimated that 80% of cases of glaucoma in the United States are 
POAG.20 Our clinics treat many more patients with POAG than PACG, so the availability of 
study subjects was anticipated to be adequate if we focused only on POAG. 
 
2.1.2	Prevalence	
 Glaucoma is estimated to affect 70 million people worldwide20 with the number expected 
to rise to 79.6 million by 2020.23 Worldwide, prevalence of open-angle glaucoma (OAG) is 
estimated to be greatest in African-descent populations, somewhat elevated in Latin American 
and Chinese populations, and lower in European, Indian, and Japanese populations.23 Seventy-
four percent of glaucoma sufferers worldwide in 2010 are estimated to have OAG, including 
89% in European populations and 96% in African populations, while angle-closure glaucoma 
accounts for nearly half the cases in China.23 
 In the United States, 2.71 million people were estimated to have POAG in 2011.24 The 
onset of glaucoma typically occurs after the age of 60.21 Glaucoma prevalence increases with 
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age, although leveling off in the oldest age groups; POAG affects 5.1% of the population aged 70 
to 79 and 4.0% aged 80 or older.24 Women account for slightly more of the cases than men, but 
after adjusting for the age distribution, both sexes have equal prevalence.24 Prevalence of POAG 
is much higher in African Americans (1.6%) and Latinos (1.4%) than in non-Hispanic Whites 
(0.6%).24,25 After adjustment for age, POAG prevalence may be as much as four to five times 
higher in African Americans than in Whites, starting at a younger age and ultimately reaching 
over 10% in African Americans age 80 or older.26 By 2050, an estimated 50% of POAG cases in 
the US may be in Latinos, as the Latino population continues to increase and Latino life 
expectancy also increases, especially for Latino men.24 Overall, the number of Americans with 
POAG is expected to almost triple to 7.32 million by 2050. 
	
2.1.3	Health	impact	
 Glaucoma is generally asymptomatic in its early stages, but then leads to a gradual 
constriction of the visual field in its advanced stages, ultimately resulting in total blindness for 
some patients.20 Due to the lack of symptoms in early glaucoma, only about 10-50% of people 
who have glaucoma are aware of their condition.20 However, as the disease progresses, the 
impact can rapidly become more severe, and an estimated 10% of glaucoma sufferers worldwide 
are blind in both eyes.23 Glaucoma is the second leading cause of blindness globally, and, in the 
US and other developed countries, only age-related macular degeneration causes more 
blindness.27 In a chart review by Peters et al., one-sixth of open-angle glaucoma patients 
eventually became bilaterally blind.2  
 POAG has a particularly profound effect on health-related quality of life in African 
Americans, both due to increased genetic susceptibility and less successful treatment compared 
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to White patients.22 Age-adjusted POAG prevalence is four to five times higher in African 
Americans,26 and African Americans were found to be 45% less likely to receive surgery than 
one would expect given the prevalence, strongly suggesting undertreatment in this population.14 
As a result, rates of blindness from glaucoma in African American patients were six to eight 
times higher than in White patients.26,28 To improve outcomes in African Americans with 
glaucoma, more frequent screening has been emphasized in the hope of detecting glaucoma 
earlier.3,22 Better medication treatment, including earlier initiation of eye drops and greater 
attention to ensuring correct usage of eye drops, is also a key to reducing the persistent racial 
disparity in glaucoma outcomes, as will be discussed in sections 2.3 and 2.4. 
 
2.1.4	Economic,	quality-of-life,	and	societal	impact	
 Due to the frequent vision loss and eventual blindness that often results from glaucoma, 
uncontrolled glaucoma is associated with substantial economic impact. Rein et al. estimated the 
economic burden from glaucoma at $2.9 billion direct costs in 2006.29 However, Varma et al. 
estimate that the burden could be twice as large if all patients were treated.30 For patients who 
become blind, indirect costs become the main reason for high costs.30 Data from a US setting are 
sparse, but a study in Europe estimated that the total costs associated with glaucoma-related 
blindness rise from 429-523 euros per patient to 11,578-19,111 euros once indirect costs, such as 
assistance provided by families or professional caregivers, are considered.31 Thus, preventing 
blindness with more attention to glaucoma treatment is probably cost-effective, despite the high 
cost of glaucoma medications.30,32,33 To the extent that there is debate about cost-effectiveness of 
IOP-lowering treatment, it concerns whether to treat people who have ocular hypertension but 
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have not yet been diagnosed with glaucoma.32 There is agreement that glaucoma, once 
diagnosed, must be treated. 
 Even relatively early-stage glaucoma can affect patient health-related quality of life 
(HRQOL).34 Negative HRQOL impact is associated in an approximately linear fashion with the 
extent of vision loss. Societal burden from glaucoma can include burden on caregivers when 
patients lose the ability to live independently due to loss of vision. Even for patients with less 
severe impairment, vision loss can hinder them from walking, reading, or driving, creating a 
significant impact on activities of daily living and causing them to require additional help from 
others to perform basic tasks.30,34,35 In addition, vision loss can start a downward spiral in quality 
of life if it impairs patients from being able to instill eye drops accurately into the eye, causing 
diminished medication effectiveness. This issue will be addressed in section 2.3. 
	
2.2	Treatments	for	Glaucoma:	The	Role	of	Eye	Drops	
2.2.1	Overview	of	glaucoma	treatments	
 Both medical and surgical options exist for treating POAG.36 All these options are 
directed at lowering IOP to prevent glaucoma progression and minimize the adverse 
consequences of POAG; lowering IOP receives a strong recommendation in the American 
Academy of Ophthalmology (AAO) Preferred Practice Pattern® Guidelines.36 In addition to 
managing the IOP in a target range, the goals of treatment also include maintaining a stable optic 
nerve and retinal nerve fiber layer (RNFL) status, and stable visual fields. The target IOP should 
be set at a value that is expected to maintain a patient’s vision and result in minimal quality-of-
life impact for the rest of the patient’s lifetime.36 There is good evidence that reducing IOP by 
25% substantially slows progression of glaucoma.36 However, a greater target reduction may be 
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desirable if a patient is already suffering rapid progression or major damage from glaucoma, or 
in the presence of additional risk factors such as a family history of poor outcomes from 
glaucoma.20,36 Meanwhile, a smaller target reduction may be chosen if a patient is particularly 
intolerant to treatment or has only a short life expectancy remaining.35,36 
 The main treatment options to lower patient IOP are medications, laser trabeculoplasty, 
and incisional glaucoma surgery.36 Medications are considered the first-line treatment for most 
patients, with multiple medications often being used when response to the first medication is 
suboptimal. Laser trabeculoplasty can be considered a first-line option for patients who are 
especially unable to adhere to a medication regimen or have intolerance to medications. For 
example, patients who are physically unable to instill eye drops and cannot obtain assistance 
from a caregiver may not be appropriate candidates for medication therapy.35 Incisional 
glaucoma surgery, such as trabeculectomy, is often associated with more complications, but can 
be considered first-line therapy in rare cases.20,36 Both laser trabeculoplasty and incisional 
glaucoma surgery can also be considered as second-line options when IOP is not effectively 
controlled by medications.20,36 However, most POAG patients will initially be prescribed 
medications, so there is a significant opportunity to improve glaucoma outcomes by addressing 
medication technique and adherence (see sections 2.3 and 2.4). 
 
2.2.2	Eye	drops	in	glaucoma	treatment	
 Guidelines suggest initiating medication therapy for POAG with topical medications, 
specifically eye drops.36 Prostaglandin analogs are the most common eye drops prescribed and 
generally considered the first-line therapy,20 but there are also several other categories of eye 
drops such as beta-blockers, alpha2-adrenergic agonists, parasympathomimetics, and carbonic 
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anhydrase inhibitors.36 Prostaglandin analogs are normally dosed once daily and include 
bimatoprost, latanoprost, and travoprost.35 A meta-analysis of 114 RCTs suggested that the 
prostaglandin analogs were the most effective, with bimatoprost showing the greatest mean IOP 
reduction, followed by latanoprost and travoprost.37 All the classes of drugs that were studied 
showed significant efficacy compared to placebo; however, the meta-analysis suggests that 
prostaglandin analogs may offer the best chance to achieve the recommended 25% IOP 
reduction.37 Latanoprost was the most commonly prescribed glaucoma medication in the United 
States in a study using 2006-2009 data.38 Both latanoprost and travoprost are now available as 
generics.39,40 Using the Clinformatics DataMart database, Stein et al. reported that adherence 
increased when patients switched from brand-name bimatoprost, latanoprost, or travoprost to 
generic latanoprost.39 Guidelines do not currently specify that any single prostaglandin analog 
should be preferred over the others.36 However, prescribing generics would help to alleviate cost-
related barriers.41 
 Barriers to successful real-world use of eye drops include difficulty instilling the eye 
drops correctly, as well as poor adherence for a variety of reasons, including cost, side effects, 
forgetfulness, complex regimens, running out of medication early, and beliefs that the 
medication will not help. These barriers will be discussed in detail in the next two sections. 
 
2.3	Eye	Drop	Technique	
2.3.1	Importance	
 Correct eye drop technique is critically important to reaping the full benefit of eye drops 
in preventing progression of glaucoma. This section will explain how poor eye drop technique is 
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widespread and results in patients not controlling their IOP, causing faster progression to 
blindness. 
 Correct eye drop technique requires a number of steps that are essential to get the 
medication into the conjunctival sac (or pocket) of the eye where it can confer the greatest 
benefit, while avoiding contamination of the bottle that can result in unwanted side effects. The 
steps that are addressed in the Meducation video are shown in Table 2.1. Polyglot Systems 
referenced the same resources reviewed in this dissertation, such as practice guidelines and 
evidence-based online instructional materials derived from the guidelines, when developing the 
video.42-49 
Table 2.1: Steps in eye drop technique11 
• Washing hands before instillation* 
• Mixing the medication by turning the bottle over* 
• Squeezing the bottle to instill a single drop 
• Holding open the lid with the finger  
• Getting the drop accurately into the eye 
• Not touching the bottle tip to the eye or face 
• Closing the eye after instillation 
• Punctal occlusion* 
• Removing excess fluid* 
*Cannot be measured in this study 
 
First, patients must wash their hands to keep the bottle sterile when they touch it. Second, 
they should mix the medication by turning the bottle over several times. Shaking the bottle 
introduces unwanted air bubbles, but turning the bottle over mixes the medication without 
creating air bubbles. Third, patients must squeeze the bottle firmly for just long enough to 
squeeze out one drop, not several drops or a stream of drops. The eye can only hold one drop, so 
squeezing out multiple drops, even if they are aimed accurately, tends to cause liquid to spill out 
of the eye and down the face. Fourth, patients must hold open the lower eyelid with the finger of 
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the non-dominant hand to expose the conjunctival sac. Fifth, patients must get the drop 
accurately into the eye. Sixth, they must not touch the eye or face with the bottle tip at any time, 
due to risk of contaminating the bottle with the facial microbiota. Seventh, they must close the 
eye after instillation. Eighth, they should perform punctal occlusion by placing the finger on the 
inside of the closed eye and exerting gentle pressure to prevent the medication from traveling 
through the tear duct into the nose. Finally, they should remove excess fluid from the face with a 
tissue. As described below in section 2.3.2, not touching the eye or face with the bottle is the 
most frequently missed step in the existing literature, followed by squeezing out more than one 
drop and getting the drop accurately into the eye.5,9,50,51 The other steps may also be problematic, 
but have rarely been assessed in studies. 
The present study did not assess 4 of the steps included in Table 2.1: hand washing, 
mixing the medication, punctal occlusion, and removing excess fluid. Although the 4 excluded 
steps are also among the steps covered in the Meducation video, objective video recording of 
technique is intended to make this study more rigorous, and the excluded steps cannot be directly 
observed. Mixing the medication is necessary only for some suspensions such as brinzolamide, 
while most glaucoma medications are solutions.52 Punctal occlusion is also not necessarily 
recommended by all ophthalmologists for all patients; gently closing the eye for one minute is 
considered an equivalent alternative.42 Many studies have assessed only three steps: squeezing 
the bottle to instill a single drop, getting the drop accurately into the eye, and not touching the 
bottle tip to the eye or face.5,9,53 At the opposite extreme, Feng et al. used a 15-point checklist, 
deducting points for making multiple attempts in each eye, and also including tilting the head 
back, looking up, replacing the bottle cap without touching the tip, and two separate items related 
to contaminating the bottle.10 McVeigh and Vakros (using self-report) assessed 12 steps, 
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including waiting 5 minutes between instilling multiple eye drops, using drops before using 
ointments, and discarding the bottle after 28 days of use.11 The first two of these are only 
applicable to patients who use multiple eye drops or ointments in addition to eye drops, and 
discarding the bottle after 28 days cannot be objectively assessed.  
 The consequences of incorrect technique can be severe in terms of both effectiveness and 
safety. In addition to low medication effectiveness from not getting the medication correctly into 
the eye, poor eye drop technique can include contamination of the bottle and consequent eye 
infection with the microorganisms that grow on the contaminated bottle (infectious 
keratoconjunctivitis).12,54 Eye infection can be painful and can itself endanger vision. 
In addition, patients who routinely squeeze the bottle incorrectly, producing multiple 
drops or a stream of drops, are likely to run out of drops more quickly than intended. They may 
not be able to obtain a new supply of drops until the next date they are allowed to get a refill. 
Even if they are allowed to get a refill sooner, eye drops are expensive at approximately $62 out-
of-pocket for a 5 mL bottle,55 and patients may not be able to afford the cost. By needing extra 
refills, patients who waste drops also incur unnecessary costs to the broader healthcare system, 
including Medicare, Medicaid, and private payers. Wong et al. performed a cost-consequence 
analysis of bimatoprost 0.01% versus bimatoprost 0.03% and estimated that $3433 could be 
saved over each patient’s lifetime by using bimatoprost 0.01% instead of bimatoprost 0.03%, due 
to savings in medical resource use from the better average adherence to bimatoprost 0.01%.55 
These results did not take into account imperfect technique, and therefore the more adherent 
bimatoprost 0.01% patients were assumed to incur $466 more in drug costs over their lifetime, 
which was outweighed by a $3900 savings in non-drug costs such as medical visits, skilled 
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nursing facility care, and home healthcare. Therefore, the results may be even more dramatic if 
poor technique is taken into account.  
 
2.3.2	Observational	studies	on	eye	drop	technique	
Patients report receiving little education from their providers on eye drop technique.5,56 
Just 18.5% of patients in the study by Gupta et al. in India reported receiving instruction from 
their physician on correct technique.5 Similarly, in a study of 738 patients by Cohen Castel et al. 
in Israel, 16% of patients reported being explained eye drop technique by their family 
physician.56 In a US context, in a large observational study where the medical visit was 
videotaped, analysis of the videotapes revealed that only 40 of 255 patients (16%) received 
instruction about eye drop administration.9 Patients who did not have questions about eye drop 
administration had 4.8 times the odds of instilling exactly one drop as those who had at least one 
question, indicating that it is important to elicit questions from patients who may not have good 
understanding, and provide additional instruction if needed.9 Having received instruction on eye 
drop instillation has been associated with better technique.16 
Using the PubMed search terms “eye drop AND technique AND glaucoma”, 17 
observational studies were found that collected data on eye drop technique (Table 2.2a). Most 
studies were in agreement that not getting the medication into the eye, touching the tip of the 
bottle to the eye or face, and wasting drops were a problem for a significant number of patients. 
Five studies found that more than half the patients touched the bottle tip to the eye or 
contaminated the bottle.5,9,12,50,57 
  
 Table 2.2a. Observational studies assessing eye drop instillation technique 
Author, Year Design Outcome Measure Results 
Hennessy 
201054 
Single-group 
observational, n=204 
Successful instillation of a 
drop onto the ocular 
surface from video 
recording of technique 
71% able to get any drops onto the ocular surface; 52% able to get exactly 1 drop 
onto the ocular surface; 39% able to get exactly 1 drop onto the ocular surface w/o 
touching ocular surface 
Hennessy 
201158 
Prospective observational 
of pts w/visual impairment, 
n=205 
Correct instillation 
measured by video 
recorded observation 
33% touched the eye with bottle tip; 29% could not get a drop into the eye 
Sleath 201153; 
Sleath 201259 
Longitudinal observational, 
n=102 
Video recording of 
technique 
38% had perfect technique; 80% got a drop in the eye on the first attempt; 70% 
instilled only 1 drop; 34% touched eye or eyelash with bottle tip; 52% touched face 
Tatham 201316 Cross-sectional 
observational, n=85 
Video recording of 
technique 
54.1% had poor technique; 11.8% missed eye, 15.3% touched tip of bottle to eye, 
27.1% touched tip of bottle to eyelid or lashes 
Strungaru 
201460 
Observational cross-
sectional, n=30 
Video recording of 
technique 
After implementing a mirror-hat drop delivery aid, 13% contaminated the bottle 
(p=0.02); 86.7% could see the drop with the device (p=0.0005) 
Sayner 20169; 
Carpenter 
201561 
Longitudinal observational, 
n=279 
Video recording of 
technique 
51% instilled exactly 1 drop; 90% got the drop in the eye on the first attempt; 60% 
touched the eye or face with the bottle tip; Provider education about adherence and 
provider inclusion of patient input into treatment plan predicted decrease in IOP; 
Relationships not mediated by adherence or eye drop technique 
Tsai 200718 Single-group observational 
survey, n=253 
Self-reported method of 
administering eye drops 
82.6% self-administered drops; 36.4% administered drops standing, 37.8% sitting, 
31.6% lying down; 16.3% used mirror; 36.4% always washed hands before 
administration; 25.4% always, usually, or sometimes touched their eye w/tip of bottle 
Kholdebarin 
200817 
Observational survey, 
n=500 
Self-reported 6.8% missed eye, 28.8% contaminated bottle when instilling drops 
Curtis 200962 Cross-sectional survey, 
n=100 
Self-reported (responses 
to questionnaire) 
23% did not know the names of their eye drops; 13% said they had problems 
instilling the drops; 49% correctly closed their eyes after instillation; 41% had poor 
understanding of glaucoma, 49% had partial understanding, 10% had good 
understanding 
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 Author, Year Design Outcome Measure Results 
Kawai-Tsuboi 
201563 
Single-group cohort, n=67 Self-reported (5-item 
questionnaire of technique 
and adherence) 
76.1% instilled exactly 1 drop; 62.7% instilled it accurately 
Taylor 200264 Focus groups, n=21 NA Most patients had misconceptions about technique, although they thought they 
knew the correct technique 
Brown 198457 Observational cross-
sectional, n=150 
Direct observation by 
examiner 
13% failed to instill drops in both eyes after one or more attempts; 80% 
contaminated the bottle; 82% claimed to have no difficulty using the medications 
properly; 21% unnecessarily tried to instill >1 drop in one or both eyes 
Hosoda 199550 Single-group 
observational, n=142 
Direct observation by 
examiner 
39.4% instilled one drop; 54.9% touched eye with tip of bottle 
Konstas 
200065 
Observational survey, 
n=100 
Direct observation by 
examiner 
53% very capable of instilling medication correctly 
Ikeda 200866 Single-group 
observational, n=27 
Direct observation by 
examiner 
20% performed entire technique correctly; 60% did not close eyes, 70% did not 
compress the nasolacrimal region after application; 63% reported they sometimes 
forgot to apply eye drops; 41% washed hands before using eye drops; 85% applied 
exactly one drop 
Gupta 20125 Single-group cohort, n=70 Direct observation by 
examiner 
Used 1.8 drops per instillation; 50% squeezed out exactly 1 drop; 68.6% did not 
misdirect the drop; 75.7% touched the eye with the bottle tip; 8.5% performed all 
steps correctly 
Schwartz 
201351 
Secondary analysis of 
RCT data, n=163 
Direct observation by 
examiner 
88.6% reported having no difficulty administering eye drops; 18.2% touched eye or 
adnexa with bottle; 10.3% missed eye; 11.3% administered more than 1 drop 
 
 
IOP, intraocular pressure; NA, not applicable; RCT, randomized controlled trial
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 Most studies assessed the eye drop technique steps of instilling exactly one drop, getting 
the drop accurately into the eye, and avoiding contamination of the bottle; a few also assessed 
hand washing, closing the eye after instillation, and punctal occlusion (Table 2.2a). 
Contaminating the bottle by touching the eye or face was the most frequently missed step. 
Reported rates of contaminating the bottle in eight different studies ranged from 18.2%51 to 80% 
(Table 2.2b).57 Two other studies reported separate estimates for touching multiple sites with the 
bottle; 34% of patients touched the eye or eyelash and 52% touched the face in the study by 
Sleath et al.,59 and 15.3% touched the eye and 27.1% touched the eyelid or lashes in the study by 
Tatham et al.16 The three studies with the lowest rates of contaminating the bottle used a self-
reported measure of technique17,18 or used patients already enrolled in an RCT;51 therefore, it is 
likely that the higher estimates are more accurate for typical patients. 
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Table 2.2b. Frequency of missing each eye drop technique step in observational studies 
Step (number of studies) Range of 
estimates of 
patients 
performing step 
incorrectly 
Estimates 
Contaminating the bottle (n=10) 18.2 – 80% 18.2%,51 25.4%,18 28.8%,17 33%,58 
54.9%,50 60%,9 75.7%,5 80%57, 34% 
(eye or eyelash) and 52% (face)59, 
15.3% (eye) and 27.1% (eyelid or 
lashes)16 
Instilling exactly one drop (n=7) 11.3 – 60.6% 11.3%,51 15%,66 23.9%,63 30%,53 
49%,9 50%,5 60.6%50 
Missing the eye (n=8) 6.8 – 37.3% 6.8%,17 10%,9 10.3%,51 11.8%,16 
20%,53 29%,58 31.4%,5 37.3%63 
Washing hands before 
instillation (n=1) 
59% 59%66 
Closing eyes after instillation 
(n=1) 
60% 60%66 
Compressing the nasolacrimal 
region after instillation (n=1) 
70% 70%66 
 
Instilling exactly one drop was another frequently missed step. The number of patients 
missing this step in seven different studies ranged from 11.3%51 to 60.6%.50 Missing the eye was 
not as frequent, but still a significant problem, performed incorrectly by 6.8%17 to 37.3%.63 
Poorer accuracy had consequences in the sense that it was correlated with more bottles used, 
which could cause patients to experience more cost-related barriers to adherence.63 In addition to 
contaminating the bottle, instilling a single drop, and missing the eye, the study by Ikeda et al. 
also measured several other steps with direct observation and found that only 41% washed their 
hands before instillation, 60% did not close their eyes after instillation, and 70% did not 
compress the nasolacrimal region after instillation.66  
Four studies stated that older age was associated with poorer technique.16,17,54,58 Other 
factors significantly associated with poorer technique included not having received instruction on 
 24 
eye drop technique,16 female gender,9 arthritis,9 more severe visual field defect,9 lack of positive 
reinforcement to take eye drops,61 lower educational level,9,17 low self-efficacy,59,61 and being 
seen at a clinic rather than a private practice.57 No effect of race has been observed in relation to 
technique in most studies, although Sayner et al. found that African Americans were less likely 
to touch their face with the bottle tip during instillation.9 However, given the wide racial 
disparity in glaucoma outcomes with respect to blindness,14 it is important to assess the potential 
differences in effect of the video intervention by race, so that health disparities may be 
minimized.  
The next section will turn to interventional studies addressing eye drop technique and 
their results. 
 
2.3.3	Outcomes	of	interventions	addressing	eye	drop	technique	
Only 8 studies included an intervention together with a control group or control phase 
that provided a basis for comparison (Table 2.2c). Six of these (75%) showed a significant 
benefit of the intervention on at least one main outcome measure, such as technique, specific 
steps in technique, or ease of use.10-12,67-69 Three of the six used a mechanical dosing aid or 
modification to the bottle to make eye drop instillation easier.67-69 In a crossover study, 
Nordmann et al. found that the Xal-Ease delivery device reduced the number of patients who 
needed help instilling their drops, the number who touched their eye with the bottle tip, and the 
number who often or always missed their eye with the drop.67,70 Stack and McKellar found that 
compared to a standard bottle, 87.5% of patients rated a black-tipped bottle (where the tip was 
painted black) as easier to use, and 67.5% used extra drops less frequently when using the black-
tipped bottle.68 Dietlein et al. found that patients age 80 or older were more able to open the 
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container with no help or explanation when a new single-dose bottle was used, compared to the 
standard bottle.69 The patients were also more likely to correctly get a drop into the corneo-
conjunctival area when they used the new bottle.69
 Table 2.2c. Intervention studies assessing eye drop instillation technique 
 
Author, 
Year 
Design Intervention Outcome 
Measure 
Results in intervention group or 
phase 
Results in control group or non-intervention 
phase 
Stack 
200468 
Pre-post 
intervention, 
n=40 
Black 
colored 
bottle tips 
Ease of use, 
technique 
87.5% said black tipped bottles were 
easier to use; 67.5% said they instilled 
extra drops less frequently with black 
tipped bottles 
NA 
Salyani 
200571 
Pre-post 
intervention, 
n=93 
Eye drop 
guide 
Scale of ease 
of use of the 
guide 
Mean rating of ease of use with guide: 
6.0 of 10 
Mean rating of ease of use without guide: 8.0 of 10 
(p<0.01) 
Dietlein 
200869 
Observational 
cross-
sectional, n=44 
New single-
dose bottle 
Direct 
observation by 
examiner 
Patients age >80 with new single-dose 
bottle: 34% opened container w/o help 
or explanation; 43% placed no drop on 
corneo-conjunctival area 
Patients age 50-65: 73% opened container w/o help 
or explanation (p=0.002); 5% placed no drop on 
corneo-conjunctival area (p=0.001); Patients age 
>80 using standard bottle: 64% opened container 
w/o help or explanation (p=0.009); 11% placed no 
drop on corneo-conjunctival area (p=0.003) 
Nordmann 
200967 
Randomized 
crossover, 
n=211 
Xal-Ease 
delivery 
device 
Self-reported 
technique 
6.9% would need someone to help with 
instillation (p<0.001); 3.2% touched eye 
with bottle tip (p<0.001); 62.4% rarely or 
never missed eye with drop (p=0.03) 
18.1% would need someone to help with instillation; 
35.6% touched eye with bottle tip; 49.9% rarely or 
never missed eye with drop 
McVeigh 
201511 
Pre-post 
intervention, 
n=25 
Printed eye 
drop chart 
tool 
Correct 
instillation 
(assessment 
method 
unclear) 
Hand hygiene: 92% (p=0.029); Shaking 
bottle before use: 84% (p=0.001); Tear 
ducts occlusion: 72% (p=0.015) 
Hand hygiene: 64%; Shaking bottle before use: 
40%; Tear ducts occlusion: 44% 
Lazcano-
Gomez 
201512 
Pre-post 
intervention, 
n=45 
Ophthalmol-
ogist 
education 
Video 
recording of 
technique 
Patients squeezed out mean of 1.2 
drops (p=0.011); 28.9% touched the 
eye or face with the bottle tip (p=0.05) 
Patients squeezed out mean of 1.5 drops; 64.4% 
touched eye or face with bottle tip 
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 Author, 
Year 
Design Intervention Outcome 
Measure 
Results in intervention group or 
phase 
Results in control group or non-intervention 
phase 
Al-Busaidi 
201672 
Observational 
cross-sectional 
study, n=55 
Small-group 
glaucoma 
educational 
sessions 
Video 
recording of 
technique 
16% of patients who attended a small-
group educational session had good 
technique (p=0.498) 
23% of patients who never attended an educational 
session had good technique 
Feng 201610 Pre-post 
intervention, 
n=34 
Educational 
video and 
handout 
Video 
recording of 
technique 
Average eye drop technique score post-
intervention: 6.15 of 15 points (p=0.008) 
Average eye drop technique score pre-intervention: 
2.53 points 
 
NA, not applicable; NS, not significant. All p-values represent between-group comparisons (intervention vs control).
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Three studies successfully used educational interventions to improve eye drop 
technique.10-12 Feng et al. performed a pre-post study of an educational video and handout, and 
found that the average technique score improved from 2.53 pre-intervention on a 15-point scale 
to 6.15 post-intervention (p=0.008).10 Out of 15 items assessed, four showed statistically 
significant improvements: holding open the eyelid, squeezing one drop into the pocket 
(conjunctival sac), closing the eye for 1 minute, and punctal occlusion.10 In a pre-post study of an 
eye drop chart explaining proper technique, McVeigh and Vakros found that hand hygiene, 
shaking the bottle before use, and tear duct occlusion occurred more frequently in the post-
intervention phase; nine other steps showed no significant improvement.11 In the other study, 
Lazcano-Gomez et al. measured eye drop instillation technique before and after the 
ophthalmologist provided instruction on technique.12 The patient’s initial technique was 
videotaped and the patient then watched the video with the ophthalmologist, who pointed out the 
patient’s mistakes and explained how to instill the eye drops correctly. After patients received 
education, the mean number of drops squeezed out of the bottle decreased from 1.5 to 1.2 
(p=0.011) and the percentage of patients who touched the eye or face declined from 64.4% to 
28.9% (p=0.05).12 
There were two exceptions to the generally successful results. Salyani and Birt found that 
the mean rating of ease of use of eye drops was actually worse after patients started using an eye 
drop guide – a device designed to direct the bottle accurately toward the eye – than before.71 Al-
Busaidi et al. found that both a group who attended glaucoma educational sessions and a group 
that did not attend had poor technique at the time of assessment more than 1 year later.72 Sixteen 
percent of people who attended the sessions had good technique, compared to 23% of those who 
did not attend (p=0.498). The majority of patients had attended the sessions at least 3 years 
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before the study was done, which may have been too long to retain any benefit from attending. 
Patients may have also received eye drop technique education from sources other than the 
hospital’s educational program, such as their pharmacists. 
 Since there have been only three intervention studies that used an educational 
intervention to improve technique, none of which were randomized or had control groups,10-12 
more studies of practical educational interventions are needed. The other studies used a 
mechanical delivery aid or modification to the bottle, which was helpful, but they have not been 
widely adopted.67-69 Even if mechanical delivery aids are used, patients still need to know how to 
get a single drop into the eye accurately without contaminating the bottle, so there still is a need 
for effective educational interventions. While the printed material intervention by McVeigh and 
Vakros showed some success, only three of twelve steps showed significant improvement after 
the intervention, the design lacked a control group, and a self-report measure of technique was 
used.11 Lazcano-Gomez et al. used objective video recording of technique, but the intervention 
required significant provider effort, and this study also lacked a control group.12 Feng et al. also 
showed improvement and used an objective technique measure, but their study was small and 
lacked a control group.10 No randomized controlled trials of educational interventions for eye 
drop technique have been published, and only one of the eye drop technique interventions used a 
video.10 Also, none of the existing studies measured the relationship between eye drop technique 
and adherence (see section 2.4.5 below). Therefore, a randomized study of an easily 
understandable educational video intervention, which is very practical for routine use and does 
not take significant time for clinicians to deliver, may be a significant advance in the field. 
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2.3.4	Measurement	of	eye	drop	technique	
This section will discuss the ways that eye drop technique has been measured and the 
benefits and drawbacks of each method. Of the 25 technique studies reviewed – 17 observational 
studies from Table 2.2a and 8 interventional studies from Table 2.2c – 9 studies measured 
technique by video recording the patient’s technique,9,10,12,16,53,54,58-61,72 8 asked patients to self-
report their technique (including one qualitative focus group study),17,18,62-65,70,71 6 studies 
involved direct observation by a study team member,5,50,51,57,66,69 and 2 did not state the technique 
assessment method clearly.11,68 
Self-report does not appear to have as much systematic error in relation to eye drop 
technique as for some other behaviors, such as medication adherence, in which self-report 
consistently underestimates adherence.17,18,63,67 Results of studies using self-report and 
objectively assessed eye drop technique have both found high rates of incorrect use (Table 2.2). 
Patients seem fairly willing to admit that they incorrectly perform eye drop instillation.17,18,63,67 
However, self-report may still be less reliable than more objective measures. 
 More objective measures of eye drop technique include direct observation and video 
recording. In direct observation, an observer watches the patient attempt to instill eye drops and 
completes a checklist of which steps on a list are correctly performed. Video recording of 
patients’ eye drop technique can be even better since it can allow multiple raters to watch the 
video, and then interrater reliability can be calculated. Even if multiple raters cannot be used, a 
masked observer can grade the patient’s performance, minimizing bias that might be introduced 
by an unmasked researcher. The main difficulty is that the video recording needs to be made 
carefully enough so that the viewer of the video can tell whether the patient performed the steps 
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correctly or not. In the observational study by Sayner et al., 34.9% of patients were graded as 
“unclear” on whether they squeezed the bottle to produce a single drop, 30.6% were graded as 
unclear whether they instilled a single drop, and 21.6% were graded as unclear on whether they 
touched their eye or face with the bottle tip.9 These problems often occurred because patients 
blocked the video camera, or the camera was out of focus.9 
 Video recording of technique was used in the present study because it is the most reliable 
way to know exactly which steps patients performed correctly, and unlike direct observation, 
video recording allows a masked assessor to score the patients’ technique. Self-reported 
technique can be biased if patients mistakenly think they have improved their technique but are 
still not performing some steps correctly. If a self-report measure were used, intervention group 
patients would probably be especially susceptible to reporting that they have improved their 
technique when they actually have not; it is not possible for subjects to be blinded to their group 
assignment. Therefore, it is especially important to measure technique objectively with video 
recording in this type of study. 
 
2.3.5	Eye	drop	technique	self-efficacy	and	its	measurement	
 According to Social Cognitive Theory (SCT), self-efficacy, or confidence in one’s ability 
to perform a behavior correctly, is one of the most important determinants of successful 
performance of health behaviors.13,73 Higher eye drop technique self-efficacy has been associated 
with better eye drop technique.53,59,74 In 2010, Sleath et al. developed a 35-item glaucoma self-
efficacy scale with a 21-item medication adherence subscale and a 14-item technique subscale.74  
In 2012, the investigators aimed to validate a shorter version of the technique scale and published 
a validated 6-item short version called the Eye Drop Technique Self-Efficacy Scale.59 This study 
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found that higher technique self-efficacy was associated with both a better ability to instill one 
drop, and a lower chance of touching the eye, eyelash, or face with the bottle.59 In another 
observational study of 102 patients using a 10-item short version of the adherence self-efficacy 
scale and the 6-item technique self-efficacy scale, subjects who had worse adherence and worse 
adherence self-efficacy had greater visual field defect severity, while eye drop technique and 
technique self-efficacy did not predict visual field defect severity.53  
Sayner et al. used the 6-item Eye Drop Technique Self-Efficacy Scale in a later study of 
279 patients and found no association between eye drop technique self-efficacy and correct 
technique in this population.9 It is unclear why this study found such a different result from the 
study that validated the scale. Patients may have been overconfident in their ability to administer 
their eye drops correctly or unaware of their poor performance.9 However, no other scales for 
measuring eye drop technique self-efficacy exist, and given the scale’s face validity and strong 
theoretical justification for the expected association between self-efficacy and eye drop 
technique, it was reasonable to use the 6-item Eye Drop Technique Self-Efficacy Scale in the 
present study. 
 
 
2.4	Eye	Drop	Adherence	
2.4.1	Importance	
 Medication adherence is defined as the degree to which medication is taken as prescribed 
by a healthcare provider.75 A review article shows that the literature is in agreement that good 
adherence is essential for control of IOP and prevention of glaucoma progression.35 Poor eye 
drop adherence has been associated with higher IOP,70,76 and some studies that have successfully 
 33 
intervened to improve adherence have shown decreases in IOP.77,78 In a 36-month observational 
study by Rossi et al., patients who had stable vision over the course of the study had median 
electronically monitored adherence of 85%, while patients whose vision worsened had median 
electronically monitored adherence of 21%.79 Sleath et al. also found that having less than 80% 
eye drop adherence was associated with more severe visual field defect.53 
 Poor glaucoma medication adherence also has a broader societal impact. As noted above 
in section 2.3.1, a cost-consequence analysis showed that patients using bimatoprost 0.01% 
would be estimated to save $3433 over each patient’s lifetime compared to patients using 
bimatoprost 0.03%.55 This result was due to better adherence and resulting glaucoma control 
with bimatoprost 0.01%; in the model, the IOP reduction efficacy of bimatoprost 0.03% was 
assumed to be slightly greater when other factors were equal, but more patients were assumed to 
be adherent to bimatoprost 0.01% than 0.03%. The adherence estimates, stated as percentage of 
days covered (PDC) over a 12-month period, were calculated from real-world Medicare claims 
data. In both groups, the effectiveness of the drug in reducing IOP was assumed to be 100% of 
the efficacy observed in the phase III clinical trials for patients with more than 80% PDC, 50% 
of the efficacy from the trials for patients with 20-80% PDC, and 0% for patients with less than 
20% PDC. The difference in economic outcomes resulted from a difference in clinical outcomes. 
The model predicted that 12.60% of patients in the bimatoprost 0.01% group, and 17.28% of 
patients in the bimatoprost 0.03% group, would eventually become blind.55 Based on a prior cost 
estimation study by Bramley et al.,80 blind patients incurred greater costs for services such as 
medical visits, skilled nursing facility care, and home healthcare. The burden to families in 
supporting their blind family member may be even greater. Therefore, if an intervention could 
raise the percentage of patients who achieve an 80% PDC significantly above 29.1%, then 
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potentially much greater benefit in terms of both clinical and economic outcomes could be 
achieved. 
 
2.4.2	Observational	studies	of	glaucoma	eye	drop	adherence	
 This section will explain what is known from the existing observational studies of 
glaucoma eye drop adherence. Of 59 glaucoma studies collecting data on adherence to eye drops, 
40 were observational studies with a single group or cohort, 2 were observational studies with 
multiple groups, and 17 were intervention studies that included multiple study groups or phases 
that could be compared. The 40 single-group observational studies are shown in Table 2.3a.  
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Table 2.3a. Adherence results in observational studies with no comparison group or phase 
Author, Year Design Outcome 
Measure 
Adherence results 
Sleath 201153 Longitudinal 
observational, 
n=102 
MEMS 89% of patients were at least 80% adherent 
Boland 
201481 
Observational 
cohort, n=491 
MEMS 82.8% took medications correctly at least 75% of days 
Slota 201582; 
Sayner 
201583; 
Carpenter 
201561 
Longitudinal 
observational, 
n=279 
VAS, MEMS Mean VAS adherence: 89%; mean MEMS percent 
adherence: 97.5%; mean MEMS timing adherence: 
83.7%; Provider education about adherence and 
provider inclusion of patient input into treatment plan 
predicted decrease in IOP; Relationships not mediated 
by adherence or eye drop technique 
Barker 
201584 
Observational 
cohort, n=47 
MEMS Mean adherence: 79.7% 
Kumar 
201685 
Observational 
cohort, n=137 
MEMS, MPR, 
VAS, 2-question 
self-report survey 
Mean MEMS adherence: 84.4%; Mean MPR: 1.49; 
76.6% of patients >8 cm on VAS; 81% of patients “very 
confident” they remember to take their medications 
Okeke 200986 Observational 
cohort, n=196 
Travatan Dosing 
Aid (TDA) 
55.6% patients took >75% of expected doses 
Rossi 201087 Observational 
cohort, n=56 
TDA 30.3% had more than 90% adherence at every visit 
Ajit 201088 Observational 
cohort, n=37 
TDA 23 pts had good adherence (dosed within 4 hours of 
prescribed time at least 80% of the time), 3 had early 
discontinuation, 4 had frequent drug holidays, 7 
frequently missed doses 
Nordmann 
201070 
Observational 
cohort, n=113 
TDA Mean adherence: 60.0% 
Dreer 201289 Prospective 
observational, 
n=116 
TDA 64% adherence (proportion of days taking prescribed 
number of drops within 3 hr of prescribed time) 
Mansberger 
201376 
Cross-sectional 
with focus groups 
(n=20) and case 
series (n=57) 
TDA 49.1% adherent (took at least 1 drop within 6 hr of 
designated time at least 90% of days) 
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Author, Year Design Outcome 
Measure 
Adherence results 
Cate 201590 Secondary analysis 
of Norwich 
Adherence 
Glaucoma Study 
RCT, n=208 
TDA, Morisky 
scale, self-report 
54% of pts were adherent by Travalert Dosing Aid, 60% 
by Morisky scale, and 57% by Frequency of Missed 
Dose self-report 
Norell 198091 Observational 
cohort, n=82 
Medication 
monitor, 
fluorescein test 
to detect 
medication in 
eye 
Mean dose interval for 3-times-daily pilocarpine: 8.7 hr; 
18% of dose intervals >=12 hr; 11% of dose intervals 
<=4 hr 
Hermann 
201092 
Observational 
cohort, n=6 
glaucoma pts (28 
total pts) 
Electronic 
monitor 
55% adherence; 1.15 attempts/application 
Quigley 
200793 
Observational 
cohort from 
HealthCore claims 
database, 
n=13,977, and 
chart review, n=300 
MPR MPR 68% for chart review, 63% for non-charted patients 
from database; 72 of 300 charts contained negative 
physician comments on adherence, while 81 contained 
mixed or positive comments 
Friedman 
200894 
Observational 
survey with 
database and chart 
reviews, n=300 
MPR Median MPR: 0.48 for doctor-dependent learners, 0.66 
for collaborative learners, 0.69 for independent learners 
(p<0.05) 
Asefzadeh 
201495 
Retrospective 
review of EMR, 
n=161 
MPR 69% mean MPR 
Cohen 
Castel 201456 
Cross-sectional 
survey, n=738 
MPR 71% had MPR >=80% 
Campbell 
201496 
Observational 
cohort from Source 
Lx Database, 
n=12,985 
12-month PDC Adherence to bimatoprost: 0.540 (p<0.001) versus 
adherence to travoprost Z: 0.486; 29.1% at least 80% 
adherent to bimatoprost versus 22.3% for travoprost Z 
(p<0.001) 
Stein 201539 Cohort of 
Clinformatics 
DataMart 
database, n=8427 
PDC Adherence increased from 62% to 65% when pts 
switched from brand-name to generic latanoprost; 47% 
to 61% when switching from bimatoprost to generic 
latanoprost; 43% to 54% when switching from travoprost 
to generic latanoprost 
Rotchford 
199897 
Observational 
cohort, n=86 
Dispensing data 
on quantity of 
eye drops 
dispensed to 
each patient 
24% admitted nonadherence; 51% did not acquire 
enough medication to medicate as prescribed 
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Author, Year Design Outcome 
Measure 
Adherence results 
Patel 199598 Observational 
survey, n=100 
Self-report 
according to 
interview 
59% admitted not using medication exactly as prescribed 
Konstas 
200065 
Observational 
survey, n=100 
Self-reported 
adherence 
44% not fully adherent 
Balkrishnan 
200399 
Cross-sectional 
survey, n=358 
Self-reported 
adherence 
82% reported "regular" use of eye drops; 14% had 
difficulty self-administering eye drops and 17% needed 
assistance to instill eye drops 
Stewart 
2004100 
Survey of pts and 
physicians, n=250 
patients and 250 
physicians 
Self-reported 
adherence 
Most physicians said 0-25% of pts were noncompliant; 
34% of patients rated themselves noncompliant 
Chawla 
2007101 
Observational 
cross-sectional, 
n=83 
Self-reported 
adherence 
31% missed >10% of doses 
Kholdebarin 
200817 
Observational 
survey, n=500 
Self-report 27.9% missed at least one dose of eye drops per week 
or could not accurately describe their regimen 
Olthoff 
2009102 
Observational 
survey, n=166 
Self-reported 
adherence 
26.7% nonadherent 
Sleath 201074 Observational 
survey, n=191 
Self-reported 
adherence, 2 
self-efficacy 
scales 
30.2% of patients nonadherent by Morisky scale 
Rees 2010103 Cross-sectional 
survey, n=131 
Reported 
Adherence to 
Medication scale 
45% reported nonadherence, of which 66.1% reported 
unintentional, 16.9% reported intentional, and 16.9% 
reported both 
Vanden-
broeck 
2011104 
Observational 
survey, n=663 
Self-reported and 
ophthalmologist-
reported 
adherence 
39.2% self-reported nonadherence, 2.1% of patients 
identified as nonadherent by their ophthalmologist 
Park 2013105 Observational 
cross-sectional, 
n=581 
Adherence 
questionnaire 
60.2% had highest possible adherence score; Most 
common reasons were forgetfulness (50.1%), busy daily 
schedule (19.1%), patient's indifference (18.4%) 
Moore 
2014106 
Observational 
cohort, n=236 
Survey on 
factors related to 
early bottle 
exhaustion 
5.1% at least "often" ran out of drops; 25.4% ran out at 
least once 
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Author, Year Design Outcome 
Measure 
Adherence results 
Kawai-
Tsuboi 
201563 
Single-group 
cohort, n=67 
5-item 
questionnaire of 
technique and 
adherence 
95.5% adherent by self-report 
Tamrat 
2015107 
Cross-sectional 
observational, 
n=200 
Self-report of 
missed 
medications, 
missed 
appointments, or 
physician-
reported poor 
adherence 
67.5% of patients were nonadherent 
Newman-
Casey 
2015108 
Observational 
survey, n=190 
Self-reported 
adherence and 
barriers 
27% reported poor adherence; 10% cited 1 barrier, 61% 
cited >=2 barriers 
Killeen 
2016109 
Qualitative analysis 
of interviews to 
develop 
intervention, n=21 
MMAS-8 57% were adherent; Patients age 75 or older more likely 
to report difficulty instilling eye drops and more likely to 
say they did not understand the purpose of their 
medication 
Taylor 200264 Focus groups, 
n=21 
NA Patients cited forgetfulness, side effects as major 
reasons for nonadherence 
Lacey 200915 Qualitative analysis 
of focus groups or 
home-based 
interviews, n=24 
NA Patients identified as barriers: Poor education, low 
motivation due to doubts about efficacy, forgetting, 
difficulty of drop application, practical issues, 
age/individual differences 
Ikeda 200866 Single-group 
observational, n=27 
Measure not 
stated 
Adherence: 100% for twice-daily, 71% for once-daily eye 
drops 
EMR, electronic medical records; MEMS, Medication Event Monitoring System; MMAS-8, 8-item Morisky Medication 
Adherence Scale; MPR, medication possession ratio; NA, not applicable; PDC, percentage of days covered; RCT, 
randomized controlled trial; TDA, Travatan Dosing Aid; VAS, visual analog scale 
 
In general, the observational studies in Table 2.3a show that glaucoma eye drop 
adherence is poor, with estimates generally ranging between 50-65% adherence for the most 
reliable method, objective electronic monitoring (see 2.4.4 below), in the absence of any 
intervention.19,70,86,89 The literature suggests that African American race,4,19,53,76,81,84,89 lower 
health literacy,16 fewer years of education,17,56,81 shorter length of time using glaucoma 
medications,17,81,87 more severe visual field defect,9,53,107 depression,81 and being unmarried84 are 
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associated with poorer medication adherence (Table 2.3). There have been conflicting results 
regarding the effect of age; the majority of studies have found that older patients are more 
adherent,56,76,81,84,89,94,102,103 but a few studies suggested that older patients are less adherent.87,107  
African American or nonwhite race has been associated with poorer medication 
adherence in many glaucoma studies.4,19,53,76,81,84,89,110 Okeke et al. found that their video 
intervention for glaucoma medication adherence was less effective in African American patients, 
which suggests that a video must be carefully designed and implemented with attention to the 
needs of each subgroup.19 
There are conflicting data on the effects of age on glaucoma medication 
adherence.56,76,81,84,87,89,102,103,107 Older patients might be more adherent because they have more 
experience using their medications, fewer cost barriers due to Medicare eligibility, or fewer 
competing demands on their time due to being retired. On the other hand, older age could lead to 
lower adherence for many of the same reasons that it negatively influences technique: decline in 
physical and mental functioning, which may also lead to giving up if medication adherence is 
seen as being too difficult to accomplish. In addition, one study found that patients over age 65 
had a lower rate of good understanding of glaucoma than patients under 65, which may 
exacerbate the problems.62 
Low health literacy and less education are also risk factors for poor glaucoma medication 
technique and adherence.9,17,56,81 Patients with low health literacy and less education may have a 
harder time understanding instructions or learning to use their medication correctly. They may 
also have less understanding of the consequences of their disease and the importance of using the 
medication. Educational materials that use language at a high reading level are not likely to 
benefit these patients. Since the Meducation video was intended to be easier to understand than 
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other forms of instruction on eye drop use, health literacy and years of education were 
considered important covariates that may moderate the effect of the intervention on the primary 
outcomes. It was hoped that the video will provide more benefit for low literate patients, but if it 
did not, then tailoring the video more effectively on literacy level would be a focus for future 
refinement of the intervention. 
Length of time using glaucoma medications, glaucoma severity, and presence of 
comorbidities can also affect glaucoma medication technique and adherence. Patients that have 
used eye drops for a longer time tend to have somewhat better adherence,17,81,87 although no 
difference has been observed in technique. Patients who have more vision loss due to more 
severe glaucoma have shown poorer technique and adherence,9,53,107 which is not surprising since 
patients often perform better if they can see the bottle tip.68 Arthritis also inhibits patients’ ability 
to get their eye drops into the eye accurately,9,54 and depression tends to inhibit adherence to all 
types of medications, because depressed patients often believe that taking medication is 
futile.111,112 Patients who have considerable vision loss or significant arthritis may not benefit 
from the Meducation video intervention, but it is still important to control for those variables. 
Therefore, arthritis and severity of glaucoma were included as covariates in the model.  
Providing patient education is associated with higher knowledge of glaucoma and 
glaucoma treatment, as well as higher adherence.78,86 A greater number of glaucoma 
medications,82,113 as well as a more frequent dosing regimen (three-times-daily as opposed to 
twice-daily, or twice-daily rather than once-daily), are usually associated with poorer 
adherence,114-116 although one study found that adherence to once-daily medications was worse, 
which the authors attributed to side effects of the once-daily medications.66 Despite a lower 
percent of expected doses taken with a three-times-daily regimen, patients may still take more 
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total doses with the three-times-daily regimen.114,115 Switching from multiple separate products 
that must be instilled separately, to a combination product containing two drugs (e.g. 
latanoprost/timolol), is associated with better adherence.117,118 When instilling multiple eye 
drops, patients must typically wait 5 minutes between drops, which is inconvenient and not 
surprisingly, reduces adherence.117,118 A morning dosing regimen also seems to be associated 
with slightly better adherence than an evening regimen.119,120 
In addition to many single-group observational studies, there were also two observational 
studies with multiple groups, shown in Table 2.3b. Robin et al. compared adherence between a 
group that was prescribed one glaucoma medication and a group that was prescribed two 
glaucoma medications,113 while Kahook et al. compared morning dosing and evening dosing.120 
The group using a one-drug regimen had higher adherence than the two-drug group (no p-value 
reported),113, and the morning dosing group had slightly better adherence than the evening 
group.120 
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Table 2.3b. Adherence results in observational studies with multiple groups 
Author, 
Year Design 
Outcome 
Measure 
Results in first group 
or phase 
Results in second group 
or phase 
Robin 
2007113 
Parallel-group 
observational, n=60 
MEMS One-drug group: 97.5% 
adherence 
Two-drug group: 93.0% 
adherence to adjunctive 
drug, 85.6% adherence to 
entire regimen 
Kahook 
2007120 
Retrospective chart 
review, n=41 
TDA Morning group: Mean 
adherence 82.7% 
(p=0.08); Missed entire 
day of dosing 3.33 times 
(p<0.001) 
Evening group: Mean 
adherence 79.0%; Missed 
entire day of dosing 5.87 
times 
MEMS, Medication Event Monitoring System; TDA, Travatan Dosing Aid 
 
 
Next, the results of the interventional studies addressing eye drop adherence will be 
presented. 
 
2.4.3	Outcomes	of	intervention	studies	addressing	eye	drop	adherence	
 Seventeen glaucoma eye drop adherence studies conducted an intervention, and all of 
them contained multiple study groups or phases that could be compared. Of these, 10 (59%) 
found a statistically significant difference in at least one major adherence-related outcome 
measure.19,77,78,114,117,118,121-124
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Table 2.4. Adherence results in interventional studies 
Author, 
Year 
Design Intervention Outcome 
Measure 
Results in 
intervention group 
or phase 
Results in control 
group or non-
intervention phase 
Educational:     
Okeke 
200919 
RCT, n=66 Video, review of 
barriers with study 
coordinator, 
phone call 
reminders, and 
audible/visible 
reminders on 
device 
TDA 73% adherence at 3 
months (up from 54% 
at baseline, p<0.001) 
51% adherence at 3 
months (up from 46% at 
baseline, NS) 
Glanz 
2012125 
RCT, 
n=312 
Automated, 
interactive, 
tailored phone 
intervention and 
tailored print 
materials 
Interviews, 
charts, and 
pharmacy 
data 
30.2% self-reported 
adherence at 12 
months (p>0.05) 
27.0% self-reported 
adherence at 12 months 
Beckers 
201378 
RCT, 
n=588 
4 arms: 1) use of 
dosing aid; 2) use 
of drop guider; 3) 
dosing aid + 
patient education; 
4) dosing aid + 
drop guider + 
patient education 
TravAlert % patients >97% 
adherent: 55.8% 
(Arm 1), 56.0% (Arm 
2), 58.9% (Arm 3), 
62.0% (Arm 4); 
p=0.0056 
NA 
Difference in regimen:     
Kumar 
2002116 
Pre-post 
crossover, 
n=52 
Timolol in gel 
forming solution 
once-daily vs 
standard timolol 
twice-daily  
Self-
reported 
adherence 
10 patients had less 
than perfect 
adherence over 6 
weeks (p>0.05) 
3 patients had less than 
perfect adherence over 6 
weeks 
Sakai 
2005126 
RCT, n=36 Latanoprost 
versus separate 
timolol and 
dorzolamide  
Self-
reported 
adherence 
Latanoprost: 2 of 18 
patients missed >=1 
dose/week (p=0.37) 
Timolol and dorzolamide: 
5 of 18 patients missed 
>=1 dose/week 
Hermann 
2011115 
Obser-
vational 
cohort, 
n=37 
Open vs masked 
electronic 
monitoring 
Electronic 
monitoring 
device 
Masked: 77% 
adherence with twice-
daily dosing, 62% 
adherence with 3-
times-daily dosing 
Open: 70% adherence 
with twice-daily dosing, 
65% with 3-times-daily 
dosing (NS) 
Hermann 
2011114 
RCT, n=67 Twice-daily vs 3-
times-daily dosing 
Electronic 
monitoring 
device 
Twice-daily dosing: 
72% adherence 
(p=0.04); Dosing 
frequency 1.4 per day 
(p<0.001) 
3-times-daily dosing: 
62% adherence; Dosing 
frequency: 1.9 per day 
 44 
Author, 
Year 
Design Intervention Outcome 
Measure 
Results in 
intervention group 
or phase 
Results in control 
group or non-
intervention phase 
Inoue 
2011117 
Pre-post 
intervention, 
n=162 
Combination 
latanoprost/timolol 
vs separate 
products  
Adherence 
question-
naire 
71% had perfect 
adherence 1 month 
after switching to 
combination therapy 
(p=0.0115) 
59.3% had perfect 
adherence before the 
switch 
Inoue 
2012118 
Single-
group pre-
post, n=43 
Switch from 2 
separate products 
to combination 
travoprost/timolol 
Self-
reported 
adherence 
71.4% had perfect 
adherence at 1 month 
after switch (p<0.05) 
64.3% had perfect 
adherence 
Ford 
2013119 
Randomized 
crossover 
trial, n=30 
Morning vs 
evening dosing 
TDA Morning dosing: 
90.9% adherence 
(p=0.07), 91.4% in 
males (p=0.039) 
Evening dosing: 87.3% 
adherence; 85.0% in 
males 
Reminder:     
Chang 
199177 
Pre-post 
intervention, 
n=122 
Medication cap 
with memory aid 
Number of 
patients 
with 100% 
adherence 
(self-report) 
67% of patients 
completely adherent 
(p=0.0001) 
41% of patients 
completely adherent 
Laster 
1996121 
Crossover, 
n=13 
Prescript TimeCap 
electronic 
medication alarm 
device 
Amount of 
drug used, 
self-
reported 
adherence 
95.8% mean self-
reported adherence 
(p<0.01) 
83.1% mean self-
reported adherence 
Boland 
2014124 
Cohort, 
n=491 and 
RCT, n=70 
Automated text or 
voice messages 
MEMS Adherence increased 
from 53% pre-
intervention to 64% 
post-intervention 
(p<0.05) 
Adherence 51% pre-
randomization, 46% 
post-randomization (NS) 
Mechanical device: 
 
    
Lievens 
2006127 
Randomized 
crossover, 
n=32 
Proview Eye 
Pressure Monitor 
Bottle 
weight 
Average 1.742 ml 
used (NS) 
Average 1.745 ml used 
Nordmann 
200967 
Randomized 
crossover, 
n=211 
Xal-Ease® 
delivery device 
Self-
reported 
adherence 
Adherence: 95.8% in 
first period, 96.6% in 
second period (NS 
time and between-
group difference) 
Adherence: 96.9% in first 
period, 97.8% in second 
period 
Junqueira 
2015123 
Randomized 
self-
controlled, 
n=32 
Eyedrop® delivery 
device 
VAS rating 
of satis-
faction with 
device; 
pattern of 
fluorescein 
in each eye 
Mean satisfaction 
rating 7.6 of 10 
Mean satisfaction rating 
6.2 of 10 (p<0.01) 
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Author, 
Year 
Design Intervention Outcome 
Measure 
Results in 
intervention group 
or phase 
Results in control 
group or non-
intervention phase 
EHR-based online 
systems: 
 
    
Kashiwagi 
2014122 
RCT, 
n=171 
Internet-based 
glaucoma support 
system with 
Personalized 
Health Record 
(PHR) 
Change in 
MPR 
MPR 82.3% pre-
intervention, 91.1% 
post-intervention 
(p=0.03) 
MPR 84.0% pre-
intervention, 82.9% post-
intervention 
 
MEMS, Medication Event Monitoring System; MPR, medication possession ratio; NA, not applicable; NS, not 
significant; PHR, personalized health record; RCT, randomized controlled trial; TDA, Travatan Dosing Aid; VAS, 
visual analog scale
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The interventions used can be classified as educational (sometimes together with 
reminders), differences in regimen, reminders alone, mechanical devices, or EHR-based online 
systems (Table 2.5). Educational interventions are those that strive to educate the patient about 
the need to use eye drops regularly, using print materials, videos, or face-to-face instruction. 
Differences in regimen interventions attempt to simplify a regimen so it does not need to be used 
as often, or requires only one eye drop containing multiple active ingredients, instead of two 
separate products. Reminder interventions consist of a device on the bottle that alerts the patient 
when to take a dose, or text or voice message alerts sent to patients. Mechanical device 
interventions consist of physical objects that can be mounted on the face to direct the eye drop 
bottle more accurately toward the eye. Examples include the Xal-Ease delivery device which 
holds the bottle in a position directed straight toward the center of the eye, and has a button that 
patients can press to administer a single drop, thus avoiding the risk of squeezing out multiple 
drops.67 EHR-based online system interventions may allow patients to log on to a secure health 
record and track how well they are doing in controlling their IOP and preventing glaucoma 
progression. 
 
Table 2.5 Types of interventions used to improve eye drop adherence and number of studies for 
each patient outcome 
Type of intervention Favors 
intervention 
(p<0.05), n 
No significant 
difference, n 
Favors control, n 
Educational 219,78 1125 0 
Difference in regimen 3114,117,118 3116,119,126 0 
Reminders alone 377,121,124 0 0 
Mechanical devices 1123 267,127 0 
EHR-based online systems 1122 0 0 
Total 10 6 0 
Note: Hermann’s study of open vs masked electronic monitoring was not included in this table since it was not clear 
which should be considered the intervention group.115  
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2.4.3.1	Educational	interventions	
 Educational interventions showed success in two of three studies.19,78,125 In a 4-arm RCT, 
Beckers et al. found that a dosing aid, drop guider, and patient education resulted in 62.0% of 
patients being at least 97% adherent, while only 55.8% were adherent with the dosing aid alone, 
56.0% with the drop guider alone, and 58.9% with the dosing aid and patient education.78 Okeke 
et al. found that a multifaceted intervention including educational videos, review of barriers with 
the study coordinator, phone call reminders, and audible and visible reminder devices produced 
73% adherence in the intervention group at 3 months compared to 51% for the control group.19 
The unsuccessful example was the I-SIGHT trial, an RCT of an automated, tailored, interactive 
phone intervention and tailored print materials by Glanz et al.125 In this trial, 30.2% of 
intervention patients and 27.2% of control patients were considered adherent (defined as not 
having missed any doses in the last month by self-report) after 12 months, versus 10.2% of 
intervention patients and 13.5% of controls at baseline. The between-group difference at 12 
months was too small to be statistically significant even with the large sample size of 312 
patients, but both groups did significantly improve their adherence from baseline (p<0.01).  
 
2.4.3.2	Difference	in	regimen	interventions	
 A different regimen or change in regimen showed statistically significant successful 
results in three of six studies.114,116-119,126 Hermann et al. found that 72% of doses were taken 
correctly in patients randomized to twice-daily dosing compared to 62% for three-times-daily.114 
Inoue et al. used a pre-post design to compare adherence to a combination latanoprost/timolol 
product with the two products separately and found that 71% had perfect adherence 1 month 
after the switch compared to 59.3% at baseline.117 In another pre-post study by the same author, 
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patients were switched from separate products to a combination travoprost/timolol product, and 
71.4% had perfect adherence 1 month after the switch compared to 64.3% at baseline.118 The 
unsuccessful results came from an RCT by Sakai et al.,126 and crossover studies by Kumar et al. 
and Ford et al.116,119 All of these studies showed trends in the expected direction of better 
adherence with the simpler regimen but were likely underpowered as they contained between 30 
and 60 participants each.116,119,126 Therefore, the overall evidence in favor of simpler regimens 
for maximizing adherence remains very strong. 
 
2.4.3.3	Reminder	interventions	
 In addition to education and simplifying regimens, reminder interventions, such as a 
memory aid, alarm on a medication cap, or automated voice or text message, have improved 
adherence.19,77,121,124 Although some patient populations can be averse to reminders, the mostly 
elderly glaucoma population seems to benefit. Reminders were successful in all three studies that 
used them alone,77,121,124 in addition to the previously discussed study by Okeke et al. that used 
them together with educational interventions. In Chang et al.’s pre-post study of a medication 
cap with a memory aid, 67% of patients were completely adherent after introducing the 
intervention compared to 41% before the intervention.77 Laster et al. performed a crossover study 
of an electronic medication alarm device and found that mean self-reported adherence was 
95.8% in intervention phases compared to 83.1% in control phases.121 Boland et al. tested 
automated voice and text messages in an RCT and found that adherence improved from 53% to 
64% in the intervention group compared to a nonsignificant decline from 51% to 46% in the 
control group.124 
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2.4.3.4	Mechanical	device	interventions	
 Mechanical device interventions for facilitating eye drop instillation, though effective for 
improving technique (see 2.3.5 above), were less effective for improving adherence, succeeding 
in just one of three studies.67,123,127 The successful cross-over study by Junqueira et al. found that 
rating of the facility of drop instillation was 7.6 of 10 with a special delivery device and 6.2 
without the device.123 No measure of adherence itself was provided, and the difference between 
groups in IOP change was not significant. Unsuccessful studies of devices included randomized 
crossover trials by Nordmann et al. and Lievens et al.67,127 The Xal-Ease delivery device tested 
by Nordmann et al. was effective in improving technique, but there may have been a ceiling 
effect inhibiting detection of a significant effect on adherence, as self-reported adherence was 
already 95.8% in the intervention group and 96.9% in the control group at baseline.67  
 
2.4.3.5	Electronic	health	record	interventions	
 An Internet-based personalized health record system was also successful in improving 
medication adherence.122 Kashiwagi and Tsukahara implemented an Internet-based glaucoma 
support system with a Personalized Health Record (PHR), and found that intervention group 
patients’ adherence improved from 82.3% before intervention to 91.1%, while control group 
patients’ adherence was 84.0% before and 82.9% after the implementation date.122 With this 
system, patients used a secure online connection to view their IOP results and visual field test 
results from their past visits, their medication history, as well as personalized graphs showing the 
likelihood of glaucoma progression. 
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2.4.3.6	Summary	of	eye	drop	adherence	interventions	
 The present study tested an educational intervention because educating patients about 
how to use their medication correctly had shown success,19,78 but had not yet been adapted to an 
online video format. An online video allows patients to watch the video as much as they want 
from anywhere they can access an Internet-connected device. The Meducation video also may be 
more effective than the general video about glaucoma tested by Okeke et al., which did not focus 
on technique and therefore may have left patients lacking the skills that they needed to achieve 
successful clinical outcomes from their eye drops.19  
 
2.4.4	Measurement	of	eye	drop	adherence	
 Eye drop adherence can be measured with electronic monitoring, pharmacy refill data, 
self-report measures, or weight of medication bottle used.104 In the observational studies of eye 
drop adherence in Table 2.3, 16 studies used self-report measures,74,82,85,90,98-109 8 studies used the 
Travatan Dosing Aid (TDA),19,70,76,87-90,120 6 studies used Medication Event Monitoring System 
(MEMS®) caps,4,53,81,84,85,113 2 studies used some other type of electronic monitor,91,92 and 8 
studies used refill-based measures.39,56,85,93-97 Meanwhile, in the intervention studies of methods 
to improve eye drop adherence in Table 2.4, 9 studies used self-report measures,67,77,116-
118,121,123,125,126 3 studies used the TDA or TravAlert,19,78,119 1 study used MEMS caps,124 2 studies 
used some other type of electronic monitor,114,115 2 studies used medication weights,121,127 and 2 
studies used refill-based measures.122,125  
Electronic monitoring, in which the bottle or bottle cap automatically records each time 
the bottle is opened, is considered the gold standard for measuring adherence, but has some 
drawbacks, including the expense of the caps (about $100 each) and possible Hawthorne effects 
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on adherence.104 Hawthorne effects refer to the way in which subjects change their behavior 
because they know their performance is being monitored. Subjects who know their adherence is 
being monitored are likely to make an effort to be more adherent.128-130 The Hawthorne effect 
may resemble “white-coat” adherence in which patients are more adherent just before a medical 
visit, expecting their doctor will notice if they were not adherent in the last few days.128,130,131 
 Pharmacy refill data are also considered an accurate measure and are more practical in 
large data sets drawn from real-world patients not necessarily enrolled in trials. In glaucoma, 
pharmacy refills show similar average adherence results when compared to electronic 
monitoring.39,93,96 Studies using pharmacy refills typically report adherence rates using 
Medication Possession Ratio (MPR) or Percentage of Days Covered (PDC). Both measures 
attempt to determine what percentage of days the patient had medication available to use, based 
on the number of days’ supply that the patient obtained each time a prescription was filled. 
Although the measures have been operationalized in different ways, they differ mainly in that 
MPR often includes only the time while the patient was persistent with the medication in cases of 
discontinuation, whereas PDC includes potential periods of nonpersistence up to a predetermined 
study endpoint.132 Thus a patient who fills medications monthly for the first half of the year and 
then discontinues could have 100% MPR, but only 50% PDC.132 Advocates of using pharmacy 
refill measures argue that pharmacy refill data from large retrospective observational studies 
reflect more accurately how typical patients behave, because clinical trial patients are 
unrepresentative of the general population, tending to be more conscientious and adherent than 
patients who do not enroll in trials.133 However, pharmacy refills do provide somewhat less 
detailed data than electronic monitoring and are more problematic with topical medications like 
eye drops, which are less straightforward in terms of dosage amounts than oral medications.90 If 
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patients obtain medication but never use it, or if they throw out the bottle before exhausting it – 
which is recommended if the bottle gets contaminated11 – pharmacy refills would not capture the 
fact that the patient did not use the whole bottle. Pharmacy refills could also overestimate 
adherence for glaucoma patients who inappropriately squeeze out more than one drop, and thus 
run out of medication quickly. 132 These patients could be incorrectly classified as adherent based 
on refill data because they used the same amount of medication as adherent patients, but used too 
many drops on the first few days and then were nonadherent on the days after they had run out. 
Self-report measures that have been used include the Visual Analog Scale (VAS),82 the 
Morisky Medication Adherence Scale,90,109 and various other questionnaire measures. The VAS 
was validated for eye drops by comparing it to 60-day MEMS objective electronic monitoring 
results in a large observational study of 279 patients.83 Patients were asked to mark on a 10-cm 
line their answer to, “All things considered, how much of the time do you use ALL of your 
glaucoma medications EXACTLY as directed?” with endpoints “None of the time” and “All of 
the time.” The VAS was moderately correlated with MEMS (r=0.32) and when treated as a 
binary variable classifying patients with at least 80% adherence as “adherent”, VAS identified 
adherent patients with 85% sensitivity and 38% specificity.83 
Kumar et al. explored adherence in an observational cohort study of glaucoma patients 
simultaneously monitored with MEMS, pharmacy refill data, and two self-report measures: VAS 
and a two-question survey.85 Patients were rated adherent on the two-question survey if they 
answered “yes” to “How confident are you that you can carry out the following task: always 
remembering to use your glaucoma medications?” and “no” to “In the past 4 weeks, did you ever 
forget to take your medicine?” The authors found that the majority of patients with medication 
possession ratios (MPR) in a low, medium, or high range were at least 80% adherent according 
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to MEMS. Fifty-nine percent of patients with MPR less than 1.2 (low), 63% of those with MPR 
of 1.2 to 1.8 (medium), and 88% of those with MPR above 1.8 (high) were at least 80% adherent 
according to MEMS.85 These ranges were chosen to correspond to an undersupply of medication, 
an appropriate supply, and an oversupply, respectively. It may be that an apparent oversupply of 
medication is actually what patients need, to compensate for wasting drops that are not 
accurately instilled. Compared to patients with low scores, patients with high scores on each of 
the two self-report measures were more likely to be at least 80% adherent according to MEMS 
(OR: 2.78, 95% CI: 1.19-6.52 for the two-question survey; OR: 2.35, 95% CI: 0.96-5.75 for 
VAS).85 
The Morisky Medication Adherence Scale (MMAS) is one of the most common self-
report adherence measures and was used in glaucoma by Cate et al. in an 8-month RCT of 208 
patients that compared three different adherence measures: the 4-item Morisky Scale, the 
Travalert Dosing Aid (TDA), and Frequency of Missed Dose (FMD) self-report questionnaire.90 
Medication possession ratio (MPR) data were also calculated from pharmacy refills. The 
percentage of patients who were at least 80% adherent was 60% according to the Morisky scale, 
54% by TDA, and 57% by the Frequency of Missed Dose questionnaire. The two self-report 
measures agreed well with each other (k=0.632) but both agreed poorly with the TDA electronic 
monitor (k=0.117 for the Morisky scale, k=0.233 for Frequency of Missed Dose). The TDA 
results also agreed poorly with the refill measure MPR (Spearman’s coefficient=0.216). The 
authors suggested that the results did not lead them to endorse any of the measures strongly since 
all had significant limitations.90 
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2.4.4.1	Comparison	of	eye	drop	adherence	measures		
As shown in Tables 2.3 and 2.4, studies using electronic monitoring have typically 
reported around 50-65% adherence for glaucoma eye drops without any intervention, which is 
lower than the results from self-report measures and similar to those from pharmacy refill 
data.19,83 For example, Slota et al. reported mean self-reported adherence of 89% using a Visual 
Analog Scale (VAS).82 Other self-report studies have measured medication adherence as the 
percentage of patients who reported less than perfect adherence, such as whether the patient 
missed any doses in the last 2 weeks;104 this measure is difficult to compare to the non-self-report 
studies that usually considered adherence as a continuous measure. Meanwhile, studies using 
pharmacy refills gave mean MPR estimates of 68%,93 67%,94 and 69%95 using chart review and 
63%93 from a claims database. As discussed above, the study by Cate et al. that used two 
different self-report measures and electronic monitoring suggested that adherence (defined as 
percentage of patients at least 80% adherent) was about the same using all three measures: 60% 
were adherent using the Morisky Medication Adherence Scale, 57% using the Frequency of 
Missed Dose questionnaire, and 54% using the Travatan Dosing Aid (TDA) electronic monitor.90 
However, this was a secondary analysis of an RCT, and the same patients were being monitored 
by all three different measures. Therefore, the results may not be typical of ordinary patients who 
are not being electronically monitored. 
Since the VAS is validated against MEMS data and is simple and intuitive to use, we 
used the VAS as the measure of adherence in the present study.83 Because of the modest 
correlation between single-item VAS and MEMS results in prior studies, a new 5-item VAS 
measure asking patients to rate each item by placing a mark on a 10-cm line was developed as 
part of this study, as explained in section 3.3.3.83 For a pilot study such as this, MEMS caps were 
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too expensive (about $100 each), and since they require placing the eye drop bottle in a larger 
bottle that fits the MEMS cap, they also would have served as a constant reminder of being 
monitored. Therefore, if MEMS had been used, the results might have reflected Hawthorne 
effects on adherence that are difficult to replicate outside of the context of a research study. 
Pharmacy refills are also impractical and would have required a great deal of time to obtain 
records from every pharmacy that study participants have used. In the study by Kumar et al., 
pharmacy refills were only collected for the subset of patients who were in the Veterans Affairs 
system, where all pharmacy records were available in a single electronic system.85 In addition, 
pharmacy refills are not ideal for topical medications, where the number of doses in a bottle is 
not always possible to determine precisely, complicating the computation of adherence.85 It 
would have been difficult to know whether a patient who used a large amount of medication was 
very adherent, or simply wasted a great deal of medication by squeezing out extra drops. Also, 
the follow-up period of only 1 month would have been too short to obtain good accuracy with 
pharmacy refills. Therefore, the VAS was used to assess adherence in this study. 
 
2.4.5	Relationship	between	eye	drop	technique	and	glaucoma	medication	adherence	
 Although a few studies have assessed both glaucoma eye drop technique and glaucoma 
medication adherence,17,53,59,61,63,65,66 the relationship between these two variables is not known. 
Sleath et al. included eye drop technique self-efficacy as an independent variable in a multiple 
regression model predicting adherence, but it was not a significant predictor.59 Similarly, 
medication adherence self-efficacy was not a significant predictor of eye drop technique. 
However, the relationship between adherence and technique has not been assessed in any prior 
glaucoma studies.59  
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In other disease states such as asthma and chronic obstructive pulmonary disease 
(COPD), an association between better adherence and better technique has been suggested, but 
not directly shown.134-138 In a nonrandomized observational study, better self-reported COPD 
medication adherence was observed for patients using pharmacies that provided enhanced 
inhaler technique education compared to those using pharmacies that did not provide enhanced 
inhaler technique education.136 In another study by the same author, self-reported asthma 
adherence was significantly better in patients who reported having received more instruction on 
inhaler technique.134 One observational study in asthma showed better adherence to metered dose 
inhalers than dry powder inhalers,138 which the authors attributed to better technique despite not 
actually measuring technique. However, another study showed no difference in technique 
between metered dose inhalers and dry powder inhalers, while adherence was actually better 
with the dry powder inhalers.137 
The existing studies in asthma and COPD have either used proxy measures of adherence 
or technique, such as an easier-to-use inhaler type as a proxy for better technique,138 or they have 
not directly analyzed the relationship between adherence and technique. Therefore, the present 
study was the first to provide insight into the association between medication adherence and 
objectively measured video-recorded eye drop technique. 
The next section will discuss educational video interventions in a more general sense 
across all types of chronic conditions. 
 
2.5	Educational	Video	Interventions	
 This section will review the literature surrounding educational video interventions for 
improving self-management behavior in chronic conditions. This helps to define where gaps in 
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the literature exist that may be filled with a particularly innovative online video intervention. 
This literature also helps inform what an appropriate study design is, what intervention 
characteristics need to be included, and what outcomes should be included in the present study. 
The brief, often rushed visits that characterize modern medicine afford little time for 
conveying essential information about critical disease self-management skills.139 Communicating 
how to perform these essential skills, as well as coaching and motivating patients to keep up their 
chronic disease self-management over periods of many years, are areas where eHealth, defined 
as “the use of emerging information and communication technology, especially the Internet, to 
improve and enable health and health care”,140 may be able to fill the gap by providing education 
that cannot fit into short provider visits. For example, physicians often do not have time to ensure 
that their patients know how to perform basic self-management skills ranging from managing 
their diet to taking various types of medications. That is especially true with medications that are 
less straightforward than taking a pill, such as eye drops,141 injected medications,142 or inhalers.6 
The results of studies assessing medication technique and adherence in these chronic conditions 
suggest that providers are not engaging in patient education on how to use these medications for 
maximum benefit.6,19 
Videos are a simple and intuitive means of communicating health information and are 
now increasingly being posted online to educate the public about health. Videos may be a 
preferred format for people with low health literacy, who may find video easier to learn from 
than text-heavy websites or written materials.8 Videos can also demonstrate exactly how to 
perform a task, which would be much more difficult to explain with text or pictures alone. 
However, it is currently unknown how effective educational health videos are at improving 
technique and how their effectiveness might be increased further. 
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2.5.1	Intervention	characteristics	
 Using a PubMed search, 179 studies were found on educational video interventions. 
Thirty studies were reviewed that were related to patient self-management of a chronic condition 
and did not meet any of the following exclusion criteria: the intervention was intended as a 
decision aid, they addressed only the development of the intervention and did not test it, they 
addressed video games, they addressed videoconferencing or care manager interventions with 
heavy provider involvement, or they were review articles. 
 Studies considered several different areas of chronic disease self-management, including 
adherence to medications or vitamins; control of blood glucose, blood pressure, and cholesterol; 
asthma inhaler technique; as well as diet, exercise, and avoidance of smoking as part of larger 
chronic disease self-management programs. The chronic conditions studied included diabetes (5 
studies),143-149 asthma (5 studies),6,150-153 coronary artery disease (3 studies),154-156 end stage renal 
disease (2 studies),157,158 glaucoma (2 studies),8,19 HIV (2 studies),159,160 and 1 study each in 
atopic dermatitis,161 amblyopia,162 obstructive sleep apnea,163 atrial fibrillation,164 fragility 
fracture,165 post-transplantation risk of skin cancer,166 chronic fatigue syndrome,167 physical 
functioning after hip repair surgery,168 heart failure,169 and epilepsy.170 One study also addressed 
medication misuse in a variety of conditions.171 
 Only two studies specifically considered an online video intervention.149,161 Most studies 
considered videos that were watched during the clinic visit or were given to the patient as a DVD 
to watch at home. 
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2.5.2	Designs	
Twenty-one of the studies used an RCT design (Table 2.6).6,8,19,143-148,150-
152,154,155,158,159,161-167 Seven studies used a quasi-experimental design;149,153,157,160,168,169,171 six 
measured outcomes in the same group of participants before and after watching the 
video,149,153,157,160,169,171 and the other study168 did not state clearly how the intervention and 
comparison groups were determined. One study used a choice design, where participants could 
choose between video plus a written handout, or a handout only.170 One study used a single-
group cross-sectional design, measuring outcomes only after all participants watched the 
video.156 
Among the 21 RCTs, 16 had two arms, 4 had three arms, and 1 had four arms. Wilson et 
al.’s four-arm RCT promoting self-management of asthma randomized patients to receive video 
education, print education, both, or neither.150 Among 3-arm RCTs, two compared two different 
videos to usual care. Mahler et al. compared a diet and exercise video using a Mastery frame to a 
video using a Coping frame to standard care.155 The Mastery frame was designed to be more 
optimistic and emphasize recovery as a “steady forward progression”, while the Coping frame 
was designed to prepare patients more intensively for problems that would likely arise.155 The 
other study by Nordfeldt et al. compared a video specifically about diabetes self-management to 
a general diabetes video to usual care.146,147 Another 3-arm trial by Beaudoin et al. compared 
video plus print material to print material only to usual care.165 Finally, a 3-arm RCT by Liu et 
al. compared face-to-face asthma education to group education to home-based video 
education,152 while also recruiting a no-intervention comparison group from a neighboring 
hospital. 
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Among two-arm RCTs, 4 compared a video to usual care,8,143-145,167 4 compared a 
multifaceted intervention using video plus other components to usual care,19,151,162,163 2 compared 
a video to printed materials,161,166 2 compared a video to live in-person education,158,159 2 
compared two different videos,6,148 1 compared video plus printed materials to printed materials 
only,154 and 1 compared video plus printed materials plus live education to printed materials 
only.164 
The study reported in this dissertation used a two-arm RCT design comparing the 4-
minute Meducation eye drop technique video to a 3-minute nutrition video on cooking with 
whole grains as the active comparator (see Chapter 3, Methods). Using another video as an 
active comparator allows better assessment of the value of the video content than a usual care 
comparator would. Print materials could also be used as an active comparator. However, print 
materials have only been tested in one small quasi-experimental pilot study of 25 patients with 
no control group.11 It is considered preferable to use an active comparator with known efficacy 
when one exists,172 but due to the lack of a large, well-controlled study on print materials for 
glaucoma education, print materials do not currently meet this standard. Thus, the results of a 
study comparing the Meducation video to print materials might not have been readily 
interpretable. A three-arm design with two video arms and usual care is also worth considering, 
but is not feasible considering the limited time and budget for this study. The nutrition video 
being used as a comparator173 was not expected to provide appreciable improvement in eye drop 
technique or medication adherence, so there would probably have been little value in having both 
a nutrition video arm and a usual care arm.   
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Table 2.6. Summary of study designs and results for educational video interventions. 
 
Author, 
Year, 
Country 
Behavior 
considered Design 
Theory 
used 
Description of 
intervention(s) Results 
Glasgow 
1995, 
Glasgow 
1996, 
US144,145 
Self-
management 
of diabetes 
RCT: Interactive 
video vs usual 
care 
SCT, social 
learning 
theory, 
systems 
approaches, 
stages of 
change 
Interactive video 
tailored to stage of 
change and 
barriers identified. 
Videos are on 
eating away from 
home, eating at 
home, or food 
purchasing 
Intervention group showed 
more improvement in 
calories per day, % calories 
from fat, % calories from 
saturated fat, serum 
cholesterol (all p<0.01); NS 
change in HbA1c 
Nordfeldt 
2005, 
Nordfeldt 
2003, 
Sweden 
146,147 
Prevention of 
severe 
hypoglycemia 
in type 1 
diabetes 
RCT: 
Video/brochure 
about self-
management vs 
Video/brochure 
with general 
diabetes info vs 
usual care 
None 
mentioned 
Two videos (17 
min and 18 min) 
on preventing 
hypoglycemia, 
symptom 
recognition, and 
treatment; 
General diabetes 
group received 
13-min video 
containing only 
general diabetes 
info 
Reduced incidence of 
hypoglycemia at 24 mo in 
targeted video arm only 
(p=0.0241); NS at 12 mo 
Gerber 
2005, 
US148 
Self-
management 
of diabetes 
RCT: 
Supplemental 
computer 
multimedia vs 
control multimedia 
(diabetes quizzes) 
Gagne's 
theory of 
learning, 
component 
design 
theory 
19 tailored 
computer-based 
multimedia 
lessons that could 
be done in any 
order 
Video group had higher 
perceived susceptibility to 
complication (p=0.009) but 
other outcomes NS 
different 
Dyson 
2010, 
UK143 
Type 2 
diabetes self-
management 
RCT: Video vs no 
intervention 
None 
mentioned 
Three 10- to 15-
min videos on 
"Food Choices", 
"Physical Activity", 
"Weight 
Management" 
Increased knowledge after 
intervention in video group 
(p=0.024); no change in 
control group 
Davis 
2016, 
US149 
Self-
management 
of type 2 
diabetes 
Quasi-
experimental pre-
post study: All 
patients received 
online video 
IMB model Nine 2-min video 
modules tailored 
to patients’ 
individual barriers 
No statistically significant 
improvement in adherence 
or self-efficacy; self-
efficacy improved more in 
patients with eighth-grade 
or lower reading level 
(p=0.02)  
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Author, 
Year, 
Country 
Behavior 
considered Design 
Theory 
used 
Description of 
intervention(s) Results 
Cordina 
2001, 
Malta151 
Asthma self-
monitoring and 
self-
management 
Cluster RCT: 
Pharmacies 
randomized to 
provide verbal 
counseling+ 
video+leaflet+ 
monitoring with 
reinforcement, vs 
routine services 
None 
mentioned 
Video educating 
about asthma and 
demonstrating 
inhaler technique 
Significant improvement in 
QOL (p=0.044) and inhaler 
technique (p=0.021) in 
intervention group at 12 
mo; Intervention group had 
better PEF at 12 mo than 
control (p=0.009) 
Liu 2001, 
Australia 
152 
Self-
management 
of asthma 
RCT: Face-to-face 
education 
(individualized or 
not) vs group 
education vs 
home-based video 
education. In 
addition a no-
intervention 
control group was 
recruited at a 
different hospital 
PRECEDE 
model 
2 videos 
containing the 
same information 
delivered in the 
educational 
sessions 
All intervention groups 
gained knowledge; 
however, video group 
experienced similar asthma 
severity to controls, and 
face-to-face education 
group performed 
significantly better than 
other groups 
Wilson 
2010, 
US150 
Self-
management 
of asthma 
symptoms and 
triggers 
RCT: Video vs 
print vs both vs no 
education 
Cognitive 
learning 
theories 
4-min video about 
triggers/symptoms 
and 3-min video 
about inhaler use; 
print materials 
with same content 
Both interventions worked 
better than no intervention; 
NS difference between 
print and video 
Carpenter 
2015, US6 
Asthma inhaler 
technique 
RCT: Inhaler 
technique video 
vs nutrition video 
(functioning like 
placebo) 
SCT 3-min video 
explaining MDI 
technique 
Intervention group 
performed more steps 
correctly (mean difference 
1.08 steps, 95% CI: 0.53, 
1.63) than control group 
immediately after video 
Carpenter 
2016, 
US153 
Asthma inhaler 
technique 
Pre-post 
assessment of 
technique before 
video, 
immediately after, 
and at 1 month 
None 
mentioned 
1-2 min tailored 
video giving step-
by-step feedback 
on inhaler 
technique steps 
performed 
correctly or 
incorrectly 
Technique steps performed 
correctly increased from 
6.4 before video to 7.6 
immediately after (p=0.03) 
in patients who used a 
spacer, and 4.5 before 
video to 7.2 immediately 
after (p<0.01) in patients 
who did not use a spacer 
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Author, 
Year, 
Country 
Behavior 
considered Design 
Theory 
used 
Description of 
intervention(s) Results 
Mahler 
1999, 
US155 
Adherence to 
diet and 
exercise 
following 
CABG 
RCT: Video with 
Mastery frame vs 
Video with Coping 
frame vs standard 
care 
Self-
regulation 
theory 
Instructional video 
on adherence to 
diet and exercise 
after CABG, from 
either a Mastery 
or Coping frame 
Both video groups had 
higher dietary self-efficacy 
immediately after video 
(p=0.0055) and at 1 month 
(p<0.01), lower dietary fat 
at 1 month (p<0.05); 
Coping video produced 
best exercise behavior 
(p<0.05 compared to both 
other conditions) 
Klein-
Fedyshin 
2005, 
US156 
Adherence to 
medications 
and healthy 
lifestyle 
following 
CABG 
Single-group 
cross-sectional 
study: All patients 
watched video 
None 
mentioned 
31-min video on 
recovery from 
heart surgery 
Most patients reported 
gaining knowledge through 
the video 
Eckman 
2012, 
US154 
Medication 
adherence, 
diet, exercise, 
and smoking 
for patients 
with CAD 
RCT: 
Video+booklet vs 
booklet only 
None 
mentioned 
30-min video with 
segments on 
"How Medications 
Help", "Managing 
Cholesterol", 
"Controlling Blood 
Pressure", 
"Quitting 
Smoking", 
"Managing 
Exercise and 
Stress", "What's In 
It For You", 
"What's Best For 
You" 
Knowledge improved in 
both groups (p=0.07 for 
difference between 
groups); both groups had 
significant improvements in 
diet and smoking 
Baraz 
2010, 
Iran158 
Dietary and 
fluid 
compliance in 
patients having 
HD 
RCT: Video 
education vs oral 
group education 
None 
mentioned 
30-min video on 
ESRD, dietary 
and fluid 
management 
Both methods produced 
improvement in 
biochemical parameters; 
NS difference between 
groups 
Baldwin 
2013, 
US157 
Phosphorus 
control in 
ESRD patients 
on HD 
Pre-post 
assessment of 
phosphorus levels 
before and 1-2 wk 
after watching 
video 
None 
mentioned 
45-min video on 
factors governing 
phosphorus levels 
in the body, 
symptoms of poor 
phosphorus 
control, how to 
control 
phosphorus levels 
Phosphorus levels lower 
after viewing video 
(p=0.0006); significant 
improvements in 
phosphorus-related 
knowledge and attitudes 
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Author, 
Year, 
Country 
Behavior 
considered Design 
Theory 
used 
Description of 
intervention(s) Results 
Okeke 
2009, 
US19 
Adherence to 
eye drops for 
glaucoma 
RCT: 
Video+review of 
barriers+phone 
call 
reminder+visible 
reminders on 
device vs no 
intervention 
None 
mentioned 
10-min video on 
importance of 
medication 
adherence and 
ways to remember 
to take eye drops 
Intervention group more 
likely (p=0.01) to have 
improved adherence at 6-
mo follow-up 
Muir 2012, 
US8 
Glaucoma 
medication 
adherence 
RCT: Video 
education vs 
standard care 
None 
mentioned 
2-5 min video 
tailored to health 
literacy level (at 
4th, 7th, or 10th 
grade level) plus 
20-min 1-on-1 
session with study 
coordinator 
No overall difference 
between intervention and 
control; in lowest literate 
subgroup, intervention 
participants had NS fewer 
DWM (mean of 51 vs 92, 
p=0.173) 
Brock 
2007, 
US160 
Adherence to 
HIV 
medications 
Quasi-
experimental pre-
post study: 
Assessment 
before and after 
watching video 
None 
mentioned 
17-min video 
attempting to 
maximize self-
efficacy to adhere 
to HIV 
medications 
Improved knowledge of 
disease and medications 
after watching video 
(p<0.05); improved 
adherence 4-6 wk after 
watching video (p=0.005) 
Sampaio-
Sa 2008, 
Brazil159 
ART 
adherence for 
HIV 
RCT: Educational 
workshop vs video 
Information-
Motivation-
Behavioral 
Skills Model 
Four 8-12 min 
videos on HIV, its 
transmission and 
its treatment. 
Patients could ask 
a physician 
questions after the 
video 
No difference between 
groups in adherence or 
viral load after 12 mo 
Tappen 
2003, 
US168 
Restoration of 
physical 
functioning 
after hip repair 
surgery 
Quasi-
experimental 
study: Intervention 
vs comparison 
group (details 
unclear) 
None 
mentioned 
Generic video on 
appropriate 
activity during 
recovery, plus 
individualized 
video on 
exercises 
demonstrated by 
therapist 
Greater improvement in 
distance and time walked 
in intervention group 
(p<0.05) 
Alemagno 
2004, 
US171 
Avoidance of 
medication 
misuse in 
seniors 
Single-group pre-
post study: All 
patients received 
video clips 
None 
mentioned 
Multiple 5-7 
minute video clips 
customized based 
on patient's 
answers to 
questions 
38% of participants had 
started using a pill box 2 
mo after intervention; 24% 
reported changing their 
medication use behaviors 
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Author, 
Year, 
Country 
Behavior 
considered Design 
Theory 
used 
Description of 
intervention(s) Results 
Smith 
2005, 
US169 
Self-
management 
of heart failure 
Pre-post 
assessment of 
knowledge and 
health status 
before and after 
watching video 
Triandis 
model of 
health 
behavior, 
Smith Family 
Care Theory 
4 videotapes on 
weight 
management, 
medication 
adherence, 
dietary sodium 
control, exercise, 
and other topics 
12.5% mean increase in 
heart failure knowledge 
score (no p-value given) 
Armstrong 
2011, 
US161 
Self-
management 
of AD 
RCT: Online 
video-based 
patient education 
vs pamphlet 
None 
mentioned 
Online video 
about symptoms 
of AD, 
environmental 
triggers, 
treatments, 
bathing/hand 
washing, 
moisturizers 
Online video group had 
greater improvement in 
POEM (p=0.0043) and 
knowledge (p=0.011) than 
pamphlet group 
Bakker 
2011, 
Netherlands
167 
CFS 
management 
and prevention 
of school 
absence 
RCT: Video vs 
usual care 
None 
mentioned 
Video about 
coping strategies 
and treatment for 
CFS 
Becoming persistently 
fatigued with school 
absence was 3.3 times 
more common in the 
intervention group 
(intervention had a 
negative effect) 
Hua 2011, 
Germany 
164 
Adherence to 
OAT 
Physician-level 
cluster RCT:  
Video+brochure+ 
nurse education 
vs brochure only 
None 
mentioned 
20-min 
video/brochure on 
OAT 
purpose/benefits, 
nutrition, drug 
interactions, 
adherence; 20-30 
min nurse 
education 
None available 
Lai 2014, 
Hong 
Kong163 
Adherence to 
CPAP 
treatment for 
OSA 
RCT: 
Video+Interview+
Phone follow-up 
vs usual care 
SCT, MI 
theory 
25-min video, 20-
min patient-
centered 
interview, 10-min 
follow-up phone 
call 
Intervention group had 
better CPAP adherence 
(p<0.001) and self-efficacy 
(p=0.012) 
Beaudoin 
2014, 
Canada165 
Adherence to 
calcium and 
Vitamin D 
supplements 
post-fragility 
fracture 
RCT: 
Video+written 
material vs written 
material only vs 
usual care 
None 
mentioned 
15-min video on 
osteoporosis diag-
nosis and treatment, 
fragility fracture; 
written materials on 
preventive behaviors 
for osteoporosis, 
fragility risk, and 
supplements 
Calcium and Vitamin D 
intake increased more in 
the video group compared 
to usual care (p=0.026 for 
calcium, p=0.012 for 
vitamin D); difference 
between video and written 
material groups NS 
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Author, 
Year, 
Country 
Behavior 
considered Design 
Theory 
used 
Description of 
intervention(s) Results 
Trinh 
2014, 
US166 
Adherence to 
sun-protective 
behaviors in 
transplant 
patients at risk 
of skin cancer 
RCT: Video vs 
pamphlet 
None 
mentioned 
2-min video on 
skin cancer 
epidemiology, 
risks, treatment, 
complications, 
prevention; brief 
pamphlet on same 
content 
Video group had more 
improvement in knowledge 
(p<0.01) and higher 
satisfaction 
Pradeep 
2014, 
UK162 
Adherence to 
patching for 
amblyopia 
RCT: Multifaceted 
educational/ 
motivational 
intervention vs 
usual care 
None 
mentioned; 
semi-
structured 
interviews 
used for 
needs 
assessment 
Video, cartoon 
story book, 
information 
booklets, sticker 
charts, session 
with researcher 
Adherence higher in 
intervention group 
(p=0.0027); no significant 
difference in visual 
outcomes 
Pascual 
2015, 
US170 
Epilepsy self-
management 
Nonrandomized 
pre-post study: 
Patients chose 
video+handout or 
handout only, ER 
visits assessed 
before and after 
None 
mentioned 
14.75-min 
Epilepsy 
Foundation video 
on general 
epilepsy care, 
medications, 
avoiding triggers, 
first aid, when to 
call 911 
No patients in either group 
had ER visits in 4 mo after 
study (p<0.0001 compared 
to before); no difference 
between groups 
 
AD, atopic dermatitis; ART, antiretroviral therapy; BG, blood glucose; BP, blood pressure; CABG, coronary artery 
bypass graft; CAD, coronary artery disease; CFS, chronic fatigue syndrome; CPAP, continuous positive airway 
pressure; DWM, days without medication; EMR, electronic medical records; ER, emergency room; ESRD, end-stage 
renal disease; HD, hemodialysis; HIV, human immunodeficiency virus; IMB, Information-Motivation-Behavioral Skills; 
MDI, metered dose inhaler; MI, motivational interviewing; NS, not significant; OAT, oral anticoagulant treatment; 
OSA, obstructive sleep apnea; PEF, peak expiratory flow; POEM, patient-oriented eczema measure; QOL, quality of 
life; RCT, randomized controlled trial; SCT, social cognitive theory
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 The next section will turn to the outcomes and overall effectiveness of video 
interventions tested in the literature. 
 
2.5.3	Outcomes	of	video	interventions	
Among 10 RCTs comparing video intervention (with or without other components) to 
usual care, eight found statistically significant results favoring the video intervention (Table 
2.6),19,143-147,151,155,162,163,174 while Muir et al. found no significant difference between groups of 
glaucoma patients,8 and Bakker et al. found that their video intervention had a negative 
impact.167 Outcomes that were significantly improved in the successful trials included 
diet,144,145,155 exercise,155 adherence to medications,19,162,163 knowledge,143 self-efficacy,155,163 
inhaler technique,151 quality of life,151 as well as clinical measures such as hypoglycemic 
episodes,146,147 cholesterol,144,145 and peak expiratory flow (PEF).151 
Five RCTs compared video to print materials in some form.150,154,161,165,166 Armstrong et 
al. found that an online video for improving atopic dermatitis self-management outperformed a 
pamphlet in improving patient-oriented eczema measure (POEM) scores (p=0.0043) and 
knowledge (p=0.011).161 Trinh et al. reported greater improvement in skin cancer knowledge in a 
group that watched a 2-min educational video compared to those receiving the same information 
in a pamphlet.166 The other three studies found that video produced significant benefits, but not 
significantly greater than print materials.150,154,165 The difference in knowledge between video-
plus-booklet and booklet-only groups for improving healthy lifestyle in coronary artery disease 
(CAD) patients was almost statistically significant in Eckman et al.’s study (p=0.07).154 
Four studies used some form of comparison between video and live in-person education; 
one of these published only the protocol without any results.164 Baraz et al. found no difference 
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between video education and oral group education for improving dietary and fluid compliance in 
patients having hemodialysis.158 Sampaio-Sa et al. also found no difference in improving 
antiretroviral therapy (ART) adherence for HIV between an educational workshop and a video 
format, supplemented with the ability to ask a physician questions after the video.159 On the other 
hand, Liu et al. found that face-to-face individual education for asthma self-management 
performed significantly better than delivery of the same information by group education or 
home-based video education.152 Although all three intervention groups gained knowledge, the 
video group had similar asthma severity to the control group at the end of the study. 
Two studies compared a video intervention condition to a similar format with different 
content.6,148 Carpenter et al. randomized children with asthma to watch the Meducation video on 
asthma inhaler technique or a video on nutrition, which functioned like a placebo control since it 
was not expected to improve the inhaler technique outcome.6 The intervention group performed 
more steps correctly after the video than the control group (p<0.05). Gerber et al. randomized 
diabetes patients to 19 tailored computer-based multimedia lessons on diabetes self-management 
that could be done in any order, or a control multimedia group that received only diabetes 
quizzes.148 The video group had higher perceived susceptibility to complications (p=0.009), but 
most outcomes were not significantly different between groups.148 
In addition, although not an RCT and without a comparison group, a pre-post study of a 
tailored inhaler technique video also by Carpenter et al. demonstrated that patients performed 
significantly more steps correctly after the video than before (p<0.05 for both subgroups, with 
and without spacer).153 
Overall, it appears that video-based education for self-management of chronic conditions 
is a valuable tool. Video education has almost always outperformed usual care, sometimes 
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produced better results than printed materials,161,166 and sometimes performed as well as much 
more resource-intensive live education.158,159 Most studies did not use online videos, which may 
produce better effects than videos watched in the clinic setting only. Unlike videos shown in the 
clinic, online videos can easily be watched as many times as patients want, including just before 
they attempt to use the medication in their usual setting. 
Since the proposed intervention in this study is a Meducation video, the next section will 
turn to studies specifically testing Meducation products. 
 
2.5.4	The	Meducation	system	
 The Meducation system developed by Polyglot Systems consists of both print and video 
materials that are designed to provide easy-to-understand, practical instruction on correct 
medication use.175 These include tailored patient-specific printable medication instructions with 
pictograms to visually communicate the proper timing for taking doses, as well as videos on how 
to take medications correctly. The instructions are presented in the patient’s choice of any of 21 
languages, at a fifth- to eighth-grade reading level, in large font, and accessible at any time 
online through a patient portal.175 All Meducation products are easy to disseminate through 
health systems that use Polyglot Systems’ products. 
 Meducation has been tested successfully in both a pediatric population with asthma,6 and 
an adult population of veterans with cardiovascular disease risk factors.7 In the asthma study, as 
discussed above in section 2.5.3, patients who watched the Meducation video on inhaler 
technique performed significantly more steps correctly after watching the video than a control 
group that watched a nutrition video.6 In the cardiovascular disease study, a pre-post design was 
used to assess antihypertensive medication adherence, weight, and blood pressure before and 
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after receiving a Meducation calendar.7 The Meducation calendar prints all the medications the 
patient must take and lists the quantity to take in the morning, at noon, in the evening, and at 
bedtime in a handy chart form. After using the Meducation calendar, patients had a medication 
possession ratio (MPR) that was 3.2 percentage points higher at 6 months compared to baseline 
(p=0.73), and also had improved scores (p-values not stated) on 6 of 7 items of a modified 
Morisky self-reported adherence scale. Body weight also decreased by a mean of 3.6 pounds, 
and systemic and diastolic blood pressure decreased by a mean of 0.5 and 1.5 mmHg, 
respectively.7 Given the small sample size of only 23 participants, none of the differences in 
adherence or clinical measures were statistically significant. Therefore, although the results seem 
promising, further testing with larger samples is needed. Unlike the cardiovascular disease study, 
the present study was adequately powered and used a randomized controlled design. 
 
2.5.5	Research	gaps	
 Although many studies have shown success in using videos to improve chronic disease 
self-management, few online videos have been tested, and no studies in which videos were 
hosted on social media platforms were found. Simply placing an educational video online to be 
watched without any provider involvement seems that it would have been straightforward, but 
only two studies evaluated the effects of this method on medication outcomes.149,161 Despite the 
very large number of videos on social media such as YouTube, including many health-related 
videos from famous academic medical centers and government agencies, none of the studies 
evaluated the effects of social media videos. According to the RE-AIM criteria (reach, 
effectiveness, adoption, implementation, and maintenance), which strive to assess the real-world 
impact of an intervention by emphasizing its potential for wide implementation and 
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dissemination, social media videos should have an advantage on all criteria except possibly 
effectiveness.176 However, perhaps researchers are reluctant to place videos on social media 
because they want to preserve the integrity of the intervention by preventing control patients 
from accessing it. There might also be a concern about harming patients by posting public online 
videos that turn out to be ineffective or even harmful. 
Not only were health videos rarely online, but in many cases the patients only had the 
ability to view the video once.150 For example, Wilson et al. compared a video that was watched 
once in the clinic to print materials that patients could take home; one study arm also received 
both.150 This type of design may seem to give an unfair advantage to print material interventions. 
Investigators should strive to compare similar delivery methods for videos and print materials by 
giving patients a DVD copy of the video if online video access is impossible or unsuitable due to 
the limited technological savvy of the patient population. For educating patients on complex 
behaviors such as use of inhalers or eye drops, it is essential that patients be able to view videos 
multiple times, including at home if that is where they usually take their medications. Home 
access also helps to ensure that essential caregivers can watch the videos as well, which may 
increase social support for patients to take their medications. 
Few studies explicitly mentioned tailoring or making their video accessible to patients 
with low health literacy. Patients with low health literacy are one of the most vulnerable 
populations, and may be the most in need of a video format to compensate for their limited 
ability to comprehend either printed material or text-heavy websites.177 Sadly, one of the studies 
that did give special attention to health literacy, the glaucoma adherence study by Muir et al., did 
not find that the video on the anatomy of the eye and process of vision loss, tailored to patients at 
a fourth-grade, seventh-grade, or tenth-grade level, outperformed usual care.8 However, patients 
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in the lowest literate subgroup did experience a mean of 51 days without medication (DWM) in 
the intervention group, compared to 92 days for the lowest literate subgroup of control patients 
(p=0.173). It should be noted that with only 13 low-literate subjects in each group, the power to 
detect a statistically significant difference in this subgroup analysis was very low; the authors 
noted that 97 low-literate subjects per group would have been needed to have 80% power to 
detect a statistically significant difference given the observed effect size. In addition, it was 
encouraging that the mean of 51 DWM for low-literate intervention patients was better than the 
means of 85 DWM for marginal-literate and 74 DWM for adequate-literate intervention 
patients.8 These results suggest that perhaps more video education studies need to focus on the 
lowest literate group that may initially have the poorest understanding of how and why to carry 
out the prescribed health behavior. 
Although the present study was not limited to low literate patients, the Meducation eye 
drop technique video was well suited to low literate patients, since Meducation videos are 
written at a fifth- to eighth-grade reading level, and appeal to visual learners with their 
animations of correct eye drop technique.175 The Meducation video avoids complex medical 
terminology, such as “systemic absorption”, that is present in other eye drop technique videos.48 
Therefore, the present study was expected to fill a gap in the literature by providing an effective, 
easily accessible intervention that meets the needs of patients at all literacy levels. 
 
2.6	Conceptual	Model	
 This section will begin by describing the theoretical frameworks used in the literature 
surrounding both 1) eye drop technique and adherence, and 2) educational video approaches to 
improve performance of chronic disease self-management behaviors. Then the rationale for 
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grounding the present study in Social Cognitive Theory (SCT) will be discussed, and the specific 
model to be used in the study will be presented and justified. The individual constructs included 
in the model will also be defined and the reasons for the expected relationships among variables 
will be described. 
 
2.6.1	Theoretical	frameworks	used	in	prior	literature	
 Of the studies on glaucoma eye drop technique and adherence reviewed in sections 2.3 
and 2.4, six studies, all of which were observational studies, described being rooted in a specific 
theoretical framework. One study conceptualized eye drop use with Street’s model of 
communication,61 three studies used the Health Belief Model (HBM),76,84,108 and two used Social 
Cognitive Theory.4,82 None of the intervention studies focused on improving eye drop technique 
or adherence mentioned being rooted in a theoretical framework.11,12,19 
Street’s model of communication was used in an observational study by Carpenter et al. 
to conceptualize the impact of communication on glaucoma patients’ IOP, a relationship 
theorized to be mediated by eye drop technique and adherence.61 More education about 
adherence and inclusion of patient input into the treatment plan were associated with 
improvement in IOP, but technique and adherence did not mediate these associations. The 
present study is not focused on patient-provider communication, but instead tests a video 
designed to be watched outside of the patient’s time with the provider. Therefore, Street’s model 
would not have been appropriate for the present study. 
The Health Belief Model emphasizes the role of beliefs about perceived barriers, 
perceived benefits, perceived susceptibility, and perceived severity in influencing performance of 
health behaviors.178 The Health Belief Model was used by Mansberger et al. and Barker et al. in 
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the development of a measure called the Glaucoma Treatment Compliance Assessment Tool 
(GTCAT).76,84 In the first study, Mansberger et al. conducted 5 focus groups with a total of 20 
participants, and classified 826 of the 931 adherence-related statements that participants made 
into one of the constructs of the Health Belief Model.76 The statements included 30.9% that were 
about barriers, 14.1% about cues to action, 12.5% about susceptibility, 12.4% about benefits, 
9.8% about severity, 9.1% about self-efficacy, and 11.3% about other reasons. Principal 
components analysis revealed that items loaded on seven factors: two related to severity, one 
related to susceptibility, two related to different aspects of barriers (difficulty of use and side 
effects), one related to knowledge, and one factor that was unidentified. Fifty-eight patients were 
then enrolled into an observational case series to test construct validity, test-retest reliability, and 
predictive validity using the automated monitoring Travatan Dosing Aid as a gold-standard 
measure of adherence. Glaucoma medication adherence was best predicted by 3 specific 
questionnaire items: personal knowledge of risk factors for glaucoma, agreement that “I am 
likely to use the drop every night,” and self-reported side effects of eye drops. 
In the second study using the Health Belief Model results from the Glaucoma Treatment 
Compliance Assessment Tool were compared to results from objective electronic monitoring 
with MEMS caps for the same 201 participants in a large multicenter trial.84 Principal 
components analysis showed that the 47 items loaded on six components, which were classified 
as knowledge, forgetting due to lack of cues to action, susceptibility, self-efficacy, severity, and 
barrier/medication side effects. The best predictors of higher glaucoma medication adherence 
were 4 items from the Health Belief Model, white ethnicity, older age, and being married. The 4 
Health Belief Model items were categorized as one severity construct (“If I lost the same amount 
of vision over the next five years as I have over the past five, it would have no effect on my 
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quality of life”), one forgetting due to lack of cues-to-action construct (“Over the last month I 
have not missed taking my drops”), one barriers construct (“Sometimes I am out of drops”), and 
one self-efficacy construct (“There are things I can do to control my glaucoma”). No item 
relating to benefits turned out to be among the useful predictors. The researchers also attributed 
the effect of being married to the lack of cues to action for unmarried patients, and the effect of 
age to potential cost-related barriers in the younger population, which would not generally have 
Medicare. 
 Newman-Casey et al. aimed to identify barriers to optimal use of eye drops in a cross-
sectional survey study.108 Six of 11 barriers tested were significantly more prevalent in patients 
classified as nonadherent by the Morisky Adherence Scale, compared to adherent patients: low 
self-efficacy, difficulty administering drops, forgetfulness, side effects, life stress, and difficult 
medication schedules. The authors were surprised that beliefs about glaucoma and beliefs about 
medication, such as skepticism that glaucoma will cause vision loss or that eye drops will 
prevent vision loss, were not significantly different between adherent and nonadherent patients. 
 Based on these studies, the Health Belief Model has a number of weaknesses for studying 
eye drop technique and adherence. None of the studies using the Health Belief Model assessed 
eye drop technique, which is more of a skills-based behavior. The Health Belief Model might be 
more helpful in studying behaviors where lack of motivation may be more central to the 
nonadherent behavior. In addition, two of the studies did not find that beliefs about glaucoma or 
beliefs about medication were associated with better adherence.84,108 Instead, the barriers that 
were identified, such as low self-efficacy and difficulty administering drops, may be better 
addressed within the context of Social Cognitive Theory, which emphasizes building self-
efficacy to maximize the chance to acquire a skill. Self-efficacy was not originally a part of the 
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Health Belief Model, but was later inserted after its importance was recognized by other 
theorists. Since the key outcome of technique in the current study has not been studied using the 
Health Belief Model, and appears to be linked more to self-efficacy and lack of skills than to 
health beliefs, Social Cognitive Theory is likely a better theoretical framework for the current 
study. 
 The studies on educational videos reviewed in section 2.5 also support using Social 
Cognitive Theory for the present study. Of these studies, eleven studies mentioned a theoretical 
framework that was used. There was little consensus on theoretical frameworks. The only 
theoretical frameworks that were used in more than one study were Social Cognitive Theory, 
which was used in three studies,6,144,145,163 and the Information-Motivation-Behavioral Skills 
(IMB) model, which was used in two studies.149,159 Since I used Social Cognitive Theory, I will 
discuss the findings using Social Cognitive Theory. Lai et al. used Social Cognitive Theory to 
study adherence to continuous positive airway pressure (CPAP) treatment for obstructive sleep 
apnea (OSA),163 Carpenter et al. used it to study asthma inhaler technique,6 and Glasgow et al. 
used it to study self-management of diabetes.144,145 All three studies emphasized the central 
Social Cognitive Theory concept of self-efficacy as a key to producing the desired healthy 
behavior. Lai et al. found that self-efficacy was significantly higher in the intervention group 
(p=0.012) at 3 months,163 while Carpenter et al. found that the difference just barely failed to be 
statistically significant (p=0.052).6 Glasgow et al. did not report self-efficacy results, but did 
determine correlations between several other psychosocial constructs and the primary outcome 
measures (dietary self-care and attributes of diet). Specifically, in a diabetic population, higher 
scores on barriers significantly predicted less improvement in terms of calories from fat, calories 
from saturated fat, and cholesterol, while the constructs of seriousness and importance together 
 77 
predicted better food habits and less improvement in cholesterol.145 Therefore, the successful 
results of past studies using Social Cognitive Theory to develop educational videos supported the 
use of Social Cognitive Theory in the present study. 
 
2.6.2	Social	Cognitive	Theory	
 Social Cognitive Theory, developed by Albert Bandura in the 1970s,179,180 is well suited 
to studying educational interventions because it emphasizes the influence of self-efficacy on 
behavioral outcomes. Social Cognitive Theory emphasizes that even when individuals have 
knowledge about the need to engage in healthy behaviors, they are unlikely to expend effort on 
performing a behavior unless they have a belief in their personal efficacy to succeed.73 Goals 
mediate the relationship between self-efficacy and behavior, since people with greater self-
efficacy set more ambitious goals and are more likely to display the persistence needed to reach 
those goals when setbacks occur.13 People’s self-efficacy can be improved through mastery 
experiences, vicarious experiences provided by social models, social persuasion, and changing 
their interpretations of physical and emotional states.73 Self-efficacy can affect health both by its 
effect on biological processes – such as patients experiencing activation of the endocrine system 
because they believe they lack the ability to cope with a challenge – as well as more indirectly 
through its effect on performance of healthy behaviors.73 Besides self-efficacy and collective 
efficacy (a group’s belief in its ability to perform together), other concepts influencing the 
performance of health behaviors in Social Cognitive Theory include outcome expectations, 
observational learning, incentive motivation, facilitation, self-regulation, and moral 
disengagement.178 Reciprocal determinism refers to the way that the environment influences 
people and groups, but people and groups can also change their environment to improve their 
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chances of performing desired behaviors.178 The determinants fit into three broad categories 
(Figure 2.1): (a) environmental factors such as observational learning, incentive motivation, and 
facilitation; (b) personal factors such as self-efficacy, collective efficacy, and outcome 
expectations; and (c) behavioral factors such as self-regulation and moral disengagement.179 
 
Figure 2.1 Reciprocal Determinism in Social Cognitive Theory179 
 
Outcome expectations and sociostructural factors (facilitators and impediments) are 
important mediators of the relationship between self-efficacy and goals, because people are more 
likely to set more ambitious goals, be more persistent in striving toward the goals, and then 
achieve those goals if they have higher outcome expectations, many facilitators, and few 
impediments (Figure 2.2).13 
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Figure 2.2 Social Cognitive Theory13 
  
As described in section 2.6.1, Social Cognitive Theory has been previously used in a 
major observational study of factors influencing glaucoma patients’ eye drop technique and 
adherence,4,82 as well as other studies of video education for self-management behaviors in 
asthma,61 obstructive sleep apnea,163 and diabetes.145 In general, higher self-efficacy in using 
medications has been associated with higher medication adherence in a wide range of studies 
across multiple diseases,181,182 including glaucoma.74,108,183 Higher eye drop technique self-
efficacy has also been associated with better eye drop technique.53,59,74 
Particularly relevant is the fact that Social Cognitive Theory has been used to assess 
determinants of eye drop adherence with a focus on patient-provider communication.4,82 In a 
study by Sleath et al., ophthalmologist visits were video-recorded to assess the content and 
quality of patient-provider communication.4 Among Social Cognitive Theory constructs, 
adherence self-efficacy and outcome expectations were hypothesized to be particularly important 
determinants of adherence.4 Adherence self-efficacy was measured with a general 21-item 
glaucoma self-efficacy questionnaire, outcome expectations were measured with a 4-item self-
SELF-EFFICACY 
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report measure, and adherence was measured objectively with MEMS caps.4 The results 
supported the hypothesis that adherence self-efficacy and outcome expectations were 
significantly associated with adherence. The positive effect of outcome expectations in this study 
contrasts with the Health Belief Model studies by Barker et al. and Newman-Casey et al., who 
asked patients about whether they believed eye drops would help prevent vision loss and found 
that beliefs about medication benefits had no effect on adherence.84,108 
 In another publication from Sleath’s study, Slota et al. focused on problems using 
medications and self-reported difficulty with proper instillation of drops.82 Transcripts of visits 
were coded to determine whether patients mentioned problems with using medications, side 
effects, or nonadherence to glaucoma medication. Patients who had lower than an eighth-grade 
reading level were less likely than other patients to mention a problem with administering eye 
drops.82 Patients were more likely to express a problem with nonadherence if they also had 
problems with eye drop administration or problems with side effects. Although the Social 
Cognitive Theory constructs of self-efficacy and outcome expectations were not explicitly 
included in this analysis, the results support the idea that self-efficacy and side effects – which 
are one type of negative outcome expectation – influence patient adherence. 
The proposed conceptual model for this study based on Social Cognitive Theory is shown 
in Figure 2.3. As suggested by the results of the observational study by Sayner et al., patient 
demographics affect eye drop technique self-efficacy and likely also have an independent effect 
on eye drop technique.9 Vision loss and arthritis are associated with lower self-efficacy to instill 
eye drops as well as poorer technique.9,59 Low health literacy is also a risk factor for poor technique 
and self-efficacy.16 Improving self-efficacy and technique with an eye drop technique intervention 
is expected to result in better adherence, since patients are likely to notice more benefit from the 
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medication if they know how to instill their eye drops correctly and are getting drops in their 
eyes.6,83,108 Outcome expectations are also a key component of Social Cognitive Theory; patients 
who believe that performing correct eye drop instillation is more clinically beneficial are likely to 
be more persistent at learning to instill eye drops, and thus adhere to their regimen better. 
 
 
Figure 2.3. Conceptual model based on Social Cognitive Theory 
   
 
 
 Sections 2.6.3-2.6.8 will now present the different components of the theoretical 
framework. 
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2.6.3	Intervention	
 The 4-minute Meducation eye drop technique video was used in the intervention group to 
instruct patients on the critical steps in proper eye drop instillation. The video demonstrates how 
to wash one’s hands correctly prior to eye drop use; remove the cap from the bottle and set it 
down on its side to avoid contamination; tilt the head back and direct the bottle toward the eye; 
hold open the lower eyelid; aim the bottle toward the eye and squeeze the bottle to produce a 
single drop; close the eye and occlude the tear duct; and remove excess medicine with a tissue. 
Similar to other Social Cognitive Theory-based educational videos that have shown success in 
past studies,6,144,163 the Meducation video applies Social Cognitive Theory by demonstrating the 
process of eye drop instillation in simple language, drawing on the Social Cognitive Theory 
concepts of observational learning, facilitation, and self-efficacy. The previous studies using 
videos have generally seen improvements in self-efficacy6,163 which were linked to improvement 
in final outcomes of medication technique, medication adherence, or diet change, as discussed 
above in section 2.6.1.6,144,145,163 The Meducation eye drop technique video is compatible with 
any platform, allowing it to be viewed on computers, tablets, or mobile phones. The video is 
available in 21 languages, using the same graphics, which are displayed for different lengths of 
time to fit together with narration in the patient’s preferred language. However, since 
interviewers fluent in other languages were not available for this pilot study, only the English 
version was tested in this study. 
 The video intervention was expected to influence eye drop technique self-efficacy and 
eye drop technique. Social Cognitive Theory predicts that observing a model performing the 
desired behavior of correct eye drop technique should improve self-efficacy to perform that 
behavior.179 The intervention was expected to improve eye drop technique, an effect that may be 
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mediated by eye drop technique self-efficacy. However, there could also have been an 
independent effect of the intervention on eye drop technique that was not mediated by eye drop 
technique self-efficacy. As shown in the model, the video was not expected to directly influence 
medication adherence because the video is focused on technique. 
 The control group viewed a 3-minute nutrition video called “How to Cook with Budget 
Friendly Whole Grains” produced by the US Department of Agriculture Food and Nutrition 
Service as part of the Choose MyPlate campaign.173 This video is available free on YouTube and 
explains how to use whole grains to prepare healthy dishes such as rice bowls, pasta salad, and 
breakfast burritos. It also emphasizes the health benefits of eating whole grains high in fiber. 
This video does not discuss medication use and therefore was not expected to have any effect on 
eye drop technique, technique self-efficacy, or medication adherence. While changes in diet may 
have a minor effect on blood pressure, reducing blood pressure does not improve IOP; in fact, 
lower blood pressure is likely to increase IOP.21,184 Even if the nutrition video had affected IOP, 
IOP is not an outcome in this study due to the difficulty of measuring it outside of the clinic 
setting. Therefore, no placebo effect on the major outcomes of this study was anticipated. 
 
2.6.4	Patient	characteristics	
 Patient characteristics that may influence eye drop instillation technique and adherence 
include gender, race, age, health literacy, years of education, length of time using glaucoma 
medications, severity of glaucoma or vision loss, and comorbidities such as 
arthritis.9,17,53,56,76,81,84,87,89,102,103,107,185 The literature suggests that female gender, older age, lower 
health literacy, more severe glaucoma, and having arthritis are associated with poorer medication 
technique.9,16,17,54,58 The literature also suggests that African American race,16,18,48,66,71,73-75 lower 
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health literacy,16 fewer years of education,17,56,81 shorter length of time using glaucoma 
medications,17,81,87 more severe visual field defect,9,53,107 depression,81 and being unmarried84 are 
associated with poorer medication adherence. Though not a patient characteristic, strictly 
speaking, more frequent dosing (e.g. three times a day vs twice or once daily) and greater 
number of glaucoma medications have also been associated with poorer adherence,82,115 although 
one study found better adherence with twice-daily than once-daily dosing.66 
Patient characteristics may also influence eye drop technique self-efficacy. In a study of 
102 glaucoma patients by Sleath et al., age, gender, race, and years of education were not 
associated with eye drop technique self-efficacy, but a longer time taking glaucoma medications 
was associated with better eye drop technique self-efficacy.59 The relationship of health literacy 
to eye drop technique self-efficacy is not known. It may be that low literate patients are 
overconfident in their ability to use eye drops, and therefore do not experience a decrement in 
self-efficacy. The idea that patients may be overconfident is supported by the study by Al-
Busaidi et al., where 91% of patients stated that they had no trouble instilling drops, but only 
20% actually had good technique.72 Similarly, Dietlein et al. found that all patients in their study 
judged themselves sufficiently capable of instilling their own drops, but 55% contaminated the 
bottle and only 39% instilled just one drop.69 
 
2.6.5	Outcome	expectations	
 Outcome expectations are an important component of Social Cognitive Theory, which 
theorizes that patients who anticipate a greater likelihood of a certain behavioral outcome (e.g. 
avoiding vision loss or blindness), and a greater value from that outcome, will strive more 
diligently to achieve the outcome. Few glaucoma studies have assessed outcome expectations, 
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but a validated 4-item scale does exist.74 We theorized that patients may anticipate a greater 
likelihood of successful control of their IOP after watching the video and be more persistent in 
trying to achieve successful IOP control by using their eye drops regularly. Therefore, it was 
important to control for outcome expectations when modeling the effect of the intervention on 
eye drop technique and medication adherence. 
 
2.6.6	Eye	drop	technique	self-efficacy	
 Self-efficacy is the main predictor of performance of a behavior in Social Cognitive 
Theory. Eye drop technique self-efficacy was expected to be influenced by patient characteristics 
and the intervention, and higher self-efficacy was expected to lead to better technique (Figure 
2.3). Better eye drop technique self-efficacy has been associated with better technique in several 
previous studies,53,59,74 although at least one study found no association.61 
 
2.6.7	Eye	drop	instillation	technique	
 Eye drop instillation technique is the primary outcome measure in this study. In 
accordance with Social Cognitive Theory and the eye drop technique literature cited above, eye 
drop instillation technique was expected to be influenced by technique self-efficacy, patient 
characteristics, outcome expectations, and the video intervention (Figure 2.3). Higher technique 
self-efficacy, more positive outcome expectations, and being in the intervention group rather 
than the control group were expected to be associated with better technique, defined as a greater 
number of eye drop instillation steps performed correctly, immediately after intervention and at 1 
month later. 
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2.6.8	Medication	adherence	
 Medication adherence was a secondary outcome measure in this study. Medication 
adherence is defined as the degree to which medication is taken as prescribed by a healthcare 
provider.75 Medication adherence was expected to be influenced by medication technique, as 
patients who learn to instill their eye drops correctly should be more likely to perceive 
medication use as both feasible and beneficial than patients who have not mastered correct 
technique (Figure 2.3).13 Social Cognitive Theory also suggests that technique should be related 
to adherence because patients with better technique self-efficacy and medication technique are 
likely to be more persistent when faced with obstacles to their medication adherence.13 We 
expected that improvements in both self-efficacy and outcome expectations may thus lead to 
improved adherence, defined in this study as the patient taking medication correctly a greater 
percentage of the time as reported by Visual Analog Scale. 
 
2.6.9	Limitations	
 There were a few limitations related to the use of theory in this study, mainly that not all 
Social Cognitive Theory constructs were measured. The exact learning processes that take place 
could not be readily ascertained. Future studies could compare video to other methods of 
teaching technique to determine whether video facilitates learning processes that are not possible 
with printed educational materials. Also, the Social Cognitive Theory concept of facilitation 
suggests that environmental changes and resources may make behaviors easier to perform. 
However, the environment in which patients demonstrated their technique during the study may 
be different from their environment at home. The clinic environment could be more stressful, 
unfamiliar, and challenging, but it could also be more favorable because the home environment 
 87 
might not be clean and free of distractions. Through the randomized, controlled design, the study 
methodology increased the chance that environmental factors should be balanced across the 
groups and not confound the results. 
 
2.6.10	Summary	 	
This study aimed to improve glaucoma patients’ eye drop instillation technique and 
medication adherence through an online educational video intervention demonstrating how to 
instill eye drops in an easily understood animated format. Social Cognitive Theory was an 
excellent foundation for the development of this intervention, since it has shown success in past 
studies of glaucoma medication adherence and similar behaviors.4,6,82 In contrast, studies based 
on the Health Belief Model have more often found that the constructs included, especially beliefs 
about glaucoma or glaucoma medications, are not predictive of eye drop technique and 
medication adherence.84,108 Validated instruments consistent with the principles of Social 
Cognitive Theory also exist for all the constructs that were measured in this study.74,83 Thus, it 
was reasonable from a theoretical standpoint to expect that receiving the online educational 
video intervention would be associated with better self-efficacy, more positive outcome 
expectations, and better eye drop technique and adherence. 
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Chapter 3: Methods 
3.1	Overview	
This study aimed to determine the effectiveness of a short educational video in improving 
self-efficacy, eye drop technique, and eye drop adherence at two time points: immediately after 
watching the video and 1 month later. Based on the theoretical model in Figure 2.3, the 
following aims and hypotheses were proposed: 
Aim 1: To determine whether glaucoma patients’ eye drop self-efficacy and technique are 
improved immediately after watching a video instructing them on proper technique. 
The following hypotheses were tested: 
H1: Glaucoma patients who watch the Meducation video will have better eye drop 
instillation technique immediately after watching the video than control group patients 
who do not watch the video. 
H2: Glaucoma patients who watch the Meducation video will have better eye drop 
technique self-efficacy immediately after watching the video compared to control group 
patients who do not watch the video. 
Aim 2: To determine whether intervention patients have better self-efficacy, eye drop 
technique, and medication adherence than control patients at 1 month after study 
enrollment. 
The following hypotheses were tested: 
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H3: Glaucoma patients who watch the Meducation video will have better eye drop 
technique at 1 month after first watching the video, compared to control group patients 
who do not watch the video. 
H4: Glaucoma patients who watch the Meducation video will have better eye drop 
technique self-efficacy at 1 month after first watching the video, compared to control 
group patients who do not watch the video. 
H5: Glaucoma patients who watch the Meducation video will have better medication 
adherence at 1 month, as assessed by Visual Analog Scale, compared to control group 
patients who do not watch the video. 
Aim 3: To describe patient perspectives on how to improve the video and how to 
disseminate it to other glaucoma patients. 
Aim 3 was only descriptive in nature, so no specific hypotheses were developed for this aim. 
 
To achieve the three aims, a randomized controlled trial was performed, followed by 
interview questions for the intervention group to guide the improvement and dissemination of the 
video. In the RCT (Figure 3.1), 92 glaucoma patients were randomized to watch either the 4-
minute Meducation video in the experimental group, or a 3-minute video on nutrition 
(functioning as a placebo intervention) in the control group. A previous study6 used similar 
methodology by comparing asthma patients who watched a video on inhaler technique to control 
patients who watched a nutrition video. 
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Figure 3.1: Overview of study design 
 
3.2	Procedures		
3.2.1	Recruitment	and	Eligibility	Criteria	
Adult glaucoma patients visiting an academic medical center in suburban North Carolina 
or a private ophthalmology clinic in urban Maryland, who self-administered their eye drops and 
were not blind, were referred to the research assistant (RA) by clinic staff to ask if they might be 
interested in participating in the study. The RA explained the study, and if the patient was 
interested, the RA obtained written consent. The inclusion criteria were: 
1. At least 18 years of age 
2. Able to speak and read English 
3. Mentally competent to participate as determined by the Mental Status 
Questionnaire186 (defined as making fewer than 5 errors on the 10-item questionnaire) 
4. Diagnosed with primary open-angle glaucoma in their medical record 
5. Prescribed at least one eye drop medication for use at least once daily (self-report) 
 91 
6. Patient self-administered their own eye drops 
7. Not legally blind 
8. Performed at least one of 5 eye drop technique steps incorrectly 
9. Willing to have their eye drop technique video-recorded 
 
Patients who expressed interest in participating provided written consent using a 
document approved by the Institutional Review Board (IRB). Then they were screened for 
eligibility by answering the questions on the eligibility screener (Appendix A). If they met 
eligibility criteria, they were then videotaped demonstrating their instillation technique with a 5 
mL bottle of artificial tears. If they had glaucoma in both eyes, they were instructed to instill a 
drop into their right eye; otherwise they instilled a drop into the affected eye. As we have done 
successfully in previous studies, patients used a standardized bottle of artificial tears that could 
be different in size or shape from what they use at home.9 If a patient did not qualify, they were 
thanked for their time, and the videotape was immediately erased and was not analyzed. No 
payment was given to patients who did not qualify.  
To be eligible, patients had to miss at least one of the five technique steps shown in Table 
3.1.11 The RA used a checklist to determine whether the patient missed any steps for the purpose 
of qualifying for the study. The principal investigator and RAs were trained by one of the study 
team ophthalmologists to accurately assess technique. However, the patient’s final technique 
score for the purposes of analysis was determined by a masked observer who viewed the 
videotape at a later point (see section 3.2.5 below). 
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Table 3.1: Steps in eye drop technique that were scored11 
• Squeezing the bottle to instill a single drop 
• Holding open the lid with the finger  
• Getting one drop accurately into the eye 
• Not touching the bottle tip to the eye or face 
• Closing the eye after instillation 
	
3.2.2	Randomization	
The principal investigator generated a randomization list using SAS. A single list was 
generated and divided amongst the two study clinics. Eligible patients were randomized 1:1 to 
the intervention or the control group. Opaque randomization envelopes were prepared with the 
group assignment for each patient. As recommended by guidelines, opaque envelopes help to 
protect the integrity of the randomization, assuring that research staff cannot manipulate the 
randomization process based on a personal desire to assign a particular patient to a particular 
group.187 As each patient was enrolled, the next randomization envelope was opened and used to 
assign that patient to the correct group. 
 
3.2.3	Baseline	Visit	
 As discussed above in section 3.2.1, patients who were interested in participating 
provided written consent. They were determined to be ineligible if they correctly performed all 5 
steps or failed to meet any other inclusion criteria. For patients determined to be eligible, the RA 
conducted the interview and collected all measures, including self-efficacy, outcome 
expectations, adherence measures, and demographics (Appendix B). The RA then opened the 
randomization envelope to randomize the patient to the intervention or control group. Depending 
 93 
on group assignment, the patient then viewed the Meducation eye drop technique or the nutrition 
video. The self-efficacy and outcome expectations scales were then administered again, and the 
patient demonstrated his/her eye drop technique again while being videotaped. Intervention 
group patients were given an access code and shown how to access the video at home or on a 
mobile device at their convenience. All patients were asked to schedule a time for a follow-up 
visit at their home or a location of their choice approximately 1 month later. If they did not want 
to schedule the follow-up visit at that time, the RA called them about three weeks later to 
schedule the visit. Patients received $20 for completing the baseline visit. 
 
3.2.4	Follow-up	Visit	
 Although every effort was made to schedule a visit no later than 6 weeks from the 
baseline visit, patients who did not respond to the RA’s phone calls or mailings were seen at their 
next visit to the clinic. The RA visited the patient’s home or preferred alternative location and 
administered the self-efficacy, medication adherence, and outcome expectations scales by 
interview.11,74,83 Then the RA video-recorded the patient’s eye drop technique. Intervention 
group patients were also asked with whom they have watched the video, and their subjective 
rating of the video on a 4-point scale. Intervention group patients also completed questions about 
how the video should be improved and how it should be disseminated (Appendix C). All patients 
were granted access to the Meducation video after completion of the study, thus assuring that 
control group patients were not denied the opportunity to benefit from learning about eye drop 
technique. Patients received $20 for completing the follow-up visit. 
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3.2.5	Assessment	of	eye	drop	technique	
Eye drop technique was assessed by videotaping the patient’s technique at each time 
point (baseline before and after watching the intervention or control video, and at 1-month 
follow-up) and having a masked RA watch each video to score the patient’s performance of the 
critical steps. The principal investigator and study ophthalmologist trained the masked RA on 
how to assess correct performance of each step, which was recorded on a checklist as performed 
correctly or incorrectly. The masked RA did not know the study hypotheses, and recordings from 
different time points were given to the RA in random order to minimize risk of bias. 
 
3.3	Outcome	Measures	
The primary outcome of eye drop instillation technique and the secondary outcomes of 
eye drop technique self-efficacy and medication adherence were assessed using validated 
measures. Table 3.2 shows the variables that were collected, the time points when they were 
collected, the source, and the range as well as whether the variable was treated as continuous, 
categorical, or dichotomous. The outcomes of eye drop technique, eye drop technique self-
efficacy, and medication adherence were all treated as continuous variables. While eye drop 
technique is the number of steps and therefore a count (discrete) variable, past glaucoma studies 
by our team have treated it as a continuous variable for analysis.9 Vision-related quality of life 
was also collected to assess the clinical significance of the changes that patients experience over 
the study period. 
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Table 3.2: Key Variables, Time Points Assessed, Source and Range 
Variable Time Points Source Range 
Outcomes    
Eye drop instillation technique11 Before & after 
video, 
1-month 
Assessment of video 
recording by masked 
study team member 
Discrete; 0-5 
Eye drop technique self-efficacy59 Before & after 
video, 
1-month 
6-item Eye Drop 
Technique Self-
Efficacy Scale 
Continuous; 6-18 (each item scored as 
1=not at all confident, 2=somewhat 
confident, 3=very confident) 
Medication adherence83 Before video, 
1-month 
Visual Analog Scale Continuous; 0-100% 
Vision-related quality of life188 Before video, 
1-month 
VF-14 quality-of-life 
scale 
Continuous; 0-100 
Patient characteristics    
Gender Baseline Patient interview 1=male, 0=female 
Race Baseline Patient interview 1=African American, 0=non-African 
American 
Age Baseline Patient interview Continuous 
REALM (Rapid Estimate of Adult 
Literacy in Medicine) 
Baseline Patient interview 1=eighth grade and below, 0=ninth 
grade and above 
Severity of glaucoma Baseline Medical record 0=early, 1=moderate to severe 
Length of time using glaucoma 
medications 
Baseline Patient interview Continuous 
Diagnosis of arthritis or other condition 
affecting manual dexterity** 
Baseline Medical record 1=yes, 0=no 
Years of education Baseline Patient interview Continuous 
Outcome expectations74 Before & after 
video, 
1-month 
Glaucoma Outcome 
Expectations Scale 
Continuous; 4-36 (Each of 4 items 
scored on a 9-point Likert scale) 
Number of glaucoma medications 
being taken 
Baseline Medical record Discrete 
Number of times per day the patient 
takes glaucoma medications 
Baseline Medical record Discrete 
Visual acuity in better-seeing eye Baseline Medical record Continuous (1.0=20/20 vision) 
Patient’s eyes dilated during visit Baseline Patient interview 1=yes, 0=no 
Physician educated about technique Baseline, 1-
month 
Patient interview 1=yes, 0=no 
Patient’s use of the Internet Baseline Patient interview (7 
questions) 
2 categorical and 5 dichotomous items 
Problems in using glaucoma 
medications82 
Baseline 13-item problems 
scale 
Discrete; 0-13 
Intervention-related characteristics    
Intervention versus control Baseline Randomization table 1=intervention, 0=control 
Number of times the patient watched 
the video after the baseline visit 
1-month* Electronic tracking 
system for access code 
Discrete 
Perceived usefulness of video 1-month* Patient interview 1=not at all useful, 2=a little useful, 
3=fairly useful, 4=very useful 
Whom the patient watched the video 
with 
1-month* Patient interview Categorical (1=family member, 
2=friend, 3=healthcare provider, 
4=other) 
*In intervention group patients only 
**Asked on medical abstraction form, “Does the patient have: arthritis, tremors, Parkinson’s disease, any other condition affecting 
manual dexterity (specify other)?” 
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3.3.1	Eye	drop	technique	
Eye drop technique was assessed at all time points as the number of eye drop technique 
steps performed correctly, as shown above in Table 3.1. Eye drop technique could range from 0 
to 5 steps performed correctly and was treated as a continuous variable. 
 
3.3.2	Eye	drop	technique	self-efficacy	
Eye drop technique self-efficacy was assessed at all time points using the Eye Drop 
Technique Self-Efficacy Scale. This scale is a 6-item, validated short-form measure of a longer 
version of the scale.59 Patients were asked how confident they were that they could squeeze the 
bottle, get the drop in their eye, consistently get the right amount into the eye, angle their head 
correctly, deliver the required amount of medication without missing or applying too much, and 
not touch their face with the bottle.59 These tasks correspond closely to the steps covered in the 
Meducation video. Each of the 6 items was scored as 1 (not at all confident), 2 (somewhat 
confident), or 3 (very confident), and the items were summed to give a total score ranging from 6 
to 18. In previous literature, the scale had a Cronbach’s alpha of 0.84.9 In the present study, 
Cronbach’s alpha of the 6-item scale at baseline was 0.68. 
 
3.3.3	Medication	adherence	
Medication adherence was assessed using a VAS measure, which had been validated 
against the gold standard of electronically monitored adherence in a large observational study of 
279 patients.83 Patients marked on a 10-cm line their responses to the question, “All things 
considered, how much of the time do you use your eye drops EXACTLY as directed?” with 
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endpoints “None of the time” and “All of the time”. The number of centimeters from the left end 
of the line to the patient’s mark was divided by 10 and then multiplied by 100 to give a 
percentage adherence score between 0% and 100%.  
In a secondary, exploratory analysis, a new 5-item VAS adherence measure was 
developed. Patients marked on a 10-cm line their responses to each of 5 questions worded in the 
form, “How often do you miss taking your eye drops because ... ?” The 5 items were: 1) you 
forget; 2) they cause side effects; 3) they are too expensive; 4) you run out of eye drops before 
you can get a refill; 5) they are hard to use. Each item was rated on a 10-cm line with endpoints 
“Never” and “Very often”. There was a potential benefit to developing a new measure because 
although the 1-item VAS adherence measure generally has good properties,83 a single-item 
measure tends to be weaker than a multi-item measure. A multi-item measure allows reliability 
(Cronbach’s alpha) to be calculated, and a basic factor analysis to be performed. Items were 
tested in an exploratory factor analysis using the Factor command in SPSS, and items that loaded 
too low (less than 0.6), or proved to be redundant, were dropped. Principal components analysis 
was performed to determine the number of factors in the scale. A scree plot was used to plot the 
eigenvalues of the correlation matrix, and factors with an eigenvalue greater than 1 were 
retained. 
After factor analysis had been performed for the new 5-item scale, the overall adherence 
score was calculated as the mean summary score of all 5 items. Medication adherence was 
treated as a continuous variable with a range of 0% to 100%. 
 The factor analysis revealed that the new 5-item VAS for medication adherence had two 
factors. Three items, “How often do you miss taking your eye drops because you forget?”, “How 
often do you miss taking your eye drops because they are too expensive?”, and “How often do 
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you miss taking your eye drops before you can get a refill?” loaded on the first factor, which had 
an eigenvalue of 1.846. The other two items, “How often do you miss taking your eye drops 
because they cause side effects?” and “How often do you miss taking your eye drops because 
they are hard to use?” loaded on the second factor, which had an eigenvalue of 1.196. No items 
were dropped due to loading less than 0.6 on both factors. The results of the factor analysis are 
shown in Table 3.3. A parallel analysis produced a similar 2-factor solution with eigenvalues of 
1.295 for the first factor and 1.121 for the second factor. 
 
Table 3.3. Rotated component matrix for factor analysis of 5-item VAS for medication 
adherence. 
Question Factor 1 Factor 2 
“How often do you miss taking your eye 
drops because you forget?” 
0.580 0.388 
“How often do you miss taking your eye 
drops because they cause side effects?” 
-0.024 0.824 
“How often do you miss taking your eye 
drops because they are too expensive?” 
0.695 0.171 
“How often do you miss taking your eye 
drops before you can get a refill?” 
0.178 0.780 
“How often do you miss taking your eye 
drops because they are hard to use?” 
0.844 -0.167 
 
3.3.4	Vision-related	quality	of	life	
 Vision-related quality of life was assessed using the Visual Function-14 (VF-14) 
questionnaire,188,189 which has been validated in a range of diseases including glaucoma.188 This 
instrument assesses the impact of visual impairment on ability to perform each of 14 daily tasks. 
Each item is scored as 0 (unable to do) to 4 (no impairment). The 14 items are then averaged, 
and the result is multiplied by 25 to give a score between 0 (total impairment) and 100 (no 
impairment).189 The minimal clinically important difference on the VF-14 in glaucoma has not 
 99 
been established and was not used in this study, but in cataracts, a difference of about 16 points 
is considered clinically significant.190 
 
3.4	Other	Measures	
 Health literacy was measured using the REALM,191 a commonly-used, validated measure 
that has been used in previous large glaucoma studies.9 Patients were asked to pronounce each of 
66 health-related terms. Those who score 61 or higher are considered to have a ninth-grade or 
higher level of health literacy, whereas those who score 60 or lower are considered to have an 
eighth-grade or lower level of health literacy. Health literacy was treated as a dichotomous 
variable (ninth grade or higher versus eighth grade or lower). 
 Outcome expectations was measured with the 4-item scale by Sleath et al.74 This scale 
was validated in a study of 102 glaucoma patients and had a Cronbach’s alpha of 0.83.74 Each 
item was scored on a 9-point scale from 1 (not at all) to 9 (extremely), resulting in a score 
between 4 and 36.74 Examples include, “How much do you think it will help your glaucoma if 
you come to your appointments with your eye doctor?” and “How much do you think it will help 
your glaucoma if you use your eye drops regularly?” In the present study, Cronbach’s alpha for 
the outcome expectations scale at baseline was 0.86. 
 Problems with using medications was measured with the 13-item scale by Slota et al.82 
Cronbach’s alpha for this scale has not been reported in prior studies, but in the present study 
Cronbach’s alpha is 0.72. Each problem is scored as 0=none, 1=a little, or 2=a lot, and the 
responses are dichotomized (none versus a little or a lot), producing a number of problems 
between 0 and 13.82  Example items include “My medication causes side effects,” “It is difficult 
to remember all the doses,” and “It is hard to pay for the medications.” 
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 Other variables that were collected (Table 3.2) include gender (dichotomous), race 
(dichotomous – African American versus other), age (continuous), glaucoma severity (early 
versus moderate to severe, based on the diagnosis recorded in the medical record for the baseline 
visit), length of time using glaucoma medications (continuous), diagnosis of arthritis or other 
condition affecting manual dexterity (dichotomous), years of education (continuous), number of 
glaucoma medications the patient is taking (discrete, treated as continuous), number of times per 
day the patient takes glaucoma medications (i.e. whether the patient is on a once-daily, twice-
daily, or three-times-daily regimen; discrete, treated as continuous), visual acuity in the better-
seeing eye as a continuous decimal (e.g. 20/20 vision=1.0), whether the patient’s eyes were 
dilated during the visit (dichotomous), whether the physician educated the patient about 
technique (dichotomous), and how the patient uses the Internet (2 categorical questions and 5 
dichotomous questions). The medical record was used to determine glaucoma severity, diagnosis 
of arthritis or other condition affecting manual dexterity, number of glaucoma medications the 
patient is taking, number of times per day the patient takes glaucoma medications, and visual 
acuity. Other conditions possibly affecting manual dexterity included stroke, diabetic 
neuropathy, numbness of fingers and toes, peripheral neuropathy, injury to hands and arms, 
peripheral vascular disease, neurofibromatosis, neck pain, cervical radiculopathy, decreased 
range of motion cervical spine, shoulder pain, spastic hemiplegia, cognitive disorder, vascular 
dementia, carpal tunnel syndrome, muscle pain, and gout. 
 
3.4.1.	Evaluation	measures	for	intervention	patients	only		
For intervention patients only, the number of times the patient watched the video after the 
baseline visit (discrete, treated as continuous), subjective evaluation of the video’s usefulness (4-
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point scale), and with whom the video was watched (categorical), were also collected. Subjective 
evaluation of the video’s usefulness was scored as 1 (not at all useful), 2 (a little useful), 3 (fairly 
useful), or 4 (very useful). With whom the video was watched had the following response 
choices: friend, family member, healthcare provider, other (specify), or no one. Patients could 
choose multiple options (“check all that apply”). The evaluation questions are the same as those 
used by the same research team in a study of an online diabetes educational video149 and in an 
ongoing RCT of an online educational video intervention for adolescents with asthma.192  
The patient’s access code was used to determine the number of times the patient watched 
the video after the baseline visit. We worked with Polyglot Systems, which had the ability to 
electronically track who used an access code to watch the video and when they watched it. 
Intervention group patients were also asked the evaluation questions (Appendix C): 
1. “Would you suggest that other patients watch the video?”  
2. “How would you change the video?” 
3. “What other topics would you like to cover in videos?” 
4. “In what ways did the video help you?” 
5. “How would you want the video to be made available?” 
6. “What do you think is the best way to make the video available to other glaucoma 
patients?” 
 
3.5	Sample	Size	
 Our previous study of 279 glaucoma patients showed that for patients meeting the 
inclusion criteria for the present study – not having perfect technique at baseline and self-
administering their eye drops – the mean number of steps performed correctly was 1.54 of 3 
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steps with a standard deviation of 0.53.61 There were no previous studies that have intervened on 
eye drop technique with a similar intervention that could be used to determine an expected effect 
size. If we used the same three steps, we estimated that the video intervention would improve 
technique by at least one step per three patients. Using the standard deviation computed from the 
previous observational study,61 a difference of one step per three patients is 0.3333/0.53=0.63 
standard deviations and considered a clinically important difference. Using SAS PROC POWER, 
we calculated that to have 80% power to detect a difference of 0.63 SD with two-sided a=0.05, 
we would need 42 subjects per group. Allowing for 10% loss to follow-up, we needed 46 
subjects per group for a total of 92 subjects. This was considered to be a conservative estimate 
given that measuring 5 steps, as opposed to 3, may increase power. Although using more steps 
could also increase the standard deviation and thus decrease the effect size, using more steps also 
gives patients an opportunity to show at least a minimal one-step improvement on a wider range 
of different potential technique issues. 
 
3.6	Preliminary	Analyses	
All data were analyzed using SPSS 24 (IBM SPSS, Armonk, New York). All statistical 
tests were performed as two-sided tests at the a=0.05 level. Preliminary analyses were performed 
to examine the distributional properties of the data and check reliability of scales. Frequencies and 
descriptive statistics of each variable were generated to check for outliers and potential errors. 
Reliability of all scales was calculated using Cronbach’s alpha. Preliminary bivariate analyses also 
included t-tests for continuous variables, or chi-square tests for dichotomous variables, to assess 
the unadjusted differences between intervention and control groups in technique, adherence, and 
self-efficacy at both the baseline and 1-month time points. 
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3.7	Aim	1	Analysis	
Aim 1: To determine whether glaucoma patients’ eye drop self-efficacy and technique are 
improved immediately after watching a video instructing them on proper technique. 
The following hypotheses were tested: 
H1: Glaucoma patients who watch the Meducation video will have better eye drop 
instillation technique immediately after watching the video than control group patients 
who do not watch the video. 
A multivariable linear regression model was used to predict the number of eye drop technique 
steps performed correctly immediately after watching the video at the baseline visit. The key 
independent variable was group assignment (intervention versus control). Baseline technique 
(number of steps performed correctly prior to watching the video) was included as a covariate to 
minimize the impact of baseline differences between the intervention and control groups, and 
baseline self-efficacy was included due to its relationship with technique in the theoretical model.  
The other covariates included in the model were selected as those that either 1) were 
significantly associated with the outcome in a correlation matrix with p<0.05, or 2) changed the 
regression coefficient associated with group assignment by at least 10% when included in the 
regression model.193 Covariates considered for inclusion were age, race, gender, health literacy, 
glaucoma severity, length of time using glaucoma medications, diagnosis of arthritis or other 
condition affecting manual dexterity, years of education, baseline outcome expectations, number 
of glaucoma medications being taken, number of times per day the patient takes glaucoma 
medications, visual acuity in the better-seeing eye, whether the patient’s eyes were dilated, and 
whether the patient was previously educated about technique. 
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There were two possible ways to account for baseline technique in the model: using the 
technique score at the later time point, with adjustment for baseline technique, or using a change 
score (i.e. number of steps improvement). Using the technique score at the later time point with 
adjustment for baseline technique was preferred because it is more conservative and less biased.194 
A significant imbalance in baseline values between intervention and control groups would allow 
one group more room for improvement, which could bias the comparison between groups if a 
change score were used.194 
Additionally, a multivariable logistic regression was performed to predict the single step 
of getting one drop accurately into the eye. This analysis was performed because the 
ophthalmologists on the study team considered getting the drop into the eye to be a particularly 
important step, and expected that readers of ophthalmology journals would be especially interested 
in knowing the effect of the video on this step. The key independent variable was group assignment 
(intervention versus control). As in the main model, getting the drop accurately into the eye prior 
to watching the video (yes/no) was included as a covariate, and other covariates included in the 
model were selected as those that either 1) were significantly associated with the outcome in a 
correlation matrix with p<0.05, or 2) changed the regression coefficient associated with group 
assignment by at least 10% when included in the regression model.193 The covariates considered 
for inclusion were age, race, gender, health literacy, glaucoma severity, length of time using 
glaucoma medications, diagnosis of arthritis or other condition affecting manual dexterity, years 
of education, baseline outcome expectations, number of glaucoma medications being taken, 
number of times per day the patient takes glaucoma medications, visual acuity in the better-seeing 
eye, whether the patient’s eyes were dilated, and whether the patient was previously educated 
about technique. 
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H2: Glaucoma patients who watch the Meducation video will have better eye drop 
technique self-efficacy immediately after watching the video compared to control group 
patients who do not watch the video. 
A multivariable linear regression model was used to predict the eye drop technique self-efficacy 
score immediately after watching the Meducation or nutrition video. The key independent 
variable was group assignment (intervention versus control). Eye drop technique self-efficacy 
prior to watching the video was included as a covariate.  
Other covariates included in the model were selected as those that either 1) were 
significantly associated with the outcome in a correlation matrix with p<0.05, or 2) changed the 
regression coefficient associated with group assignment by at least 10% when included in the 
regression model.193 The covariates considered for inclusion were age, race, gender, health 
literacy, glaucoma severity, length of time using glaucoma medications, diagnosis of arthritis or 
other condition affecting manual dexterity, years of education, baseline outcome expectations, 
number of glaucoma medications being taken, number of times per day the patient takes 
glaucoma medications, visual acuity in the better-seeing eye, whether the patient’s eyes were 
dilated, and whether the patient was previously educated about technique. 
 Techniques to handle missing data will be discussed in section 3.9. 
 
3.8	Aim	2	Analysis	
Aim 2: To determine whether intervention patients have better self-efficacy, eye drop 
technique, and medication adherence than control patients at 1 month after study 
enrollment. 
The following hypotheses were tested: 
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H3: Glaucoma patients who watch the Meducation video will have better eye drop 
technique at 1 month after first watching the video, compared to control group patients 
who do not watch the video. 
A multivariable linear regression model was used to predict the number of eye drop technique 
steps performed correctly at 1-month follow-up. The key independent variable was group 
assignment (intervention versus control). Baseline technique (number of steps performed correctly 
prior to watching the video) was included as a covariate to minimize the impact of baseline 
differences between the intervention and control groups, and baseline self-efficacy was included 
due to its role in the theoretical model.  
Other covariates included in the model were selected as those that either 1) were 
significantly associated with the outcome in a correlation matrix with p<0.05, or 2) changed the 
regression coefficient associated with group assignment by at least 10% when included in the 
regression model.193 The covariates considered for inclusion were age, race, gender, health 
literacy, glaucoma severity, length of time using glaucoma medications, diagnosis of arthritis or 
other condition affecting manual dexterity, years of education, baseline outcome expectations, 
number of glaucoma medications being taken, number of times per day the patient takes glaucoma 
medications, visual acuity in the better-seeing eye, whether the patient’s eyes were dilated, and 
whether the patient was educated about technique. 
 Additionally, a multivariable logistic regression was performed to predict the single step 
of getting the drop accurately into the eye at 1 month. The key independent variable was group 
assignment (intervention versus control). As in the main model, getting the drop accurately into 
the eye prior to watching the video (yes/no) was included as a covariate, and other covariates 
included in the model were selected as those that either 1) were significantly associated with the 
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outcome in a correlation matrix with p<0.05, or 2) changed the regression coefficient associated 
with group assignment by at least 10% when included in the regression model.193  
The covariates considered for inclusion were age, race, gender, health literacy, glaucoma 
severity, length of time using glaucoma medications, diagnosis of arthritis or other condition 
affecting manual dexterity, years of education, baseline outcome expectations, number of 
glaucoma medications being taken, number of times per day the patient takes glaucoma 
medications, visual acuity in the better-seeing eye, whether the patient’s eyes were dilated, and 
whether the patient was educated about technique. 
H4: Glaucoma patients who watch the Meducation video will have better eye drop 
technique self-efficacy at 1 month after first watching the video, compared to control group 
patients who do not watch the video. 
A multivariable linear regression model was used to predict the eye drop technique self-efficacy 
score at 1-month follow-up. The key independent variable was group assignment (intervention 
versus control). Eye drop technique self-efficacy prior to watching the video was included as a 
covariate.  
Other covariates included in the model were selected as those that either 1) were 
significantly associated with the outcome in a correlation matrix with p<0.05, or 2) changed the 
regression coefficient associated with group assignment by at least 10% when included in the 
regression model.193 The covariates considered for inclusion were age, race, gender, health 
literacy, glaucoma severity, length of time using glaucoma medications, diagnosis of arthritis or 
other condition affecting manual dexterity, years of education, baseline outcome expectations, 
number of glaucoma medications being taken, number of times per day the patient takes glaucoma 
medications, and visual acuity in the better-seeing eye.  
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H5: Glaucoma patients who watch the Meducation video will have better medication 
adherence at 1 month, as assessed by Visual Analog Scale, compared to control group 
patients who do not watch the video. 
A multivariable linear regression model was used to predict medication adherence at 1-month 
follow-up. The key independent variable was group assignment (intervention versus control). 
Baseline adherence was included as a covariate. Other covariates included in the model were 
selected as those that either 1) were significantly associated with the outcome in a correlation 
matrix with p<0.05, or 2) changed the regression coefficient associated with group assignment 
by at least 10% when included in the regression model.193  
The covariates considered for inclusion were age, race, gender, health literacy, glaucoma 
severity, length of time using glaucoma medications, diagnosis of arthritis or other condition 
affecting manual dexterity, years of education, baseline outcome expectations, number of 
glaucoma medications being taken, number of times per day the patient takes glaucoma 
medications, visual acuity in the better-seeing eye, and problems with using glaucoma 
medications. As discussed above in section 3.3.3, the single-item VAS was used as the main 
secondary outcome measure, and the new 5-item VAS was used in an exploratory analysis. 
 
3.9	Missing	data	
 Missing data occurred due to patients being lost to follow-up or refusing to respond to 
certain questions during the patient interviews, because some of the video recordings did not 
show certain steps clearly, and also because a few patients could not see well enough to complete 
the REALM. 
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3.9.1.	Missing	data	for	covariates		
For missing covariate data resulting from failure to answer a question, the mean value of 
the missing variable across all subjects at the relevant time point became the imputed value. For 
example, if a patient refused to answer their number of years of education, the mean number of 
years of education for all study subjects was imputed as that patient’s value. If only some items 
from a scale were missing, the missing values were imputed as the mean value of the other items 
from the scale for that patient at the same time point. Since REALM scores were being treated as 
a dichotomous variable, it was not possible to impute a value and we instead used years of 
schooling, which was highly correlated with REALM score (r=-0.460, p<0.001), in all the 
analyses. Due to the missing data and the fact that imputation of health literacy was not feasible, 
health literacy was not included in any regression models. Overall, a total of five patients were 
missing REALM scores, one patient refused to respond to the question about years of education, 
and self-efficacy scores were missing for one patient at baseline, one patient immediately after 
the video, and two patients at 1 month. 
 
3.9.2.	Missing	data	for	outcomes	
To address missing outcome data, the main analysis used complete case analysis. A 
sensitivity analysis assessed whether the results differ when using simple imputation of the 
missing values. For Aim 1, we imputed missing eye drop technique steps using two scenarios: 
treating all unscorable steps as performed incorrectly, and treating all unscorable steps as 
performed correctly. For Aim 2, the sensitivity analysis was done using a best-case and worst-
case scenario, where the best-case assumed that any improvement observed at the end of the 
baseline visit was maintained, and the worst-case assumed that the entire effect of the video had 
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worn off by 1 month. Therefore, the best-case scenario used last observation carried forward 
(LOCF) for losses to follow-up, while the worst-case scenario carried forward the pre-
intervention value. Both best-case and worst-case scenarios used imputation of the mean value of 
the variable for cases where the patient refused to respond to a question. For both the best-case 
and worst-case analyses, steps that were unscorable at baseline were treated as correctly 
performed, since this was deemed the most conservative approach. 
 Complete case analysis, also known as listwise deletion, involves analyzing only the 
subjects with complete data.195 Complete case analysis is a common and conservative method, 
but could introduce bias if the data are not missing completely at random (MCAR).196,197 In 
particular, bias would be likely to result if the reasons for dropping out of the study are related to 
the key independent variable (intervention or control group) or covariates. Complete case 
analysis would also be the most likely method to lose a substantial amount of statistical power 
since any patient with any missing data would have to be excluded.197 
Simple imputation involves imputing a certain value for patients with missing data, 
usually the last available value for patients lost to follow-up.195 The main drawback of simple 
imputation was the potential for bias if the unknown values for study dropouts were actually 
systematically different from those of patients completing the study, or if the assumption of no 
change from baseline was seriously flawed. Overall, simple imputation by last observation 
carried forward is considered a conservative method, tending to produce bias toward the null.  
 
3.10	Aim	3	Analysis	
Aim 3: To describe patient perspectives on how to improve the video and how to disseminate 
it to other glaucoma patients. 
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Descriptive statistics were computed for all the video evaluation and dissemination 
questions to describe where and with whom the intervention group patients watched the video, 
how the video helped them, whether they would recommend the video to others, how the video 
should be modified, and how the video should be made available to other glaucoma patients. In 
addition, responses to open-ended questions were classified into response categories using open 
coding, and the most common responses were tabulated to inform the future dissemination plan. 
A single coder coded the responses, which has limitations because interrater reliability cannot be 
calculated as it could with multiple coders. We also collected the number of times that each 
patient watched the video using the tracking system for the access codes. The evaluation and 
dissemination results will inform a future dissemination and implementation study. We are 
working with Polyglot Systems to determine the best ways to distribute the video nationwide in 
light of the patients’ recommendations. 
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Chapter 4: Descriptive Statistics and Bivariate Associations Among 
the Independent Variables at Baseline 
 
 This chapter will discuss the population that was enrolled and the patient characteristics 
and clinical characteristics of that population. Then the chapter will present bivariate associations 
among the independent variables at baseline. 
 
4.1.	Participants	
 Eighty-two participants were enrolled at an academic ophthalmology clinic in suburban 
North Carolina between May and October 2017, and 10 were enrolled at a private 
ophthalmology clinic in urban Maryland during November 2017. Follow-up continued at both 
sites until December 2017. The CONSORT flow diagram for enrollment is shown in Figure 4.1. 
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Figure 4.1. CONSORT flow diagram for study enrollment. 
 
A total of 168 patients were approached and 43 patients refused to participate, for a 
participation rate of 74% of people approached, or 68% of eligible participants. Thirty refused 
because of lack of time or needing to get to another appointment, seven because they thought 
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they would not benefit from the study, three because they were not available for a follow-up in 1 
month, one because their eyes were too tired, one because they wanted to take the consent form 
home to have a family member read it, and one said they would participate at their next visit but 
was experiencing serious issues with blurred vision upon the return visit.  
A total of 33 patients were found to be ineligible; eleven potential subjects were 
ineligible because they had perfect technique, nine because they did not instill their own eye 
drops, five because they were unwilling to be video recorded, two because they were legally 
blind, two because they could only use preservative-free artificial tears, two because they did not 
read English, one because their spouse had already been randomized, and one because they 
always used a mechanical device to instill drops. 
One control group patient withdrew consent approximately two weeks after the baseline 
visit, mailing the study team a copy of the consent form stating “withdraw consent” without 
giving a reason. This patient’s data were destroyed and not included in any analyses, so 91 
patients were available for inclusion in baseline analyses. Three intervention group patients and 
one control group patient were lost to follow-up after the baseline visit and did not complete the 
1-month visit. Study staff were unable to reach these patients to determine why they dropped out. 
In addition, one other intervention group patient was unable to return for a follow-up visit, but 
completed the follow-up interview over the phone. 
 The demographics of the patients are shown in Table 4.1. The mean age of the 91 
participants was 69.2 with a standard deviation of 10.7. Fifty-four patients (59%) were non-
Hispanic White, 33 (36%) were Black or African American, 3 (3%) were Asian/Asian 
Indian/South Asian, and 1 (1%) was Hispanic. The mean number of years of schooling was 15.8 
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(SD: 3.3). Seventy-seven percent scored at ninth grade or above on the REALM. Five patients 
were missing REALM scores because their vision was too poor to see any of the words. 
 
Table 4.1. Demographics of participants (N=91). 
 Percent (n) 
Race  
   Non-Hispanic White 59.3 (54) 
   Black or African American 36.3 (33) 
   Asian/Asian Indian/South Asian 3.3 (3) 
   Hispanic 1.1 (1) 
Gender  
   Male 50.5 (46) 
   Female 49.5 (45) 
Health literacy (REALM)a  
   Ninth grade or above 76.7 (66) 
   Eighth grade or below 23.3 (20) 
Clinical characteristics  
   Arthritis or another condition affecting 
manual dexterity 
31.9 (29) 
   Moderate to severe glaucoma 59.3 (54) 
   Dilated during appointment 35.2 (32) 
 Mean (SD) Range 
Age 69.2 (10.7) 23 - 89 
Years of schooling 15.8 (3.3) 8 - 24 
Years using eye drops for glaucoma 9.7 (10.0) <1 - 45 
Number of glaucoma medications being 
taken 
1.93 (0.81) 1 - 4 
Number of times per day the patient 
takes glaucoma medications 
3.11 (1.73) 1 - 8 
Visual acuity in the better-seeing eye 0.77 (0.22) 0.1 - 1.0 
aFive patients missing data because they were unable to see the REALM well enough to read any 
words. 
 
 With regard to clinical characteristics, patients had used eye drops for glaucoma for an 
average of 9.7 years (SD: 10.0). Fifty-nine percent had moderate to severe stage glaucoma. The 
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mean visual acuity in the better eye was 0.77 (SD: 0.22), equating to slightly worse than 20/25 
corrected vision. A total of 32% had arthritis or another condition affecting manual dexterity; 
17% had arthritis, 20% had another condition, and 4% had both. Thirty-three percent were 
currently taking one glaucoma medication, 44% were taking two, 20% were taking three, 2% 
were taking four, and 1% were taking five. Patients used a mean number of 1.93 glaucoma 
medications and were prescribed a mean of 3.11 doses per day. Thirty-five percent of patients 
had their eyes dilated during their appointment. 
 Data on Internet usage and Internet-capable devices used are shown in Table 4.2. A slight 
majority (53%) considered themselves very comfortable with using the Internet. Sixty-three 
percent used the Internet daily, 13% used it a few times a week, 3% a few times a month, 4% 
hardly ever, and 17% never. Ninety-one percent had a cell phone and 61% of those (or 51% of 
all participants) used it to access the Internet. Thirty-three percent also used iPads, 13% used 
tablets, 36% used desktop computers, and 49% used laptop computers. Forty-two percent had 
used the Internet to learn about glaucoma. 
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Table 4.2. Participants’ usage of Internet and Internet-capable devices (N=91). 
 Percent (n) 
How comfortable with using the Internet  
   Very comfortable 52.7 (48) 
   Somewhat comfortable 22.0 (20) 
   Not very comfortable 6.6 (6) 
   Not at all comfortable 18.7 (17) 
How often patient uses the Internet  
   Once or more a day 62.6 (57) 
   A few times a week 13.2 (12) 
   A few times a month 3.3 (3) 
   Hardly ever 4.4 (4) 
   Never 16.5 (15) 
Own a cell phone 91.2 (83) 
Use cell phone to go on the Internet 56.0 (51) 
Internet access in home 85.7 (78) 
Ever used the Internet to learn more 
about glaucoma 
41.8 (38) 
Other Internet-capable devices used 
besides phone* 
 
   iPad 32.9 (30) 
   Tablet 13.2 (12) 
   Desktop computer 36.3 (33) 
   Laptop computer 49.5 (45) 
*Participants could choose more than one 
 The mean score on the scale of problems with using medications at baseline was 2.9 (SD 
2.5) with a range of 0 to 10 problems. The mean outcome expectations score at baseline was 33.9 
(SD 4.6) with a range of 12 to 36. 
 
4.2.	Baseline	characteristics	of	intervention	versus	control	group	
The comparison between the intervention and control groups on baseline characteristics 
is shown in Table 4.3. 
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Table 4.3. Baseline characteristics of intervention versus control participants (N=91). 
 Intervention 
group percent (n) 
Control group 
percent (n) 
P-value 
Race   0.36 
    Non-Hispanic White 60.9 (28) 57.8 (26)  
    African American 32.6 (15) 40.0 (18)  
    Other 6.5 (3) 2.2 (1)  
Gender, male 60.9 (28) 40.0 (18) 0.046 
Health literacy, eighth grade or 
below 
25.0 (11) 21.4 (9) 0.70 
Glaucoma severity, moderate 
to severe 
60.9 (28) 57.8 (26) 0.76 
Diagnosis of arthritis or other 
condition affecting manual 
dexterity 
34.8 (16) 28.9 (13) 0.55 
Eyes dilated 30.4 (14) 40.0 (18) 0.34 
Previously educated about 
glaucoma eye drop technique 
50.0 (23) 46.7 (21) 0.75 
 Intervention 
group mean (SD) 
Control group 
mean (SD) 
P-value 
Age 69.0 (12.2) 69.5 (9.2) 0.82 
Years using glaucoma 
medications 
9.6 (10.4) 9.9 (9.6) 0.89 
Years of education 16.1 (3.7) 15.5 (2.8) 0.35 
Outcome expectations 33.5 (5.0) 34.2 (4.1) 0.48 
Self-efficacy 16.6 (1.5) 15.5 (2.1) 0.004 
Number of glaucoma 
medications being taken 
1.89 (0.80) 1.98 (0.84) 0.62 
Number of times per day the 
patient takes glaucoma 
medications 
3.09 (1.67) 3.13 (1.80) 0.90 
Visual acuity in the better-
seeing eye 
0.80 (0.18) 0.73 (0.25) 0.16 
Eye drop technique* 2.65 (1.23) 2.25 (1.43) 0.17 
*Three intervention group participants and one control group participant are not included here 
because they could not be scored on some steps. 
 
Unadjusted for covariates, the variables that showed a statistically significant difference between 
intervention and control groups at baseline were eye drop technique self-efficacy (t=3.01, 
df=77.173, p=0.004) and gender (Pearson c2=3.96, df=1, p=0.046). Participants assigned to the 
intervention group had higher mean baseline self-efficacy and were more likely to be male than 
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participants assigned to the control group. The intervention group had slightly better baseline eye 
drop technique, but the difference was not statistically significant (p=0.17). 
 
4.3.	Bivariate	relationships	among	the	variables	at	baseline	
Bivariate relationships among patient characteristics, clinical characteristics, and baseline 
values of the outcomes are shown in Table 4.4. 
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Baseline 
self-
efficacy 
Baseline eye 
drop 
technique 
Baseline 
med 
adherence 
Age Gender, 
female 
Race  
(African 
American) 
Years 
schooling 
How long 
used drops 
Baseline self-efficacy 1               
Baseline eye drop 
technique 
-0.016 1             
Baseline med 
adherence 
.318** 0.144 1           
Age -0.059 -0.001 0.020 1         
Gender, female -0.127 -0.030 0.090 0.140 1       
Race (African 
American) 
-0.036 -0.131 -0.093 -0.135 -0.060 1     
Years of schooling -0.021 0.043 0.073 .283** 0.129 -.470** 1   
How long used drops .220* 0.032 .233* .280** 0.048 -0.061 0.198 1 
REALM 0.042 -0.133 -0.078 -0.151 -0.152 .440** -.460** -0.153 
Previously educated 
about technique 
0.080 -.248* -0.003 0.021 0.099 0.139 0.154 .269* 
Dilated 0.041 -0.026 0.029 -0.067 -0.038 .258* -.283** -0.073 
Glaucoma severity -0.037 -0.137 -0.065 -0.039 -.300** 0.113 -0.175 -0.113 
# glaucoma meds -0.020 0.081 -0.100 -0.022 -0.001 0.033 0.040 0.019 
Doses taken/ day 0.001 0.002 -0.105 -0.076 -0.050 0.071 -0.044 0.086 
Visual acuity - better 
eye 
0.083 0.097 0.065 -0.128 0.124 -0.109 0.149 -0.117 
Outcome 
expectations 
0.074 0.153 .367** 0.062 0.147 -0.183 -0.099 0.098 
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 REALM Previously 
educated about 
technique 
Dilated Glaucoma 
severity 
# glaucoma 
meds 
Doses taken/ 
day 
Visual acuity - 
better eye 
Baseline self-
efficacy 
              
Baseline eye 
drop technique 
              
Baseline med 
adherence 
              
Age               
Gender, female               
Race (African 
American) 
              
Years of 
schooling 
              
How long used 
drops 
              
REALM 1             
Previously 
educated about 
technique 
0.038 1           
Dilated .264* -0.114 1         
Glaucoma 
severity 
0.145 -0.005 0.141 1       
# glaucoma 
meds 
-0.047 -0.030 0.117 .375** 1     
Doses taken/ 
day 
0.022 0.015 0.047 .365** .921** 1   
Visual acuity - 
better eye 
-0.128 -.212* -0.076 -.273** -0.208* -.233* 1 
Outcome 
expectations 
-.244* 0.021 -0.098 -0.189 -0.143 -0.182 0.037 
 Table 4.4. Correlation matrix showing bivariate relationships among the variables. 
*p<0.05; **p<0.01 
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4.3.1.	Associations	between	patient	and	clinical	characteristics	
 Older age was associated with more years of schooling (p=0.007) and with using eye 
drops for a longer time (p=0.007). Female gender was associated with less severe glaucoma 
(p=0.004). African American race was associated with fewer years of schooling (p<0.001) and 
was associated with higher likelihood of having REALM scores of eighth grade or lower 
(p<0.001). Fewer years of schooling (p<0.001) and having been dilated (p=0.014) were also 
associated with REALM scores of eighth grade or lower. Having used eye drops for a longer 
time was positively associated with having been shown how to use eye drops before (p=0.01). 
Worse visual acuity in the better eye was associated with higher likelihood of reporting having 
been shown how to use eye drops (p=0.044), possibly because patients with worse visual acuity 
had had glaucoma longer. More severe glaucoma was associated with being prescribed more 
medications (p<0.001), more doses per day (p<0.001), and having worse visual acuity in the 
better eye (p=0.009). Being prescribed more glaucoma medications was also associated with 
being prescribed more doses per day (p<0.001) and worse visual acuity was associated with 
being prescribed more doses per day (p=0.026) and with more glaucoma medications (p=0.047). 
 
4.3.2	Associations	between	patient	and	clinical	characteristics,	and	baseline	values	of	outcome	
variables	
 Having used eye drops for a longer time was associated with better baseline self-efficacy 
(p=0.037) and better baseline medication adherence (p=0.026). Better baseline self-efficacy 
(p=0.002) and better baseline outcome expectations (p<0.001) were associated with better 
baseline adherence. Surprisingly, baseline technique was negatively associated with self-reports 
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of having been shown how to use eye drops before (p=0.021). Patients who did not report prior 
education had better technique. Low literacy was associated with worse baseline outcome 
expectations (p=0.024). 
 
4.4.	Summary	
 Patient and clinical characteristics were well balanced across the intervention and control 
groups at baseline, except for self-efficacy and gender. Most of the associations among patient 
and clinical characteristics and baseline outcomes were not surprising, except that having been 
previously educated about technique was associated with worse baseline eye drop technique. 
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Chapter 5: Eye drop technique and self-efficacy results immediately 
after the video 
 
 This chapter will discuss the results from Aim 1, which sought to determine whether eye 
drop technique and self-efficacy were better in the intervention group than the control group 
immediately after exposure to the intervention or control video. 
 
5.1.	Hypothesis	1:	Eye	drop	technique	immediately	after	the	video	
H1: Glaucoma patients who watch the Meducation video will have better eye drop instillation 
technique immediately after watching the video than control group patients who do not watch the 
video. 
 
5.1.1.	Distribution	of	eye	drop	technique	scores	
 Patients’ eye drop technique scores are shown in Table 5.1. 
Table 5.1. Summary of eye drop technique scores at all time points. 
Scale (Range of possible 
scores) 
Mean (SD), range 
score before video 
(N=87) 
Mean (SD), range 
score after video 
(N=85) 
Mean (SD), range 
score at 1 month 
(N=81) 
Eye drop instillation 
technique (0-5) 
2.45 (1.35) 3.19 (1.37) 3.09 (1.35) 
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The mean technique score was 2.45 steps correct before watching the video (SD: 1.35), 
3.19 immediately after watching the video (SD: 1.37), and 3.09 at 1 month (SD: 1.35). The 
number of people who performed each step correctly at each time point is shown in Table 5.2. 
Table 5.2. Number of participants who performed each step correctly at each time point 
(N=91). 
Step Percent (n) 
performing 
correctly before 
video 
Percent (n) 
performing 
correctly after 
video 
Percent (n) 
performing 
correctly at 1 
month 
Squeezing the bottle to 
instill a single drop 
53.4 (47/88) 66.7 (58/87) 65.1 (54/83) 
Holding open the lid with 
the finger 
62.6 (57/91) 73.3 (66/90) 69.8 (60/86) 
Getting the drop 
accurately into the eye 
64.8 (59/91) 76.1 (67/88) 71.1 (59/83) 
Not touching the bottle tip 
to the eye or face 
62.5 (55/88) 70.8 (63/89) 80.0 (68/85) 
Closing the eye after 
instillation (for at least 10 
seconds) 
4.4 (4/90) 25.8 (23/89) 18.6 (16/86) 
 
 The only step where patients continued to improve at 1 month was not touching the eye 
or face. Performance on other steps remained the same or declined slightly. 
 
5.1.2.	Unadjusted	comparison	between	intervention	and	control	groups	immediately	after	the	
video	
 Patients’ eye drop technique scores immediately after watching the video are shown in 
Table 5.3. Unadjusted for covariates, the intervention group performed better than the control 
group (t=4.182, df=83, p<0.001). 
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Table 5.3. Summary of eye drop technique scores immediately after watching the video. 
Scale (Range of 
possible scores) 
Intervention group 
mean (SD) score 
(n=42) 
Control group mean 
(SD) score (n=43) 
P-value 
Eye drop instillation 
technique (0-5) 
3.76 (1.12) 2.63 (1.36) <0.001 
 
Intervention and control group patients’ scores on specific steps immediately after 
watching the video are shown in Table 5.4. The steps that showed a significant between-group 
difference immediately after the video were squeezing the bottle to instill a single drop, holding 
open the lid with the finger, and closing the eye after instillation. 
 
Table 5.4. Number of participants who performed each step correctly immediately after the 
video, by group. 
Step P-value for 
Pearson chi-
square test 
Percent (n) performing correctly  
 
Intervention 
group 
Control group 
Squeezing the bottle 
to instill a single drop 
0.049 76.7 (33/43) 56.8 (25/44) 
Holding open the lid 
with the finger 
0.017 84.4 (38/45) 62.2 (28/45) 
Getting the drop 
accurately into the 
eye 
0.26 81.4 (35/43) 71.1 (32/45) 
Not touching the 
bottle tip to the eye or 
face 
0.18 77.3 (34/44) 64.4 (29/45) 
Closing the eye after 
instillation (for at 
least 10 seconds) 
<0.001 44.4 (20/45) 6.8 (3/44) 
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5.1.3	Bivariate	analyses	
Bivariate analyses showed that outcome expectations were significantly associated with 
better technique immediately after the video (r=0.222, p=0.041), and African American race was 
significantly associated with worse technique (t=2.144, df=83, p=0.035). Age, gender, glaucoma 
severity, length of time using glaucoma medications, diagnosis of arthritis or other condition 
affecting manual dexterity, years of education, number of glaucoma medications being taken, 
number of times per day the patient takes glaucoma medications, visual acuity in the better-
seeing eye, whether the patient’s eyes were dilated, and whether the patient was previously 
educated about technique were not significantly associated with technique immediately after the 
video. 
 
5.1.4.	Linear	regression	model	predicting	eye	drop	technique	immediately	after	the	video	
5.1.4.1	Multivariable	analyses:	main	regression	model	for	complete	case	analysis		
In the main analysis, 81 participants -- 39 intervention group participants and 42 control 
group participants -- were analyzed. The reason that participants were not included in this 
complete case analysis was that the eye drop technique score could not be determined with 
certainty from the video (4 participants before the video and 6 participants immediately after). 
The results of the linear regression model predicting eye drop technique immediately 
after the video are shown in Table 5.5. Besides baseline technique and baseline self-efficacy, the 
covariates that met the criteria for inclusion in the model were baseline outcome expectations 
and race, because they were significantly associated with technique immediately after the video; 
participants with more positive outcome expectations and those who were non-African American 
had better technique in the bivariate analysis. No covariates met the criterion of changing the 
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coefficient associated with the intervention by at least 10%. After adjusting for covariates, 
intervention group patients performed 0.75 steps better than controls (p=0.002). The covariates 
that were statistically significant were baseline eye drop technique (p<0.001) and baseline self-
efficacy (p=0.029). Baseline outcome expectations (p=0.21) and race (p=0.14) did not have 
significant effects in the multivariable analysis. 
 
Table 5.5. Linear regression model predicting eye drop technique immediately after 
watching the video (N=81). 
 Beta (95% CI) 
Independent variables  
    Intervention 0.75 (0.27, 1.22)** 
Covariates  
    Baseline technique 0.42 (0.25, 0.60)*** 
    Baseline self-efficacy 0.13 (0.01, 0.24)* 
    Baseline outcome expectations 0.04 (-0.02, 0.09) 
    Race, African American -0.36 (-0.83, 0.12) 
*p<0.05; **p<0.01, ***p<0.001 
 
 
5.1.4.2	Sensitivity	analyses	
After imputing the missing values, the results of the linear regression model predicting 
eye drop technique immediately after the video are shown in Table 5.6. In Table 5.6a, all steps 
that were not scorable were assumed to have been performed incorrectly. In Table 5.6b, all steps 
that were not scorable were assumed to have been performed correctly. When assuming that 
missing steps were performed incorrectly, the effect size for the intervention decreased to 0.64 
but remained statistically significant (p=0.023). When assuming that missing steps were 
performed correctly, the effect size for the intervention decreased to 0.67 and also remained 
statistically significant (p=0.005). Baseline eye drop technique remained significant in both 
models (p<0.001). Baseline self-efficacy was significant only in the model where steps that were 
not scorable were assumed to have been performed correctly (p=0.043). 
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Table 5.6a. Linear regression model predicting eye drop technique immediately after 
watching the video, with missing steps imputed as incorrectly performed (N=91). 
 Beta (95% CI) 
Independent variables  
    Intervention 0.64 (0.09, 1.19)* 
Covariates  
    Baseline technique 0.43 (0.23, 0.63)*** 
    Baseline self-efficacy 0.07 (-0.07, 0.20) 
    Baseline outcome expectations 0.06 (0.00, 0.11) 
    Race, African American -0.53 (-1.08, 0.02) 
*p<0.05; **p<0.01, ***p<0.001 
 
Table 5.6b. Linear regression model predicting eye drop technique immediately after 
watching the video, with missing steps imputed as correctly performed (N=91). 
 Beta (95% CI) 
Independent variables  
    Intervention 0.67 (0.21, 1.12)** 
Covariates  
    Baseline technique 0.50 (0.33, 0.66)*** 
    Baseline self-efficacy 0.11 (0.00, 0.22)* 
    Baseline outcome expectations 0.05 (0.00, 0.09) 
    Race, African American -0.31 (-0.76, 0.15) 
*p<0.05; **p<0.01, ***p<0.001 
 
	
5.1.5.	Getting	the	drop	in	the	eye	immediately	after	the	video	
5.1.5.1	Bivariate	analyses	
Bivariate analyses revealed that neither the intervention nor any covariates were 
significantly associated with getting the drop in the eye immediately after the video, so no 
covariates qualified to be in the model on the basis of a significant bivariate association with the 
outcome. 
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5.1.5.2	Multivariable	analyses:	main	regression	model	for	complete	case	analysis		
Three patients, all in the intervention group, were not included because it was impossible 
to tell if they got the drop in the eye from the recording immediately after the video. The results 
of the logistic regression model predicting whether the patient got the drop in the eye are shown 
in Table 5.7. Being dilated, length of time using drops, number of glaucoma medications, gender, 
visual acuity, number of doses taken per day, and arthritis or other condition affecting manual 
dexterity qualified for the model due to changing the estimate associated with the intervention by 
at least 10%. As in the bivariate analysis, the effect of the intervention was not statistically 
significant (p=0.35). Getting the drop in the eye before the video (p=0.001) and not being dilated 
during the visit (p=0.031) were associated with a higher likelihood of getting the drop in the eye 
immediately after the video. 
Table 5.7. Logistic regression model predicting whether the patient got the drop in the eye 
immediately after watching the video (N=88). 
 OR (95% CI) 
Independent variables  
    Intervention 0.51 (0.13, 2.10) 
Covariates  
    Getting the drop in the eye before the video 9.30 (2.35, 36.78)** 
    Baseline self-efficacy 1.31 (0.97, 1.77) 
    Dilated during visit 0.23 (0.06, 0.88)* 
    How long patient has used drops 1.07 (0.99, 1.17) 
    Number of glaucoma medications 0.15 (0.01, 1.51) 
    Gender, female 0.29 (0.07, 1.16) 
    Visual acuity in the better eye 4.12 (0.25, 69.20) 
    Number of doses taken per day 1.92 (0.68, 5.45) 
    Arthritis or other condition affecting 
        manual dexterity 
4.62 (1.00, 21.39) 
*p<0.05; **p<0.01, ***p<0.001 
 
5.1.5.3.	Sensitivity	analyses	
After imputing the missing values, the results of the logistic regression model predicting 
whether the patient got the drop in the eye are shown in Table 5.8. The effect of the intervention 
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continued to be nonsignificant in both models. Getting the drop in the eye before the video 
(p=0.005 when imputing missing values as incorrect and p=0.001 when imputing missing values 
as correct), and not being dilated (p=0.023 when imputing missing values as incorrect and 
p=0.046 when imputing missing values as correct), were still significantly associated with a 
higher likelihood of getting the drop in the eye immediately after watching the video. Gender 
became statistically significant when missing values were imputed as incorrectly performed; 
female gender was associated with a lower likelihood of getting the drop in the eye in this 
analysis (p=0.047). 
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Table 5.8a. Logistic regression model predicting whether the patient got the drop in the eye 
immediately after watching the video, with missing values imputed as incorrectly 
performed (N=91). 
 OR (95% CI) 
Independent variables  
    Intervention 0.45 (0.12, 1.60) 
Covariates  
    Getting the drop in the eye before the video 5.65 (1.68, 18.98)** 
    Baseline self-efficacy 1.19 (0.90, 1.56) 
    Dilated during visit 0.24 (0.07, 0.82)* 
    How long patient has used drops 1.08 (1.00, 1.17) 
    Number of glaucoma medications 0.21 (0.03, 1.77) 
    Gender, female 0.28 (0.08, 0.99)* 
    Visual acuity in the better eye 4.12 (0.29, 57.86) 
    Number of doses taken per day 1.88 (0.71, 4.96) 
    Arthritis or other condition affecting 
        manual dexterity 
3.57 (0.94, 13.65) 
*p<0.05; **p<0.01, ***p<0.001 
 
Table 5.8b. Logistic regression model predicting whether the patient got the drop in the eye 
immediately after watching the video, with missing values imputed as correctly performed 
(N=91). 
 OR (95% CI) 
Independent variables  
    Intervention 0.61 (0.16, 2.39) 
Covariates  
    Getting the drop in the eye before the video 9.54 (2.45, 37.17)** 
    Baseline self-efficacy 1.32 (0.98, 1.80) 
    Dilated during visit 0.26 (0.07, 0.98)* 
    How long patient has used drops 1.07 (0.99, 1.16) 
    Number of glaucoma medications 0.17 (0.02, 1.66) 
    Gender, female 0.34 (0.09, 1.27) 
    Visual acuity in the better eye 3.62 (0.22, 59.47) 
    Number of doses taken per day 1.85 (0.66, 5.22) 
    Arthritis or other condition affecting 
        manual dexterity 
4.06 (0.91, 18.16) 
*p<0.05; **p<0.01, ***p<0.001 
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5.2.	Hypothesis	2:	Self-efficacy	immediately	after	the	video	
 
H2: Glaucoma patients who watch the Meducation video will have better eye drop technique 
self-efficacy immediately after watching the video compared to control group patients who do 
not watch the video. 
 
5.2.1.	Distribution	of	eye	drop	technique	self-efficacy	scores	
 Patients’ eye drop technique self-efficacy scores at all time points are shown in Table 5.9. 
Table 5.9. Summary of scores on eye drop technique self-efficacy scale at all time points. 
Scale (Range of possible 
scores) 
Mean (SD), range 
score before video 
(N=90) 
Mean (SD), range 
score after video 
(N=90) 
Mean (SD), range 
score at 1 month 
(N=85) 
Self-efficacy (6-18) 16.1 (1.9), 12 - 18 16.5 (1.9), 11 - 18 15.8 (2.1), 8 - 18 
 
5.2.2.	Unadjusted	comparison	between	intervention	and	control	groups	immediately	after	the	
video	
 Patients’ eye drop technique self-efficacy scores immediately after watching the video 
are shown in Table 5.10. Unadjusted for covariates, self-efficacy was higher in the intervention 
group than in the control group immediately after the video (t=3.829, df=70.186, p<0.001). 
Table 5.10. Summary of scores on eye drop technique self-efficacy scale immediately after 
watching the video. 
Scale (Range of 
possible scores) 
Intervention group 
mean (SD) score 
(n=46) 
Control group mean 
(SD) score (n=44) 
P-value 
Self-efficacy (6-18) 17.2 (1.3) 15.8 (2.2) <0.001 
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5.2.3.	Bivariate	analyses	
Besides baseline self-efficacy, no other covariates were significantly associated with self-
efficacy immediately after the video in bivariate analyses, and no other covariates changed the 
estimate associated with intervention by more than 10% when included in the model; therefore, 
no other covariates met the criteria for inclusion in the multivariable model. 
 
5.2.4.	Multivariable	analyses:	main	regression	model	for	complete	case	analysis			
One control group patient’s self-efficacy at both time points was missing because the 
research assistant did not record answers for one or more items. Forty-six intervention group 
patients and 44 controls were included in the main analysis. The results of the linear regression 
model predicting self-efficacy are shown in Table 5.11. The intervention group had significantly 
better self-efficacy than the control group (p=0.024). 
 
 
Table 5.11. Linear regression model predicting eye drop technique self-efficacy 
immediately after watching the video (N=90). 
 Beta (95% CI) 
Independent variables  
    Intervention 0.62 (0.08, 1.15)* 
Covariates  
    Baseline self-efficacy 0.73 (0.59, 0.88)*** 
*p<0.05; **p<0.01, ***p<0.001 
  
5.2.5.	Sensitivity	analyses	
After imputing the missing values, the results of the linear regression model predicting 
self-efficacy are shown in Table 5.12. One patient’s self-efficacy at both time points had to be 
imputed because the research assistant did not record answers for one or more items. Besides 
baseline self-efficacy, no other covariates were significantly associated with self-efficacy 
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immediately after the video in bivariate analyses, and no other covariates changed the estimate 
associated with intervention by more than 10% when included in the model; therefore, no other 
covariates met the criteria for inclusion in the model. The intervention still had a statistically 
significant effect (p=0.032). No notable changes from the complete case analysis were observed. 
 
Table 5.12. Linear regression model predicting eye drop technique self-efficacy 
immediately after watching the video, after imputing the missing values (N=91). 
 Beta (95% CI) 
Independent variables  
    Intervention 0.60 (0.05, 1.14)* 
Covariates  
    Baseline self-efficacy 0.79 (0.66, 0.92)*** 
*p<0.05; **p<0.01, ***p<0.001 
	
5.3.	Summary	of	eye	drop	technique	and	self-efficacy	results	immediately	after	the	video	
 The results supported Hypothesis 1 and Hypothesis 2, which stated that eye drop 
technique and self-efficacy would be significantly better in the intervention group than in the 
control group immediately after the video. All the sensitivity analyses supported the base case 
results with p-values remaining below 0.05. Besides the intervention and baseline technique, 
only baseline self-efficacy significantly predicted eye drop technique immediately after the 
video. Baseline outcome expectations and race, which were significant in bivariate analyses, 
were not significant predictors of technique in the multivariable model. 
The results did not support the idea that intervention group patients would be more likely 
to get the drop in the eye immediately after the video. The results of this analysis remained 
nonsignificant after imputing missing values. We did not power on this outcome and therefore 
the analysis may have been underpowered.  
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Chapter 6: Eye drop technique, self-efficacy, and medication 
adherence results at 1 month 
 
 This chapter will discuss the results from Aim 2, which sought to determine whether eye 
drop technique, self-efficacy, and medication adherence were better in the intervention group 
than the control group at 1 month after study enrollment. 
 
6.1.	Hypothesis	3:	Eye	drop	technique	at	1	month	
H3: Glaucoma patients who watch the Meducation video will have better eye drop technique at 1 
month after first watching the video, compared to control group patients who do not watch the 
video. 
 
6.1.1.	Unadjusted	comparison	between	intervention	and	control	groups	at	1	month	
 Patients’ eye drop technique scores at 1 month are shown in Table 6.1. Unadjusted for 
covariates, the intervention group had better eye drop technique than the control group (t=3.025, 
df=79, p=0.003). 
Table 6.1. Summary of eye drop technique scores at 1 month. 
Scale (Range of 
possible scores) 
Intervention group 
mean (SD) score 
(n=40) 
Control group mean 
(SD) score (n=41) 
P-value 
Eye drop instillation 
technique (0-5) 
3.53 (1.28) 2.66 (1.30) 0.003 
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Intervention group participants performed 0.87 steps better than controls in eye drop 
technique at 1 month.  
Intervention and control group patients’ scores on specific steps at 1 month are shown in 
Table 6.2. 
Table 6.2. Number of participants who performed each step correctly at 1 month, by 
group. 
Step Percent (n) 
performing 
correctly in 
intervention group 
Percent (n) 
performing 
correctly in 
control group 
P-value for 
Pearson chi-
square test 
Squeezing the bottle to 
instill a single drop 
70.7 (29/41) 59.5 (25/42) 0.28 
Holding open the lid with 
the finger 
73.8 (31/42) 65.9 (29/44) 0.43 
Getting the drop 
accurately into the eye 
77.5 (31/40) 65.1 (28/43) 0.21 
Not touching the bottle tip 
to the eye or face 
92.7 (38/41) 68.2 (30/44) 0.005 
Closing the eye after 
instillation (for at least 10 
seconds) 
35.7 (15/42) 2.3 (1/44) <0.001 
 
The steps that showed a significant between-group difference at 1 month were not 
touching the bottle tip to the eye or face (p=0.005), and closing the eye after instillation 
(p<0.001). The other steps showed positive but not statistically significant effects. 
	
6.1.2.	Bivariate	analyses	
Bivariate analyses showed that baseline outcome expectations were significantly 
associated with better technique at 1 month (r=0.311, p=0.005), and self-reports of previously 
having been educated about technique was significantly associated with worse technique at 1 
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month (t=2.211, p=0.030). Age, race, gender, glaucoma severity, length of time using glaucoma 
medications, diagnosis of arthritis or other condition affecting manual dexterity, years of 
education, number of glaucoma medications being taken, number of times per day the patient 
takes glaucoma medications, visual acuity in the better-seeing eye, and whether the patient’s 
eyes were dilated were not significantly associated with technique at 1 month. 
 
6.1.3.	Linear	regression	model	predicting	eye	drop	technique	at	1	month	
6.1.3.1.	Multivariable	analyses:	main	regression	model	for	complete	case	analysis	
In the main analysis, 37 intervention group participants and 40 control group participants 
were analyzed. The reasons that participants were not included in this complete case analysis 
were that they were lost to follow-up (5 participants), and the technique score could not be 
determined with certainty from the video (4 participants before the video and 5 at 1 month). 
Besides baseline technique and self-efficacy, the other covariates that met the criteria for 
inclusion in the model were baseline outcome expectations and previously having been educated 
about technique, because they were significantly associated with the outcome in bivariate 
analyses. No covariates qualified for the model on the basis of changing the coefficient 
associated with the intervention by at least 10%. The results of the linear regression model 
predicting eye drop technique at 1 month are shown in Table 6.3. After adjusting for covariates, 
intervention patients performed 0.63 steps better than controls (p=0.011). As in the bivariate 
analysis, higher baseline outcome expectations were still associated with better 1-month 
technique (p=0.001), and having been previously educated about technique was associated with 
worse 1-month technique (p=0.036), perhaps because people with worse technique are more 
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likely to receive instruction. Baseline technique was also a significant predictor of 1-month 
technique (p<0.001). 
 
 
Table 6.3. Linear regression model predicting eye drop technique at 1 month (N=77). 
 Beta (95% CI) 
Independent variables  
    Intervention 0.63 (0.15, 1.10)* 
Covariates  
    Baseline technique 0.44 (0.26, 0.61)*** 
    Baseline self-efficacy 0.00 (-0.11, 0.12) 
    Baseline outcome expectations 0.09 (0.04, 0.15)** 
    Previously educated about technique -0.50 (-0.96, -0.03)* 
*p<0.05; **p<0.01, ***p<0.001 
6.1.3.2.	Sensitivity	analyses	
 The results of the best-case analysis, in which we assumed that improvement observed 
immediately after watching the video was sustained until the 1-month time point for patients lost 
to follow-up, are shown in Table 6.4. The effect size of intervention rose to 0.74 (p=0.001). 
Baseline technique (p<0.001) and baseline outcome expectations (p=0.001) remained statistically 
significant, while having been previously educated about technique was no longer significant 
(p=0.12). 
Table 6.4. Linear regression model predicting eye drop technique at 1 month, with best-
case analysis used to impute missing follow-up values (N=91). 
 Beta (95% CI) 
Independent variables  
    Intervention 0.74 (0.30, 1.18)** 
Covariates  
    Baseline technique 0.45 (0.29, 0.61)*** 
    Baseline self-efficacy 0.02 (-0.09, 0.12) 
    Baseline outcome expectations 0.08 (0.04, 0.13)** 
    Previously educated about technique -0.34 (-0.76, 0.09) 
*p<0.05; **p<0.01, ***p<0.001 
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 The results of the worst-case analysis, in which we assumed that patients lost to follow-
up reverted to their scores at the beginning of the study, are shown in Table 6.5. The effect size 
of intervention remained essentially the same as in the base case, and the p-value was 0.008. 
Baseline technique (p<0.001), baseline outcome expectations (p=0.001), and having been 
previously educated about technique (p=0.045) remained significant in this model. 
 
Table 6.5. Linear regression model predicting eye drop technique at 1 month, with worst-
case analysis used to impute missing follow-up values (N=91). 
 Beta (95% CI) 
Independent variables  
    Intervention 0.62 (0.16, 1.08)** 
Covariates  
    Baseline technique 0.45 (0.29, 0.62)*** 
    Baseline self-efficacy 0.03 (-0.08, 0.14) 
    Outcome expectations 0.09 (0.04, 0.13)** 
    Previously educated about technique -0.45 (-0.89, -0.01)* 
*p<0.05; **p<0.01, ***p<0.001 
 
6.1.4.	Getting	the	drop	in	the	eye	at	1	month	
6.1.4.1.	Bivariate	analyses	
Bivariate analyses showed that previously having been educated about technique was 
significantly associated with getting the drop in the eye at 1 month. Patients who reported prior 
education about technique were less likely to get the drop in the eye (c2=5.932, p=0.015). 
Patients who had more positive baseline outcome expectations were more likely to get the drop 
in the eye in the correlation matrix (r=0.301, p=0.006), but a t-test did not show a significant 
relationship (t=1.954, df=24.709, p=0.062). The t-test produced a different result because the 
groups had unequal variances (p<0.001 for Levene’s test of equality of variances) and therefore 
the t-test with unequal variances was used. The t-test is a more precise test, so baseline outcome 
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expectations did not meet the inclusion criterion of being significantly associated with the 
outcome. Age, race, gender, glaucoma severity, length of time using glaucoma medications, 
diagnosis of arthritis or other condition affecting manual dexterity, years of education, number of 
glaucoma medications being taken, number of times per day the patient takes glaucoma 
medications, visual acuity in the better-seeing eye, and whether the patient’s eyes were dilated 
were also not significantly associated with getting the drop in the eye immediately after the 
video. 
 
6.1.4.2.	Multivariable	analyses:	main	regression	model	for	complete	case	analysis	
 Eighty-three participants were included; five were excluded because they were lost to 
follow-up, and three because it was impossible to tell from the recording whether they got the 
drop in the eye at follow-up. Previously having been educated about technique was included as a 
covariate because it was significantly associated with the outcome in the bivariate analyses, and 
outcome expectations, number of doses per day, visual acuity, and years of schooling were 
included because they changed the coefficient associated with intervention by at least 10%. The 
results of the logistic regression model predicting whether the patient got the drop in the eye at 1 
month are shown in Table 6.6. The intervention did not have a statistically significant effect 
(p=0.14). Getting the drop in the eye before the video (p=0.008) and more positive outcome 
expectations (p=0.009) were associated with higher odds of getting the drop in the eye at 1 
month, while having been previously educated about technique (p=0.004) and better visual 
acuity (p=0.023) were associated with lower odds of getting the drop in the eye at 1 month. 
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Table 6.6. Logistic regression model predicting whether the patient got the drop in the eye 
at 1 month (N=83). 
 OR (95% CI) 
Independent variables  
    Intervention 2.78 (0.73, 10.61) 
Covariates  
    Getting the drop in the eye before the video 5.46 (1.55, 19.19)** 
    Baseline self-efficacy 1.02 (0.78, 1.35) 
    Baseline outcome expectations 1.30 (1.07, 1.57)** 
    Previously educated about technique 0.11 (0.02, 0.49)** 
    Number of doses taken per day 0.71 (0.48, 1.07) 
    Visual acuity in the better eye 0.02 (0.00, 0.55)* 
    Years of schooling 1.22 (0.99, 1.51) 
*p<0.05; **p<0.01, ***p<0.001 
 
6.1.4.3.	Sensitivity	analyses	
 In the best-case sensitivity analysis, intervention participants had 3.95 times the odds of 
getting the drop in the eye compared to controls (95% CI: 1.11, 13.28), and the intervention had 
a statistically significant effect (p=0.030). Getting the drop in the eye at baseline (p=0.007), and 
more positive baseline outcome expectations (p=0.027), remained significant predictors of 
getting the drop in the eye at 1 month. Having been previously educated about technique 
remained a significant predictor of lower odds of getting the drop in the eye at 1 month 
(p=0.042), but visual acuity was no longer significant (p=0.080). The results of the best-case 
analysis are shown in Table 6.7. 
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Table 6.7. Logistic regression model predicting whether the patient got the drop in the eye 
at 1 month, with best-case analysis used to impute missing values (N=91). 
 OR (95% CI) 
Independent variables  
    Intervention 3.95 (1.15, 13.60)* 
Covariates  
    Getting the drop in the eye before the video 4.65 (1.53, 14.15)** 
    Baseline self-efficacy 0.97 (0.75, 1.24) 
    Baseline outcome expectations 1.14 (1.02, 1.29)* 
    Previously educated about technique 0.29 (0.09, 0.95)* 
    Number of doses taken per day 0.78 (0.56, 1.08) 
    Visual acuity in the better eye 0.08 (0.01, 1.35) 
    Years of schooling 1.03 (0.87, 1.23) 
*p<0.05; **p<0.01, ***p<0.001 
 
 In the worst-case sensitivity analysis, the effect of the intervention was not significant 
(p=0.098). Getting the drop in the eye at baseline (p=0.002), and more positive outcome 
expectations (p=0.006), remained significant predictors of getting the drop in the eye at 1 month. 
Having been previously educated about technique remained a significant predictor of lower odds 
of getting the drop in the eye at 1 month (p=0.006), but visual acuity was no longer significant 
(p=0.15). The results of the worst-case analysis are shown in Table 6.8. 
 
Table 6.8. Logistic regression model predicting whether the patient got the drop in the eye 
at 1 month, with worst-case analysis used to impute missing values (N=91). 
 OR (95% CI) 
Independent variables  
    Intervention 2.80 (0.83, 9.48) 
Covariates  
    Getting the drop in the eye before the video 6.05 (1.90, 19.24)** 
    Baseline self-efficacy 1.06 (0.82, 1.36) 
    Baseline outcome expectations 1.22 (1.06, 1.40)** 
    Previously educated about technique 0.16 (0.04, 0.59)** 
    Number of doses taken per day 0.78 (0.55, 1.09) 
    Visual acuity in the better eye 0.13 (0.01, 2.29) 
    Years of schooling 1.14 (0.95, 1.37) 
*p<0.05; **p<0.01, ***p<0.001 
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6.2.	Hypothesis	4:	Self-efficacy	at	1	month	
H4: Glaucoma patients who watch the Meducation video will have better eye drop technique 
self-efficacy at 1 month after first watching the video, compared to control group patients who 
do not watch the video. 
 
6.2.1.	Unadjusted	comparison	between	intervention	and	control	groups	at	1	month	
 Patients’ scores on the eye drop technique self-efficacy scale at 1 month are shown in 
Table 6.9. Unadjusted for covariates, the intervention group had higher eye drop technique self-
efficacy at 1 month than the control group (t=4.100, p<0.001). 
Table 6.9. Summary of scores on eye drop technique self-efficacy scale at 1 month. 
Scale (Range of 
possible scores) 
Intervention group 
mean (SD) score 
(n=42) 
Control group mean 
(SD) score (n=43) 
P-value 
Self-efficacy (6-18) 16.7 (1.4) 14.9 (2.4) <0.001 
 
Intervention group participants had a self-efficacy score 1.8 points higher than controls, 
up from a 1.1-point difference prior to the video. 
 
6.2.2.	Bivariate	analyses	
Besides baseline self-efficacy (r=0.669, p<0.001), no other covariates were significantly 
associated with self-efficacy at 1 month in bivariate analyses, and no other covariates changed 
the estimate associated with the intervention by more than 10% when included in the model; 
therefore, no other covariates met the criteria for inclusion in the multivariable model. 
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6.2.3.	Multivariable	analyses:	main	regression	model	for	complete	case	analysis	
The results of the linear regression model predicting self-efficacy are shown in Table 
6.10. Intervention group participants had self-efficacy of 0.82 points better at 1 month (p=0.015) 
after adjusting for baseline self-efficacy. Baseline self-efficacy was also a significant predictor of 
1-month self-efficacy (p<0.001). 
 
Table 6.10. Linear regression model predicting eye drop technique self-efficacy at 1 month 
(N=84). 
 Beta (95% CI) 
Independent variables  
    Intervention 0.82 (0.16, 1.47)* 
Covariates  
    Baseline self-efficacy 0.66 (0.48, 0.84)*** 
*p<0.05; **p<0.01, ***p<0.001 
 
6.2.4.	Sensitivity	analyses	
The results of the best-case analysis, in which we assumed that improvement observed 
immediately after watching the video was sustained until the 1-month time point for patients lost 
to follow-up, are shown in Table 6.11. In the best-case analysis, the coefficient associated with 
intervention rose to 0.90 and the p-value dropped to 0.005. Baseline self-efficacy remained a 
significant predictor of 1-month self-efficacy (p<0.001). 
 
Table 6.11. Linear regression model predicting eye drop technique self-efficacy at 1 month, 
with best-case analysis used to impute missing follow-up values (N=91). 
 Beta (95% CI) 
Independent variables  
    Intervention 0.90 (0.28, 1.53)** 
Covariates  
    Baseline self-efficacy 0.68 (0.53, 0.83)*** 
*p<0.05; **p<0.01, ***p<0.001 
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 The results of the worst-case analysis, in which we assumed that patients lost to follow-
up reverted to their scores at the beginning of the study, are shown in Table 6.12. The estimated 
effect size for intervention was 0.86 (p=0.007). Baseline self-efficacy remained a significant 
predictor of 1-month self-efficacy (p<0.001). 
 
 
Table 6.12. Linear regression model predicting eye drop technique self-efficacy at 1 month, 
with worst-case analysis used to impute missing follow-up values (N=91). 
 Beta (95% CI) 
Independent variables  
    Intervention 0.86 (0.24, 1.48)** 
Covariates  
    Baseline self-efficacy 0.68 (0.53, 0.83)*** 
*p<0.05; **p<0.01, ***p<0.001 
 
	
6.3.	Hypothesis	5:	Medication	adherence	at	1	month	
H5: Glaucoma patients who watch the Meducation video will have better medication adherence 
at 1 month, as assessed by Visual Analog Scale, compared to control group patients who do not 
watch the video. 
 
6.3.1.	Distribution	of	medication	adherence	scores	
 Patients’ scores on the visual analog scales of medication adherence are shown in Table 
6.13. 
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Table 6.13. Summary of medication adherence scores at all time points. 
Scale (Range of possible 
scores) 
Mean (SD), range 
score before video (N=91) 
Mean (SD), range 
score at 1 month (N=87) 
Single-item VAS (0-
100%) 
80.8% (23.6), 4 - 100% 85.1% (18.6), 1 - 100% 
5-item VAS (0-100%) 94.2% (8.5), 49.2 - 100.0% 94.6% (7.3), 64.8 - 100.0% 
 
6.3.2.	Unadjusted	comparisons	between	intervention	and	control	groups	at	1	month	
 Patients’ scores on the visual analog scales of medication adherence at 1 month are 
shown in Table 6.14. The differences between groups were not statistically significant, both on 
the single-item scale (p=0.34), and the 5-item scale (p=0.38). 
Table 6.14. Summary of medication adherence scores at 1 month. 
Scale (Range of 
possible scores) 
Intervention group 
mean (SD) score 
(n=43) 
Control group mean 
(SD) score (n=44) 
P-value 
Adherence, single-
item VAS (0-100%) 
87.1% (13.6) 83.3% (22.5) 0.34 
Adherence, 5-item 
VAS (0-100%) 
95.3% (6.2) 94.1% (8.3) 0.38 
 
6.3.3.	Medication	adherence	on	the	single-item	Visual	Analog	Scale	at	1	month	
6.3.3.1.	Bivariate	analyses	
Bivariate analyses revealed that besides baseline adherence (r=0.547, p<0.001), no other 
covariates were significantly associated with adherence at 1 month. 
 
6.3.3.2.	Multivariable	analyses:	Main	regression	model	for	complete	case	analysis		
Four patients were not included because they were lost to follow-up and did not complete 
the 1-month interview, leaving a total sample size of 87. The results of the linear regression 
model predicting medication adherence on the single-item VAS are shown in Table 6.15. 
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Besides baseline adherence, the other covariates that met the criteria for inclusion in the model 
were age and gender, because they changed the estimate associated with intervention by at least 
10%. No covariates qualified for the model on the basis of significant bivariate association with 
the outcome. The effect of the intervention on adherence was positive but not statistically 
significant (p=0.40). Baseline adherence was a significant predictor of 1-month adherence 
(p<0.001). Older age was associated with worse adherence (p=0.009). 
 
Table 6.15. Linear regression model predicting medication adherence on the single-item 
VAS at 1 month (N=87). 
 Beta (95% CI) 
Independent variables  
    Intervention 2.8 (-3.8, 9.5) 
Covariates  
    Baseline adherence 4.2 (2.8, 5.6)*** 
    Age -0.4 (-0.7, -0.1)* 
    Gender, female 6.4 (-0.3, 13.0) 
*p<0.05; **p<0.01, ***p<0.001 
 
6.3.3.3.	Sensitivity	analyses	
 The results of the worst-case analysis, in which we assumed that patients lost to follow-
up reverted to their scores at the beginning of the study, are shown in Table 6.16. The 
intervention still had a nonsignificant effect (p=0.51). Baseline adherence still significantly 
predicted 1-month adherence (p<0.001). Older age remained associated with worse adherence 
(p=0.004), and female gender was associated with better adherence (p=0.049).  
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Table 6.16. Linear regression model predicting medication adherence on the single-item 
VAS at 1 month, with worst-case analysis used to impute missing follow-up values (N=91). 
 Beta (95% CI) 
Independent variables  
    Intervention 2.1 (-4.3, 8.5) 
Covariates  
    Baseline adherence 4.3 (3.0, 5.7)*** 
    Age -0.4 (-0.7, -0.1)* 
    Gender, female 6.4 (0.0, 12.9)* 
*p<0.05; **p<0.01, ***p<0.001 
 A best-case analysis was not possible for medication adherence since there was no 
measurement at the end of the baseline visit after the video. 
 
6.3.4.	Medication	adherence	on	the	5-item	Visual	Analog	Scale	at	1	month	
6.3.4.1.	Bivariate	analyses	
Bivariate analyses revealed that gender and number of problems with using medications 
were significantly associated with medication adherence at 1 month; women (t=2.796, 
df=69.728, p=0.007) and patients reporting fewer problems with their medications (r=-0.288, 
p=0.007) had better adherence. Baseline adherence was also significantly associated with 1-
month adherence (r=0.453, p<0.001). Age, race, glaucoma severity, length of time using 
glaucoma medications, diagnosis of arthritis or other condition affecting manual dexterity, years 
of education, baseline outcome expectations, number of glaucoma medications being taken, 
number of times per day the patient takes glaucoma medications, and visual acuity in the better-
seeing eye were not significantly associated with medication adherence at 1 month. 
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6.3.4.2.	Multivariable	analyses:	main	regression	model	for	complete	case	analysis		
Besides baseline adherence, the other covariates that met the criteria for inclusion in the 
model were gender and number of problems, because these variables were significantly 
associated with the outcome in bivariate analyses. No additional covariates qualified for the 
model due to changing the coefficient associated with the intervention by at least 10%. The 
results of the linear regression model predicting medication adherence on the 5-item VAS at 1 
month are shown in Table 6.17. The intervention did not have a statistically significant effect on 
adherence (p=0.38). Patients with better baseline adherence (p<0.001), women (p=0.001) and 
patients reporting fewer problems with using medications (p=0.004) had better 1-month 
adherence. 
 
Table 6.17. Linear regression model predicting medication adherence on the 5-item VAS at 
1 month (N=87). 
 Beta (95% CI) 
Independent variables  
    Intervention 1.2 (-1.5, 3.9) 
Covariates  
    Baseline adherence 0.4 (0.2, 0.5)*** 
    Gender, female 4.5 (1.8, 7.1)** 
    Problems using medications -0.8 (-1.3, -0.3)** 
*p<0.05; **p<0.01, ***p<0.001 
 
6.3.4.3.	Sensitivity	analyses	 	
The results of the worst-case analysis, in which we assumed that patients lost to follow-
up reverted to their scores at the beginning of the study, are shown in Table 6.18. The effect of 
intervention remained nonsignificant (p=0.56). Better baseline adherence (p<0.001), female 
gender (p=0.001) and fewer problems using medications (p=0.006) continued to be associated 
with better 1-month adherence. 
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Table 6.18. Linear regression model predicting medication adherence on the single-item 
VAS at 1 month, with worst-case analysis used to impute missing follow-up values. 
 Beta (95% CI) 
Independent variables  
    Intervention 0.8 (-1.9, 3.4) 
Covariates  
    Baseline adherence 0.4 (0.3, 0.6)*** 
    Gender, female 4.6 (2.0, 7.3)** 
    Problems using medications -0.8 (-1.3, -0.2)** 
*p<0.05; **p<0.01, ***p<0.001 
A best-case analysis was not possible for medication adherence on the 5-item VAS since 
there was no measurement at the end of the baseline visit after the video. 
 
6.4.	Summary	of	eye	drop	technique,	self-efficacy,	and	medication	adherence	results	at	1	
month	
 The results supported Hypothesis 3 and Hypothesis 4, which had predicted that eye drop 
technique and self-efficacy would be better in the intervention group than the control group at 1 
month. All the sensitivity analyses for these hypotheses supported the same conclusions as the 
base case results. In addition to the intervention, higher baseline outcome expectations and not 
having been previously educated about technique predicted better technique. In the base case, the 
analysis of getting the drop in the eye did not support the idea that intervention group patients 
were more likely to get the drop in the eye than controls at 1 month, although the best-case 
analysis did show a statistically significant positive effect. 
The results did not support Hypothesis 5, which had predicted that medication adherence 
would be significantly higher in the intervention group than the control group at 1 month. Results 
were similar for the single-item VAS and 5-item VAS measures. Female gender predicted better 
adherence at 1 month after enrollment. In addition, younger age predicted better adherence in the 
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model predicting the single-item VAS score, while fewer problems using medications predicted 
better adherence in the model predicting the 5-item VAS score.  
The trends in eye drop technique over time are shown in Figure 6.1. Technique scores 
rose by more than a full step from baseline to immediately after the video in the intervention 
group, and rose slightly in the control group. At 1 month, the scores in the control group were 
almost unchanged from immediately after the video, and the scores in the intervention group had 
declined slightly but remained significantly higher than the control group scores after adjusting 
for the baseline difference. 
 
Figure 6.1. Eye drop technique scores by group over time (N=91 before video; N=81 after 
video; N=77 at 1 month). 
 
 The trends in eye drop technique self-efficacy over time are shown in Figure 6.2. Both 
groups experienced some improvement immediately after the video, followed by declines in both 
groups at 1 month, although the between-group difference continued to increase, from 0.62 
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points immediately after to 0.82 points at 1 month. Despite the significant baseline difference 
(p=0.004), the differences at both later time points remained statistically significant after 
adjusting for the baseline difference. 
 
Figure 6.2. Mean eye drop technique self-efficacy by group over time. 
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Chapter 7: Evaluation and dissemination results 
 
 This chapter presents the results of Aim 3, which sought to determine patients’ 
perspectives on how to improve the video and disseminate it to other glaucoma patients.  
 
7.1.	Descriptive	statistics	for	evaluation	questions	
 To inform dissemination of the video, data from 43 intervention group participants were 
analyzed for Aim 3. These data included all intervention group participants except for three who 
were lost to follow-up. The tracking data for access codes revealed that a total of five 
participants (11.6%) watched the video at least once after their baseline visit. Including the 
baseline visit, two (4.7%) watched the video a total of two times each, and three (7.0%) watched 
it three times each.  
In addition to the video instruction, two patients (4.7%) reported that someone had shown 
them how to use eye drops since the baseline visit. One said they had been educated by the 
doctor, and one said they had been educated by both the doctor and the ophthalmic technician. 
Descriptive statistics for the evaluation questions are shown in Table 7.1. All 43 patients 
said they would recommend that others watch the video. No patients reported that they watched 
the video with anyone else. On a 4-point scale ranging from 1 “Not at all useful” to 4 “Very 
useful”, the mean rating of the video was 3.40 (SD: 0.85). Patients who said they thought the 
video was not at all useful or only a little useful tended to say that they knew most of the material 
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in the video already, but the video might be more useful for people who were just starting to use 
eye drops. 
African American patients rated the video at a mean of 3.85, compared to 3.20 for non-
African Americans (t=3.257, df=40.943, p=0.002). Patients who had used eye drops for a longer 
time gave the video lower ratings (r=-0.338, p=0.027). Other patient and clinical characteristics, 
including age, gender, years of schooling, previously having been educated about technique, 
being dilated, severity of glaucoma, arthritis or other condition affecting manual dexterity, 
number of glaucoma medications, number of doses taken per day, and visual acuity in the better 
eye, were not significantly associated with patient rating of usefulness of the video. In general, 
patients who gave the video ratings of “Not at all useful” or “A little useful” were 100% White 
or Asian, tended to have used drops for a long time (mean: 16.8 years) and report few problems 
with their medications (mean: 1.13 problems). 
 
Table 7.1. Descriptive statistics for evaluation questions. 
 Percent (n) 
*With whom patient watched the video  
    Family member 0.0 (0) 
    Friend 0.0 (0) 
    Healthcare provider 0.0 (0) 
    No one 100.0 (43) 
Would you recommend that others watch the video?  
    Yes 100.0 (43) 
    No 0.0 (0) 
How useful was the video?   
    Not at all useful 2.3 (1) 
    A little useful 16.3 (7) 
    Fairly useful 20.9 (9) 
    Very useful 60.5 (26) 
*Participants could choose more than one answer to this question (“check all that apply”) 
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7.2.	How	the	video	helped	participants	
 The coding categories resulting from the coding of participants’ responses to the 
question, “How did the video help you?” are shown in Table 7.2. 
 
Table 7.2. Coding categories for how the video helped patients (N=43). 
Code number Category Definition 
1 Angling head/head 
back 
Comments about angling the head or putting the head 
back in a proper position 
2 Putting cap on its 
side 
Comments about putting the cap down on its side 
rather than upright to avoid contamination 
3 Hand hygiene Comments about washing hands or not using hand 
sanitizer 
4 Not touching eye Comments about avoiding touching the eye 
5 Holding open lid Comments about holding open the eyelid or how to 
hold open the eyelid 
6 Block tear duct 
with finger 
Comments about holding the finger to block the tear 
duct (punctal occlusion) 
7 Time between two 
medications 
Comments about the time to wait between two drops or 
two separate medications 
8 Distance to hold 
bottle 
Comments about how far away to hold the bottle to 
instill the drop 
9 Technique (general) General comments about learning proper technique that 
do not fit any other category 
10 Mixing/not shaking 
medication 
Comments about mixing the bottle, not shaking the 
bottle, or avoiding bubbles in the medication 
11 Keeping eye closed 
after instillation 
Comments about keeping the eye closed, length of time 
to keep the eye closed, or not blinking after instillation 
12 Lying down Comments about lying down to instill the drop more 
easily 
13 Angling/holding 
bottle 
Comments about how to angle or hold the bottle to 
instill drops 
14 Where to aim drop Comments about where to aim the drop (at the pocket 
or well of the eye) 
15 Check expiration 
date 
Comments about checking the expiration date on the 
bottle 
16 Not sharing bottles Comments about not sharing bottles with others 
17 Wipe off 
medication 
Comments about removing excess medication 
18 Not missing eye Comments about how to not miss the eye 
19 Keeping bottle or 
tip clean 
Comments about keeping the bottle or bottle tip clean, 
other than putting cap on the side or not touching the 
eye 
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 Participants’ responses to the question, “How did the video help you?” are summarized in 
Table 7.3. The greatest number of participants said that the video helped them by teaching them 
to block the tear duct with the finger (32.6%), put the cap on its side (27.9%), mix the medication 
correctly (25.6%), or keep the eye closed after instillation (25.6%). 
 
Table 7.3. How participants said the video helped them (N=43). 
Response Percent (n) 
Block tear duct with finger 32.6 (14) 
Putting cap on its side 27.9 (12) 
Mixing/not shaking medication 25.6 (11) 
Keeping eye closed after instillation 25.6 (11) 
Angling head/head back 18.6 (8) 
Hand hygiene 16.3 (7) 
Not touching eye 16.3 (7) 
Holding open lid 16.3 (7) 
Technique (general) 14.0 (6) 
Where to aim drop 14.0 (6) 
Keeping bottle or tip clean 14.0 (6) 
Angling/holding bottle 11.6 (5) 
Time between two medications 7.0 (3) 
Lying down 4.7 (2) 
Distance to hold bottle 2.3 (1) 
Check expiration date 2.3 (1) 
Not sharing bottles 2.3 (1) 
Wipe off medication 2.3 (1) 
Not missing eye 2.3 (1) 
 
 
7.3	Suggestions	for	improving	the	video	
Participants’ responses to the question, “How could the video be improved?” are shown 
in Table 7.4. The most common suggestion was to use a real person instead of an animation. 
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Table 7.4. Suggestions for improving the video (N=43). Patients could choose as many options 
as desired, or none. 
Response Percent (n) 
Use a real person instead of an animation 32.6 (14) 
Other 32.6 (14) 
Make it easier to view on my phone 16.3 (7) 
Explain the steps differently 4.7 (2) 
Add other topics 4.7 (2) 
 
 Suggestions that participants made in the “Other” category included expressing the 
distance from the eye in inches rather than centimeters (4.7%); it was not realistic to expect 
people to wait 5 minutes or more in between drops (4.7%); it was not realistic to expect people to 
throw away a contaminated bottle (2.3%); if you use links to other topics put links at bottom but 
not in video itself (2.3%), cap rolls on counter when cap is placed on its side (2.3%); we should 
explain more fully what glaucoma is (2.3%); add reminder of life after opening and shelf life 
(2.3%); talk slower with more time before the next topic (2.3%); warn the patient to check how 
long the bottle will last (2.3%); how important the drops are (2.3%); tell patients to keep a list to 
check off morning, noon, and night (2.3%); use the point of view of the user because they can’t 
see what they are doing (2.3%); add some tips that would help get the drop in the right place 
(2.3%); the doctor should demonstrate on themselves in person in addition to the video (2.3%); 
say a relative can do it for you if you’re having trouble (2.3%); stress the importance of getting 
the right amount in the eye (2.3%); to address whether bubbles are bad because the last couple of 
drops are naturally bubbles (2.3%); discussion of how to make sure eyes are completely open, 
and looking straight up (2.3%); how to deal with different bottles (2.3%); and to remove Visine 
because it is not a good eye drop (2.3%). 
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7.4.	Suggestions	for	dissemination	
 Participants’ responses to the question, “How would you want the video to be made 
available?” are shown in Table 7.5. 
 
Table 7.5. Participants’ preferences for dissemination of the video (N=43). 
Response Percent (n) 
On the doctor’s office website 79.1 (34) 
In the waiting room at the doctor’s office 76.7 (33) 
In the exam room at the doctor’s office 76.7 (33) 
On a social media site such as YouTube  74.4 (32) 
On a DVD or flash drive that you could take home 53.5 (23) 
Other 23.3 (10) 
 
The “other” category when asking about patient preferences for dissemination included 
the hospital website (7.0%), through Google or search engines (4.7%), other glaucoma sites 
(4.7%), having the video on its own site (4.7%), and advertising it on TV (2.3%) (Table 7.5). 
Two patients (4.7%) also suggested providing the same information in print format. 
Participants’ responses to the question, “What do you think is the best way to make the 
video available to other glaucoma patients?” are shown in Table 7.6.  
 
Table 7.6. Participants’ first-choice preferences for dissemination of the video (N=43). 
Response Percent (n) 
Doctor’s office exam room 30.2 (13) 
Website (other) 18.6 (8) 
Doctor’s office and online 14.0 (6) 
Social media 7.0 (3) 
DVD/Flash drive 7.0 (3) 
Doctor’s office (unspecified whether exam 
room or waiting room) 
7.0 (3) 
No preference or preferred format other than 
video 
7.0 (3) 
Doctor’s office waiting room 4.7 (2) 
Doctor’s office website 2.3 (1) 
Family member 2.3 (1) 
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The greatest number of participants (30.2%) favored disseminating the video by showing 
it in the exam room. Unlike when allowed multiple options, when patients were asked for the 
best way to make the video available, the exam room was clearly preferred over the waiting 
room, which was selected by only 4.7%. A website (other than social media or the doctor’s 
office website) was the most frequently mentioned option for watching the video outside of the 
doctor’s office. Some patients mentioned that having the video come up first when people typed 
relevant terms into a search engine would maximize dissemination. Several wanted to show it in 
the doctor’s office and also have an online option. Some of these thought that an online option 
would be preferred by younger people, but they personally preferred to see the video in the 
doctor’s office. 
In total, 41.9% endorsed an online option (other website, doctor’s office and online, 
social media, or doctor’s office website), while 55.8% endorsed one of the options that involved 
showing the video in the doctor’s office (exam room, doctor’s office and online, doctor’s office 
unspecified, or waiting room). 
 
7.5.	Summary	
 Patients rated the video highly, with 100% saying they would recommend that others 
watch it, and more than 60% saying it was very useful. Patients most commonly reported that 
they were helped by learning about punctal occlusion, keeping the bottle clean by putting the cap 
on its side, closing the eye after instillation, and mixing the medication without shaking. About 
one-third of patients suggested improving the video by using a real person instead of an 
animation, and about one-third had a suggestion other than the ones on our list. 
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When asked to choose all dissemination options they endorsed, approximately three-
quarters of the patients endorsed each of the top four options: placing the video on social media, 
showing in the doctor’s office waiting room, showing it in the doctor’s office exam room, and 
placing it on the doctor’s office website. However, when patients were asked to choose their top 
choice alone, the doctor’s office exam room was much more popular than the other options. 
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Chapter 8: Discussion 
 This chapter presents our findings in the context of our theoretical model and prior 
literature. It also assesses limitations and strengths of the study, and presents clinical and policy 
implications of the findings. 
 
8.1	Eye	drop	technique	
 Results of eye drop technique assessment prior to intervention were similar to previous 
studies. The number of patients touching the eye or face (38%) was near the middle of the range 
from previous studies,5,9,16-18,50,51,57-59 and the number squeezing out multiple drops (47%) and 
missing the eye (35%) were near the high end of the range previously observed.5,9,16,17,50,51,53,63,66 
The percentage closing the eye after instillation prior to intervention (4%) was much lower than 
in one study that reported that 40% closed the eye correctly,66 but similar to the figure of 3% 
from another study.10 
Immediately after the video, the intervention had a statistically significant positive effect 
on performance of three of the five steps: squeezing the bottle to instill a single drop, holding 
open the lid with the finger, and closing the eye after instillation. At 1 month, not touching the 
eye with the bottle and closing the eye after instillation showed significant between-group 
differences, but the other three steps did not. The remaining steps, including getting the drop in 
the eye at both time points, showed a positive but not statistically significant effect. Power to 
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detect effects on getting the drop in the eye was limited since only about one-third of the 
participants performed this step wrong at baseline. Also, getting the drop in the eye may require 
more significant effort and practice-based skills training for patients to perform this step 
correctly, whereas holding open the lid with the finger and closing the eye are easier to change. 
Similar to our results, both Feng et al. (using an educational video intervention) and McVeigh 
and Vakros (using printed instructions) reported significant improvement in duration of closing 
the eye or duration of duct occlusion, and Feng et al. also reported significant improvement in 
squeezing out a single drop and holding down the lower eyelid to form a pocket, whereas neither 
study found significant improvement in getting the drop in the eye or not touching the eye.10,11 
Lazcano-Gomez et al. did achieve a significant improvement in not touching the eye, but they 
had a very high rate of touching the eye prior to intervention (64.4%) and used a live physician 
education intervention that physicians might not have time to perform in everyday settings.12 
Our results concur with a prior observational study by Carpenter et al. that found no 
association between eye drop technique self-efficacy and eye drop technique, and no evidence 
that self-efficacy mediated the positive relationship between patient-provider communication and 
improved IOP.61 Our study also found that eye drop technique self-efficacy was not significantly 
associated with baseline eye drop technique. Patients may not be aware of how well they 
perform, causing some patients with poor technique to report high self-efficacy. From a 
theoretical perspective, this finding may indicate that focusing on self-efficacy is not as helpful 
when patients do not have an accurate idea of whether they are performing a task correctly. 
However, teaching the skill effectively may be able to improve both self-efficacy and technique. 
The results showed that after adjusting for baseline technique, intervention participants 
performed 0.75 steps better than controls immediately after the video and 0.63 steps better than 
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controls at 1 month. This shows that the positive effect of the video was partially sustained until 
the 1-month time point. To our knowledge, this is the first study to measure the effectiveness of 
an educational intervention for eye drop technique both immediately after the intervention and 1 
month later. McVeigh and Vakros only measured the effect 1 month later, while Feng et al. and 
Lazcano-Gomez et al. only measured the effect immediately after the intervention.10-12  
Most participants did not watch the video again after the baseline visit, so they might 
have additional potential for improvement that could be realized if the video were watched more 
than once (i.e., dose response). Future studies should look at eye drop technique over a longer 
time to try to understand whether patients need to be reassessed and shown the video again. 
Besides the intervention, the other variables that were significant predictors of better eye 
drop technique were baseline technique, baseline self-efficacy (only in the model predicting 
technique immediately after the video), outcome expectations (only in the model predicting 1-
month technique), and not having been previously educated about technique (only in the model 
predicting 1-month technique). Unlike some previous studies,9,16,17,54,56,58,76,81,84,87,89,94,102,103,107 
other patient characteristics such as age, race, and gender, and clinical characteristics such as 
glaucoma severity and arthritis, were not significant predictors of eye drop technique at any time 
point. The apparent negative effect of having been previously educated about technique may be 
an artifact of recall bias in which participants cannot actually remember whether they ever 
received instruction. Providers should probably be skeptical when their patients report having 
received prior instruction on eye drop technique, and should not assume that these patients are 
more proficient at instilling drops.  
Our theoretical model13,73 and prior literature9,16,17,54,56,58,76,81,84,87,89,94,102,103,107 had 
suggested that patient characteristics and clinical characteristics might have more of an effect on 
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eye drop technique, but we did not observe an effect. Therefore, our results suggest that 
theoretical constructs from Social Cognitive Theory, such as self-efficacy and outcome 
expectations, might be more relevant in predicting patients’ eye drop technique than patient or 
clinical characteristics. Sleath et al. found that outcome expectations were associated with better 
electronically monitored adherence in a large observational study.4 The present study suggests 
that outcome expectations also predict eye drop technique. Providers may want to routinely 
assess self-efficacy and outcome expectations to identify patients who are at risk of poor eye 
drop technique. 
 
8.2.	Eye	drop	technique	self-efficacy	
The intervention group had better eye drop technique self-efficacy than the control group 
immediately after the video and at 1 month, after adjusting for the baseline value. Interestingly, 
both groups experienced some improvement immediately after the video, followed by declines in 
both groups at 1 month, although the between-group difference continued to increase, from 0.62 
points immediately after to 0.82 points at 1 month. The decline in both groups at 1 month may be 
because as some patients commented, they did not realize that there was a correct way to 
perform certain steps. Not knowing correct technique would likely have made them 
overconfident at the beginning. Also, participants could have realized after the baseline visit that 
they had problems they had never realized before. For example, they may have realized that they 
touch the eye with the bottle more frequently than they thought. The research assistant did not 
provide feedback on participants’ performance, but the content of the interview questions could 
have inadvertently served as a reminder of what the important steps were. 
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Besides the intervention and baseline self-efficacy, no other covariates qualified for the 
regression models predicting self-efficacy at either time point. Our theoretical model had 
suggested that patient and clinical characteristics might be associated with self-efficacy,13,59,73 
but this association was not observed. Having used drops for a longer time was associated with 
higher baseline self-efficacy, but was not associated with self-efficacy immediately after the 
video nor at 1-month in either bivariate or multivariable analyses. One study by Sleath et al. 
found that eye drop technique self-efficacy was higher in patients who had a longer glaucoma 
disease duration,59 but other studies had found no association between eye drop technique self-
efficacy and patient characteristics or clinical characteristics.9,53,61 
 
8.3.	Discussion	of	medication	adherence	results	
The Meducation video did not have a significant effect on medication adherence. This 
might be because the video did not directly address adherence, because the VAS measure of 
adherence was not as sensitive as non-self-report measures, or because the 1-month timeframe 
was too short to detect a meaningful change. In addition, while potential participants were 
excluded if they had perfect technique, they were not required to have low baseline adherence, 
and the study was not powered on the adherence outcome. Due to ceiling effects, including 
patients who already have good adherence is likely to reduce the ability to detect a change. 
Future studies might assess whether the video could incorporate some discussion of why it is 
important to use medications consistently. Future studies might also benefit from using MEMS® 
caps or pharmacy refill data to assess adherence more objectively than a self-report measure. In 
the previous study by Okeke et al. that successfully used a video to improve medication 
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adherence, the researchers followed patients for 6 months and monitored them electronically 
with the Travatan Dosing Aid.86 
Factors that were associated with better medication adherence at 1 month included female 
gender, younger age, and fewer reported problems with using eye drops. Younger age was only 
significant when adherence was measured with the single-item VAS, while problems with using 
eye drops was only significant when adherence was measured with the new 5-item VAS. Prior 
studies had not reported an effect of gender or problems with using eye drops on adherence, 
although few studies had explicitly measured problems with using eye drops. With regard to age, 
eight of 10 prior studies that found a significant difference suggested that older age was 
associated with better adherence.56,76,81,84,87,89,94,102,103,107 Therefore, our results do not agree with 
the majority of prior studies. With a mean age of 69.2 years, our study population was somewhat 
older than in many other studies. If adherence peaks at a certain age and then declines, we might 
have captured primarily the older part of the population in which age might be negatively 
associated with adherence. Future studies could explore this relationship more thoroughly by 
enrolling a specific number of patients from each age group, and including a squared term in the 
regression model to determine whether there might be a nonlinear association. 
 
8.4	Evaluation	and	dissemination	of	the	video	
8.4.1.	Overall	rating	of	the	video	
 The intervention was well received with a mean rating of usefulness of 3.40 on a 4-point 
scale. In prior studies of eye drop technique educational interventions, patients were only asked 
binary questions about whether they found the intervention useful and whether it made them 
more confident.10,11 In the study of a video intervention by Feng et al., 91% of patients thought 
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the video would help them in administering their drops and 91% felt more confident 
administering their drops as prescribed.10 The ratings of a printed eye drop chart in the study by 
McVeigh and Vakros were lower; 64% said the chart was useful and 60% said it helped them 
deliver their drops correctly.11 
The mean rating of the video was significantly higher in African Americans and in 
patients who had been using eye drops for a shorter time. Previous studies of educational 
interventions for eye drop technique and adherence did not report how ratings of the intervention 
varied by patient characteristics.10,11,110 Our finding is consistent with prior studies that have 
found that African Americans were more interested in learning about glaucoma than patients of 
other races.198,199 In a study of African American glaucoma patients by Sleath et al., 76% of 
survey respondents wanted education on how to use eye drops, and 84% wanted education on 
glaucoma medications in general.199 
 
8.4.2.	How	the	video	helped	patients	
Patients most frequently reported being helped by the video in learning to perform 
punctal occlusion, lay the cap down on its side, mix the medication correctly, and close the eye 
after instillation. Each of these themes was mentioned by more than 25% of the intervention 
group participants. Less frequently, patients also mentioned topics related to the other technique 
steps, such as not touching the eye and getting the drop accurately into the eye. Among the five 
technique steps that we scored, topics related to instilling a single drop were least often 
mentioned. Prior glaucoma eye drop technique intervention studies did not specifically ask 
patients how the intervention had helped them,10,11 so our results add to the literature in this area. 
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8.4.3.	Improving	the	video	
Patients most commonly suggested improving the video by using a real person instead of 
an animation, and a variety of other suggestions. About one-third of the patients wanted a real 
person in the video, such as a doctor self-administering eye drops. On the other hand, adding 
new topics was only supported by 4.7% of patients, and some patients specifically expressed the 
opinion that the video needed to be specific and not address too many different topics. Other 
videos that are more general, such as one that plays in the waiting room at one of our clinics, are 
widely available to provide general information on the nature of glaucoma and how eye drops 
work to stop progression of glaucoma. Our results suggest that this content should be kept 
separate from the Meducation eye drop technique video. 
 
8.4.4.	Disseminating	the	video	
 Most patients endorsed multiple means of disseminating the video, often including both 
online options, such as the doctor’s office website or social media, as well as in-person options, 
such as the doctor’s office waiting room or exam room. When allowed to choose as many 
options as they liked, equal numbers of patients chose the waiting room and the exam room, but 
when asked for their top choice, 30.2% chose the exam room while only 4.7% chose the waiting 
room. Giving patients the video on a DVD or flash drive was generally a less popular option than 
either in-person or online. Therefore, we conclude that the video needs to be disseminated in 
person when the drops are prescribed, most likely in the exam room, and also online in a place 
where patients can easily find it. There was not a great deal of consensus on where the best 
online location was, so it might be worthwhile to provide the video in multiple locations if 
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possible. For example, it could be posted on YouTube but also have links to it from doctor’s 
office websites, hospital websites, and general glaucoma informational websites. 
 In general, our results agree with a prior study by Rosdahl et al. that found that 
ophthalmology patients tend to prefer either one-on-one education from their doctor or materials 
recommended by their doctor.198 Patients seem to trust their doctors to recommend trustworthy 
materials, suggesting that some would not trust a video posted on social media if it was not 
endorsed by their doctor. When doctors do not have time to provide one-on-one education, they 
should make it clear what educational materials they endorse, so that patients may access the 
materials in a way that does not consume the physician’s time. 
 
8.5.	Limitations	
 Some videos of patient technique failed to show certain steps clearly enough to allow 
accurate scoring of technique. Previous studies have also found that capturing all aspects of 
technique perfectly in a video recording is very difficult.9 Sensitivity analyses suggested that the 
results changed little when values were imputed for the missing data, implying that the results 
were quite robust. 
 The study was powered only on the primary eye drop technique outcome. Power to detect 
a difference in secondary outcomes, such as medication adherence and individual technique steps 
such as getting the drop in the eye, was limited. For example, 81.4% of intervention patients and 
71.1% of control patients got the drop in the eye immediately after the video; to have 80% power 
to detect a difference of the observed size at the a=0.05 level, 112 patients per group, or 224 
total patients, would be required. Alternatively, excluding patients who already got the drop in 
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the eye at baseline could increase power to detect a difference without requiring such a large 
sample size. 
 Some patients had been dilated at their visit before we recruited them, which could have 
affected their ability to perform correct technique and also to be accurately tested with the 
REALM. However, being dilated was not significantly associated with baseline technique, and 
being dilated did not meet the criteria for inclusion in the main technique models at either time 
point (immediately after the video or at 1 month). Nonetheless, future studies should attempt to 
conduct the intervention before patients are dilated. In everyday clinical practice, providers 
would want to show the video while patients can see it best, so it is important to test the video 
the same way in research studies. 
 Performing the follow-up visit in a different setting than the baseline visit for many 
patients, such as at home instead of the clinic, could have affected the results. However, control 
group participants performed almost exactly the same immediately after the video and at 1 
month, suggesting that the setting did not have a large influence. 
Asking certain questions in interview style may have resulted in biased responses. About 
half the baseline visits and a significant minority of the follow-up visits were conducted by the 
principal investigator rather than by a research assistant who did not know the study hypotheses. 
Some questions also may have had fairly high levels of recall bias, such as whether anyone had 
previously educated the patient about technique. Many participants said they could not 
remember, but they presumed that someone must have educated them back when they first 
started using drops many years ago. The design of the interview did not allow for an “unsure” 
response to this question, so some participants may have incorrectly been counted as having 
received prior education. Asking the questions in interview style also could explain the 
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discrepancy where equal numbers of patients endorsed the waiting room and the exam room 
when allowed to choose multiple options, but many more patients preferred the exam room when 
only a single option was allowed. On the multiple-option question, “waiting room” preceded 
“exam room” and therefore some patients might have endorsed “waiting room” who would not 
have done so if they had already known “exam room” would be the next option. Social 
desirability bias may have affected answers to questions such as, “How useful was the video to 
help you learn to use your eye drops?” 
A few patients were not able to complete the REALM due to poor vision, and others may 
have been misclassified as low literate if they were having difficulty with their vision when 
tested. Years of education was strongly correlated with REALM score, so we used years of 
education in place of REALM, and it was not strongly correlated with any of the main outcomes. 
Prior studies have also found that years of education is strongly associated with health literacy as 
measured with the REALM; for example, in a study by Marks et al., the correlation was 
0.55.200,201 However, some patients who have relatively little experience with the healthcare 
system and medical terminology might have low health literacy despite high overall education, 
while some patients with relatively little schooling might have learned medical terminology well 
and perform well on the REALM. 
The population came from a limited number of physicians in just two clinics, and had a 
high average educational level of almost a bachelor’s degree. Although the video was designed 
to explain eye drop technique in simple terminology, we cannot be sure from our results that the 
video would be highly effective in less educated patients. To overcome this limitation, future 
studies should enroll at a greater number of sites, and enroll at least a certain minimum number 
of patients with only a high school education or less. Also, we only enrolled English-speaking 
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patients and only tested the English version of the video, because we did not have the staff 
needed to administer the interview in languages other than English. Future studies should test the 
Meducation video in multiple languages. The video was also accessible outside of the clinic only 
for patients with Internet access.  
The randomization did not balance the covariates exactly between groups. As a result, the 
intervention group was 61% male and had better baseline self-efficacy than the control group, so 
the evaluation and dissemination results may not be as representative of the opinions of women 
or patients with lower self-efficacy. However, gender was not significantly associated with any 
of the self-efficacy or technique outcomes, so the imbalance in gender between the groups had 
little effect on the estimates of effect of the intervention. We tried including gender in each 
model to see if it affected the estimate associated with the intervention by more than 10%, but 
this method only resulted in including gender in the adherence model, where there was no 
significant effect of the intervention regardless of whether gender was included. To minimize 
bias resulting from imbalance in demographics or self-efficacy between groups, future studies 
could also ask the control group to watch the video after completing all study measurements, and 
then ask for their feedback. Some control group patients did ask to watch the Meducation video 
at the end of their 1-month visit and spontaneously provided feedback, but we did not record or 
analyze their comments. 
The patient refusal rate of 32% for participating in the study was relatively high. 
However, patients who refused to participate were similar in race and gender to patients who 
agreed to participate. The refusal rate is not expected to mean that it would be hard to implement 
the intervention in an actual clinic setting, since patients had to spend 30 minutes at baseline and 
 174 
about 15 minutes at follow-up to participate in the study, but would only need to take 4 minutes 
to watch the video in everyday practice. 
The study did not measure clinical outcomes such as intraocular pressure. Future studies 
should seek to determine how intraocular pressure may improve when patients are more 
successful in instilling their drops correctly. Few studies so far have measured the association 
between eye drop technique and IOP. The large observational study by Carpenter et al. suggested 
no significant association,61 but another study by Ikeda et al. suggested that IOP was more likely 
to be lowered at follow-up if patients applied the drops accurately, removed excess fluid 
correctly, and had better knowledge of instillation technique at follow-up.66 Ikeda’s study did not 
state the correlation between total technique score and IOP, however. 
Patients used a standardized bottle of artificial tears that could be different in size or 
shape from the eye drop bottle they use at home. Patients might have had more trouble using a 
bottle they were not accustomed to, but some also could have had better technique with the 
artificial tears since some patients mentioned that one of their glaucoma eye drop bottles was 
particularly hard to squeeze correctly. Future studies could test whether patients have similar eye 
drop technique when using their usual bottle compared to the standardized bottle that we used in 
this study. 
Each patient’s technique was assessed by only one masked assessor. In future studies, 
having multiple masked assessors score each technique video would increase confidence about 
whether steps were performed correctly or incorrectly. 
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8.6.	Strengths	
 Unlike many prior studies which assessed only three steps, this study assessed five eye 
drop technique steps. Many participants showed improvement in holding open the lid with the 
finger and keeping the eye closed after instillation, steps that had not been assessed in most 
previous studies. 
 Statistical power was more than adequate to detect a significant effect for the primary 
outcome, even with some missing data on the primary outcome. The results regarding self-
efficacy and eye drop technique were robust despite missing data. 
The study population featured strong representation of African Americans, patients with 
moderate to severe glaucoma, and patients with complex regimens of multiple medications. It 
included significant numbers of patients with both high and low levels of using Internet and 
mobile technology. This suggests that the intervention can be effective for patients at multiple 
different levels of technological literacy. 
Unlike many other studies, this study provided extensive information on patients’ 
perspectives regarding how to improve the video and how to disseminate it to other glaucoma 
patients. 
 
8.7.	Clinical	implications	
 The study results suggest that showing a short video when patients are first prescribed 
eye drops is likely to improve their technique significantly. Even patients who have used drops 
for many years should not be assumed to have good technique. Every glaucoma patient should be 
periodically assessed for eye drop technique and given education if they do not have good 
technique. When new patients come to a clinic, they may say they have received previous 
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education on technique, but since we found that patients who reported prior education on 
technique actually had worse technique, it is probable that these patients still need further 
technique instruction. Giving patients a link to view the video online is helpful for Internet-savvy 
patients who understand that they need to view the video multiple times, but for patients with 
limited access to technology, it may be necessary to show the video again at future visits or 
provide a video on a DVD or flash drive that can be viewed offline. For patients who still cannot 
instill drops correctly after repeated education on technique, it may be best to have another 
person instill the patient’s drops, or a treatment other than eye drops should potentially be 
considered. In line with the pharmacist’s responsibility to provide counseling on medications 
being dispensed, and recognizing that many physicians are not currently providing sufficient eye 
drop technique instruction, pharmacists should also be prepared to provide education, either live 
or using a video, whenever they see patients who are newly prescribed eye drops. 
 
8.8.	Policy	implications	
This study helped to determine how much a short online educational video can help to 
provide eye drop technique education without taking a great deal of the provider’s time. The 
intervention is very easy to disseminate, low-cost, and expected to be valuable to all glaucoma 
patients who administer their own eye drops. It is also very easy for clinicians to provide at their 
practices without any significant time burden, showing that it is high in both feasibility and 
sustainability. Patients who learn to use their eye drops correctly may not only avoid loss of 
vision, but also avoid eye infections from contaminated bottles and systemic side effects from 
systemic absorption of medication. Costs to both the healthcare system and society may be 
reduced, since patients with better technique would waste less medication and likely achieve 
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better intraocular pressure control. Future work should explore provider perceptions of how the 
video could be integrated into their practice workflows. 
Based on the success of our intervention, payers and policymakers can encourage the 
inclusion of online videos in routine ophthalmological care and promote development of 
additional videos about other tasks that patients struggle with, such as remembering to take 
medication on schedule. The intervention can potentially be used worldwide due to its 
availability in 21 languages and accessibility on mobile platforms. Completion of this study has 
also shown that other interventions may be needed to effectively address medication adherence. 
These interventions may use a similar approach, but should address the importance of adherence 
directly, and describe ways that patients can remember to take their medications on schedule. 
Health insurance benefit plans now have an interest in maximizing patient adherence to improve 
their reputations and earn 5-star ratings from Medicare, so they are interested in knowing what 
type of intervention can effectively improve adherence. Large healthcare systems, such as 
academic medical centers and accountable care organizations, are also interested in improving 
their quality ratings and reputations, and should implement effective medication technique and 
adherence interventions. In summary, the intervention could have a very significant effect on 
patients’ ability to use eye drops successfully, thus preventing blindness and adverse 
consequences associated with blindness. 
 
8.9.	Conclusion	
 This study demonstrated the value of an online educational video intervention to improve 
eye drop technique in adult patients with primary open-angle glaucoma. It also confirmed that 
patients are interested in seeing the video disseminated in medical offices nationwide, as well as 
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online through multiple types of websites. To our knowledge, this is the first randomized 
controlled trial of an educational intervention to improve glaucoma eye drop technique. It 
confirms the results of past studies that found that educational materials either in the form of 
print, videos, or live in-person education were able to significantly improve glaucoma eye drop 
technique.10-12 The intervention did not significantly improve medication adherence, but future 
studies should test videos that are more directly focused on adherence. These studies should use 
electronic monitoring and follow patients over a longer timeframe. 
Future studies should test the Meducation eye drop technique video in other populations 
and other eye diseases in which eye drops are used, such as other types of glaucoma, dry eye, 
and allergies. Our population was mostly highly-educated and presumably affluent, while other 
studies could test the video in disadvantaged communities and populations who face language 
barriers. Future studies should also test other Meducation videos related to other medications 
where patients have difficulty with correct technique, such as injectable insulin, injectable 
biologics, topical creams, and rectal suppositories. High-quality, theory-based randomized 
controlled trials using objective outcome measures are recommended to demonstrate the value of 
these educational interventions. Implementing effective technique education interventions across 
many disease areas could permit the achievement of better outcomes with the same medications 
that are already available. Thus, the gap between efficacy and real-world effectiveness could be 
significantly narrowed.  
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APPENDICES 
APPENDIX	A:	ELIGIBILITY	SCREENER	
ELIGIBILITY SCREENER FOR Meducation: A Randomized Controlled Trial of an 
Online Educational Video Intervention to Improve Glaucoma Eye Drop Technique and 
Adherence 
 
Patient Inclusion Criteria 
1. Are you at least 18 years of age? 
1 Yes - CONTINUE WITH Q #2 
0 No – STOP, EXPLAIN, THANK 
 
2. Do you speak and read English? 
1 Yes - CONTINUE WITH Q #3 
0 No – STOP, EXPLAIN, THANK 
 
3. Have you been diagnosed with primary open-angle glaucoma? 
1 Yes - CONTINUE WITH Q #4 
0 No – STOP, EXPLAIN, THANK 
 
4. Have you ever been diagnosed as legally blind? 
1 Yes – STOP, EXPLAIN, THANK 
0 No – CONTINUE WITH Q #5 
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5. Are you taking at least one eye drop medication for glaucoma? 
1 Yes - CONTINUE WITH Q #6 
0 No – STOP, EXPLAIN, THANK 
 
6. Do you administer your own eye drops? 
1 Yes - CONTINUE WITH Q #7 
0 No – STOP, EXPLAIN, THANK 
 
MENTAL STATUS QUESTIONNAIRE 
7a. What is the name of this place? ___________________ 
b. Where is it located (address)? ___________________ 
c. What is today’s date? ____________________ 
d. What is the month now? ____________________ 
e. What is the year? ______________________ 
f. How old are you? ______________________ 
g. When were you born (month)? __________________ 
h. When were you born (year)? _____________________ 
i. Who is the president of the United States? __________________ 
j. Who was the president before him? ____________________ 
 
Number of errors made on Mental Status Questionnaire: _____________ 
(Patient is ineligible if they make at least 5 errors on the Mental Status Questionnaire.) 
Estimated technique score: ____ of 5 
The technique steps are listed below. Patients are ineligible if they correctly perform ALL of the following: 
• Squeezing the bottle to instill a single drop 
• Holding open the lid with the finger  
• Getting the drop accurately into the eye 
• Not touching the bottle tip to the eye or face 
• Closing the eye after instillation 
 
 181 
IF ELIGIBLE, CONTINUE with interview. 
 
 
IF NOT ELIGIBLE, STOP, explain, and thank them for their time. 
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APPENDIX	B:	BASELINE	PATIENT	INTERVIEW	
PATIENT INTERVIEW 
(Baseline) 
1.  Do you think you got the eye drop in your eye? 
 1 Yes 
 0 No 
 
2. How confident are you that you can carry out the following tasks?                         
         
 Not at all 
confident 
Somewhat 
confident 
Very 
confident 
a. Squeezing your eye drop bottle(s)? 1 2 3 
b. Getting the medication drop(s) in your eye? 1 2 3 
c. Consistently getting the right amount of eye drop medication 
in your eye each time you use it? 
1 2 3 
d. Correctly angling your head to accurately apply the eye 
drops? 
1 2 3 
e. Delivering the required amount of your eye drops to the eye 
without missing or applying too much medication? 
1 2 3 
f. Not touching your eye with the eye drop bottle? 1 2 3 
 
3. All things considered, how much of the time do you use ALL of your glaucoma  
       medications EXACTLY as directed?  
       (Interviewer: Please have the patient place a mark on the line) 
 
          
       Place a mark ( | ) anywhere on the line below to indicate your answer.  
 
 
       None of the time _______________________________________________ All of the time 
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Demographics 
 
 
  
4. In which eye do you have glaucoma? 
 1 Left 
 2 Right 
 3 Both 
 
5.  How old are you? 
 
 |___|___| years 
 
6. Please indicate whether you are male or female. (Choose only one) 
 
 1 Male 
 2 Female 
 
7. Which of the following best describes your race? (You may select more than one 
category.) 
 
 a American Indian or Alaskan Native 
 b Asian 
 c Black or African American 
 d Native Hawaiian or other Pacific Islander 
 e White 
 f Other: 7g. specify  
 
8. Are you Hispanic or Latino(a)? (Check one) 
 
 1 Yes 
 0 No 
 
9.   How many years of schooling have you completed?  
 
 |___||___| Years 
      
 
10. How long have you used eye drops for your glaucoma? 
 
 |___||___| Years 
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11. Generally speaking, how comfortable do you feel using the Internet? 
 4 Very comfortable 
 3 Somewhat comfortable 
 2 Not very comfortable 
 1 Not at all comfortable 
 
12. How often do you use the Internet? 
 5 Once or more a day 
 4 A few times a week 
 3 A few times a month 
 2 Hardly ever 
 1 Never  
 
13. Do you own a cell phone? 
 1 Yes 
 0 No (SKIP TO #14) 
 
14. Do you use your cell phone to go on the Internet? 
 1 Yes 
 0 No 
 
15. Do you use any other Internet capable devices (iPads, tablets, desktop or laptop 
computers)? 
 1 Yes (please specify: _____________________________________) 
 0 No 
 
16. Do you have Internet access in your home? 
 1 Yes 
 0 No 
 
17. Have you ever used the Internet to learn more about glaucoma? 
 1 Yes 
 0 No 
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18. How much do you think it will help your glaucoma if you come to your appointments 
with your eye doctor?  
 
    Not at all                  Somewhat                                         Extremely 
  
 1 2 3 4 5 6 7 8 9
   
 
19. How much do you think it will help your glaucoma if you use your eye drops regularly? 
 
    Not at all                  Somewhat                                         Extremely 
  
 1 2 3 4 5 6 7 8 9
   
 
 
20. How much do you think it will help your vision if you come to these appointments with 
your eye doctor? 
 
    Not at all                  Somewhat                                         Extremely 
  
 1 2 3 4 5 6 7 8 9
   
 
21. How much do you think it will help your vision if you use your eye drops regularly?  
 
    Not at all                  Somewhat                                         Extremely 
  
 1 2 3 4 5 6 7 8 9 
 
 
22. For each question below, please place a mark ( | ) anywhere on the line below to indicate 
your answer. (Interviewer: Please have the patient place a mark on the line) 
 
a. How often do you miss taking your eye drops because you forget? 
 
       Never _______________________________________________ A lot 
 
b. How often do you miss taking your eye drops because they cause side effects? 
 
       Never _______________________________________________ A lot 
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c. How often do you miss taking your eye drops because they are too expensive? 
 
       Never _______________________________________________ A lot 
 
d. How often do you miss taking your eye drops because you run out of eye drops 
before you can get a refill? 
 
       Never _______________________________________________ A lot 
 
e. How often do you miss taking your eye drops because they are hard to use? 
 
       Never _______________________________________________ A lot 
 
 
23. How much problem or concern, if any, are you having in the following areas?   
 
 None A little A lot 
 a.  My medication causes side effects 0 1  2 
 b. It is hard to remember all the doses 0 1  2 
 c. It is hard to pay for the medications 0 1  2 
 d. It is hard to get the plastic seal off a new bottle 0 1  2 
 e. It is hard to open the container 0 1  2 
 f. It is hard to get my refills on time  0 1  2 
 g. It is hard to read the print on the container 0 1  2 
 h. The dosage times are inconvenient 0 1  2 
 i. It is hard to get the drops in my eye 0 1  2 
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 None A little A lot 
 
 j. I cannot tell if the drops get into my eye(s) 0 1 2 
 
 k. Too many drops come out at the same time 0 1  2 
 l. Drops fall on cheeks 0 1  2 
 m. It is hard to squeeze the bottle 0 1  2 
 n.  My medication causes other problems or concerns 0 1  2 
  If other problems or concerns explain:_______________________________ 
 
 
24. Please rate the amount of difficulty you have had with each of the following activities: 
 
 None A little A moderate 
amount 
A great 
deal 
Unable to 
do 
a. Reading small print 4 3 2 1 0 
b. Reading a newspaper or book 4 3 2 1 0 
c. Reading a large-print book or 
newspaper 
4 3 2 1 0 
d. Recognizing people when they 
are close to you 
4 3 2 1 0 
e. Seeing steps, stairs or curbs 4 3 2 1 0 
f. Reading traffic, street, or store 
signs 
4 3 2 1 0 
g. Doing fine handiwork such as 
sewing, knitting, crocheting, or 
carpentry 
4 3 2 1 0 
h. Writing checks or filling out 
forms 
4 3 2 1 0 
i. Playing games such as bingo, 
dominos, card games, or mahjong 
4 3 2 1 0 
j. Taking part in sports such as 
bowling, handball, tennis, or golf 
4 3 2 1 0 
k. Cooking 4 3 2 1 0 
l. Watching television 4 3 2 1 0 
m. Driving during the day 4 3 2 1 0 
n. Driving at night 4 3 2 1 0 
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25. Has anyone ever shown you how to use your glaucoma eye drops before? 
 1 Yes 
 0 No (SKIP TO #26) 
 
 
 25a. Who showed you how to use glaucoma eye drops? (Check all that apply) 
  1 Doctor 
  2 Pharmacist 
  3 Ophthalmic technician 
  4 Other, specify: _____________________________ 
 
 
26. Have your eyes been dilated today? 
 1 Yes 
 0 No  
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Date ___/____/_______             Start _____ End ______                  
STUDY ID # ___ ___ ___ ___ 
REALM 
27. Please read as many words as you can from this list. Begin with the first word on List 1 
and proceeding down the list reading aloud. Then proceed with the words on List 2 and 
then List 3. When you come to a word that you cannot read, do the best you can or say 
“blank” and go on to the next word. 
List 1 List 2 List 3 
Fat Fatigue Allergic 
Flu Pelvic Menstrual 
Pill Jaundice Testicle 
Dose Infection Colitis 
Eye Exercise Emergency 
Stress Behavior Medication 
Smear Prescription Occupation 
Nerves Notify Sexually 
Germs Gallbladder Alcoholism 
Meals Calories Irritation 
Disease Depression Constipation 
Cancer Miscarriage Gonorrhea 
Caffeine Pregnancy Inflammatory 
Attack Arthritis Diabetes 
Kidney Nutrition Hepatitis 
Hormones Menopause Antibiotics 
Herpes Appendix Diagnosis 
Seizure Abnormal Potassium 
Bowel Syphilis Anemia 
Asthma Hemorrhoids Obesity 
Rectal Nausea Osteoporosis 
Incest Directed Impetigo 
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RAPID ESTIMATE OF ADULT LITERACY IN MEDICINE 
(REALM)© 
Terry Davis, PhD  •  Michael Crouch, MD  •  Sandy Long, PhD 
 
 Reading 
 Level   
  
 Grade 
Subject #     Completed    
  
Date   Clinic    Examiner   
 
 
 
List 1 
fat   
flu   
pill   
dose   
eye   
stress   
smear   
nerves   
germs   
meals   
disease   
cancer   
caffeine   
attack   
kidney   
hormones   
herpes   
seizure   
bowel   
asthma   
rectal   
incest   
 
 
 
 
 
List 2 
fatigue   
pelvic   
jaundice   
infection   
exercise   
behavior   
prescription   
notify   
gallbladder   
calories   
depression   
miscarriage   
pregnancy   
arthritis   
nutrition   
menopause   
appendix   
abnormal   
syphilis   
hemorrhoids   
nausea   
directed    
    
 
 
 
 
 
List 3 
allergic   
menstrual   
testicle   
colitis   
emergency   
medication   
occupation   
sexually   
alcoholism   
irritation   
constipation   
gonorrhea   
inflammatory   
diabetes   
hepatitis   
antibiotics   
diagnosis   
potassium   
anemia   
obesity   
osteoporosis   
impetigo    
    
 
SCORE 
List 1   
List 2   
List 3   
Raw Score   
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END OF BASELINE VISIT AFTER WATCHING VIDEO 
28.  How confident are you that you can carry out the following tasks?                         
         
 Not at all 
confident 
Somewhat 
confident 
Very 
confident 
a. Squeezing your eye drop bottle(s)? 1 2 3 
b. Getting the medication drop(s) in your eye? 1 2 3 
c. Consistently getting the right amount of eye drop medication 
in your eye each time you use it? 
1 2 3 
d. Correctly angling your head to accurately apply the eye 
drops? 
1 2 3 
e. Delivering the required amount of your eye drops to the eye 
without missing or applying too much medication? 
1 2 3 
f. Not touching your eye with the eye drop bottle? 1 2 3 
 
 
 
AFTER SECOND TIME DEMONSTRATING TECHNIQUE 
29.  Do you think you got the eye drop in your eye? 
 1 Yes 
 0 No 
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APPENDIX	C:	1-MONTH	PATIENT	INTERVIEW	
PATIENT INTERVIEW 
(1-Month Follow-Up) 
1.  How confident are you that you can carry out the following tasks?                         
         
 Not at all 
confident 
Somewhat 
confident 
Very 
confident 
a. Squeezing your eye drop bottle(s)? 1 2 3 
b. Getting the medication drop(s) in your eye? 1 2 3 
c. Consistently getting the right amount of eye drop medication 
in your eye each time you use it? 
1 2 3 
d. Correctly angling your head to accurately apply the eye 
drops? 
1 2 3 
e. Delivering the required amount of your eye drops to the eye 
without missing or applying too much medication? 
1 2 3 
f. Not touching your eye with the eye drop bottle? 1 2 3 
 
2. All things considered, how much of the time do you use ALL of your glaucoma  
       medications EXACTLY as directed?  
       (Interviewer: Please have the patient place a mark on the line) 
 
          
       Place a mark ( | ) anywhere on the line below to indicate your answer.  
 
 
       None of the time _______________________________________________ All of the time 
 
 
3. How much do you think it will help your glaucoma if you come to your appointments 
with your eye doctor?  
 
    Not at all                  Somewhat                                         Extremely 
  
 1 2 3 4 5 6 7 8 9
   
 
4. How much do you think it will help your glaucoma if you use your eye drops regularly? 
 
    Not at all                  Somewhat                                         Extremely 
  
 1 2 3 4 5 6 7 8 9
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5. How much do you think it will help your vision if you come to these appointments 
with your eye doctor? 
 
    Not at all                  Somewhat                                         Extremely 
  
 1 2 3 4 5 6 7 8 9
   
 
6. How much do you think it will help your vision if you use your eye drops regularly?  
 
    Not at all                  Somewhat                                         Extremely 
  
 1 2 3 4 5 6 7 8 9 
 
7. For each question below, please place a mark ( | ) anywhere on the line below to indicate 
your answer. (Interviewer: Please have the patient place a mark on the line) 
 
a. How often do you miss taking your eye drops because you forget? 
 
       Never _______________________________________________ A lot 
 
b. How often do you miss taking your eye drops because they cause side effects? 
 
       Never _______________________________________________ A lot 
 
c. How often do you miss taking your eye drops because they are too expensive? 
 
       Never _______________________________________________ A lot 
 
d. How often do you miss taking your eye drops because you run out of eye drops 
before you can get a refill? 
 
       Never _______________________________________________ A lot 
 
e. How often do you miss taking your eye drops because they are hard to use? 
 
       Never _______________________________________________ A lot 
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8. Please rate the amount of difficulty you have had with each of the following activities: 
 
 None A little A moderate 
amount 
A great 
deal 
Unable to 
do 
a. Reading small print 4 3 2 1 0 
b. Reading a newspaper or book 4 3 2 1 0 
c. Reading a large-print book or 
newspaper 
4 3 2 1 0 
d. Recognizing people when they 
are close to you 
4 3 2 1 0 
e. Seeing steps, stairs or curbs 4 3 2 1 0 
f. Reading traffic, street, or store 
signs 
4 3 2 1 0 
g. Doing fine handiwork such as 
sewing, knitting, crocheting, or 
carpentry 
4 3 2 1 0 
h. Writing checks or filling out 
forms 
4 3 2 1 0 
i. Playing games such as bingo, 
dominos, card games, or mahjong 
4 3 2 1 0 
j. Taking part in sports such as 
bowling, handball, tennis, or golf 
4 3 2 1 0 
k. Cooking 4 3 2 1 0 
l. Watching television 4 3 2 1 0 
m. Driving during the day 4 3 2 1 0 
n. Driving at night 4 3 2 1 0 
 
9. Has anyone shown you how to use glaucoma eye drops since we last met? 
 1 Yes 
 0 No 
 
 9a. Who showed you how to use glaucoma eye drops? (Check all that apply) 
  1 Doctor 
  2 Pharmacist 
  3 Ophthalmic technician 
  4 Other, specify: _____________________________ 
 
 
AFTER PATIENT DEMONSTRATES TECHNIQUE 
10.  Do you think you got the eye drop in your eye? 
 1 Yes 
 0 No 
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(ASK THE REMAINING QUESTIONS FOR INTERVENTION PATIENTS 
ONLY) 
11. With whom have you watched the video since we last met? (Check all that apply) 
1      Family member 
       2      Friend 
       3      Healthcare provider 
       4      Other, specify 11a. ________________________ 
       5      No one 
 
12. Would you recommend that other patients with glaucoma watch the video? 
      0      No 
      1      Yes 
 
13. How useful was the video to help you learn to use your eye drops? 
      1      Not at all useful 
      2      A little useful 
      3      Fairly useful 
      4      Very useful 
 
  
 
14. In what ways did the video help you? 
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15. How could the video be improved? (Check all that apply) 
1      Make it easier to view on my phone 
       2      Explain the steps differently 
       3      Use a real person instead of an animation 
       4      Add other topics 
       5      Other, specify 15a. __________________________________ 
 
 
16. How would you want the video to be made available? (Check all that apply) 
1      On a social media site such as YouTube 
       2      In the waiting room at the doctor’s office 
       3      In the exam room at the doctor’s office 
       4      On the doctor’s office website 
       5      On a DVD or flash drive that I could take home 
       6      Other, specify 16a. __________________________________ 
 
 
17. What do you think is the best way to make the video available to other glaucoma 
patients? 	
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